Top 100 Companies in the Genetics space
Ecologie is an insect food research and development company that focuses on crickets. The company is based in Tokyo, Japan.
Business Model: unknown
Revenue: 0 - 100000
Employees:
Industry: Genetics
Invitae is a California-based medical genetics company that develops and supplies genetic diagnostic kits for the healthcare industry.
Business Model: unknown
Revenue: 520M
Employees: 3k
Industry: Genetics
54gene is a Nigeria-based health technology platform that offers services such as genetic testing and molecular diagnostics for patients and physicians.
Business Model: unknown
Revenue: 3.2M
Employees: 100
Industry: Genetics
Natera is a medical diagnostics company that provides preconception, prenatal genetic testing, and counseling services.
Business Model: unknown
Revenue: 776M
Employees: 2.7k
Industry: Genetics
Helix is a California-based biotechnology company that provides genomic research, DNA sequencing, and related solutions for the medical sector.
Business Model: unknown
Revenue: 10M
Employees: 150
Industry: Genetics
GenapSys is a California-based biotechnology company that develops and commercializes genome DNA sequencing, CMOS detectors, and related products for the healthcare sector.
Business Model: unknown
Revenue: 6.3M
Employees: 102
Industry: Genetics
10X Genomics develops genome sequencing software and hardware products that enable researchers to discover inaccessible genomic information.
Business Model: unknown
Revenue: 497.9M
Employees: 1.2k
Industry: Genetics
Syros is a Massachusetts-based biopharmaceutical company that develops and commercializes small-molecule gene therapeutics for the treatment of cancer and genetic diseases.
Business Model: unknown
Revenue: 23.4M
Employees: 120
Industry: Genetics
Prenetics is a Hong Kong-based laboratory that provides services including genetics and diagnostic health testing for healthcare organizations.
Business Model: unknown
Revenue: 275.9M
Employees: 12
Industry: Genetics
BillionToOne is a California-based genetic testing platform that provides solutions such as molecular diagnostics and cancer detection for the healthcare industry.
Business Model: unknown
Revenue: 20M
Employees: 150
Industry: Genetics
CRISPR is a gene-editing company that develops and commercializes gene-based medicines for the treatment of serious diseases.
Business Model: unknown
Revenue: 2M
Employees: 473
Industry: Genetics
Verve is a Massachusetts-based biotechnology company that develops and commercializes gene editing medicines for the treatment of heart diseases.
Business Model: unknown
Revenue: 929k
Employees: 110
Industry: Genetics
Precision is a North Carolina-based biotechnology firm that develops and commercializes immuno-oncology therapeutics for the treatment of cancer.
Business Model: unknown
Revenue: 20.8M
Employees: 200
Industry: Genetics
HLI develops a precision health intelligence platform that offers risk analysis reports on cardiac, cancer and metabolic disorders to physicians.
Business Model: unknown
Revenue: 35M
Employees: 150
Industry: Genetics
NeoGenomics is a Florida-based clinical laboratory that provides services including oncology genetic testing, contract research and drug development for physicians.
Business Model: unknown
Revenue: 496.8M
Employees: 2k
Industry: Genetics
Mission Bio is a California-based genomics platform developer that offers single-cell DNA and multi-omics analysis solutions to researchers and clinicians.
Business Model: unknown
Revenue: 6.4M
Employees: 120
Industry: Genetics
bluebird is a Massachusetts-based biotechnology company that discovers and develops gene therapies for the treatment of genetic diseases.
Business Model: unknown
Revenue: 5.1M
Employees: 520
Industry: Genetics
Alector develops and commercializes antibody therapeutics for the treatment of cancer and neurodegenerative diseases.
Business Model: unknown
Revenue: 133.2M
Employees: 240
Industry: Genetics
Deepcell is a California-based AI-powered imaging and microfluidics platform that identifies and isolates viable cells for diagnostic testing and therapeutic applications.
Business Model: unknown
Revenue: 3.2M
Employees: 55
Industry: Genetics
Biotia is a New York-based health-tech company that provides solutions such as AI-driven genome sequencing and drug discovery for the healthcare industry.
Business Model: unknown
Revenue: 2.2M
Employees: 25
Industry: Genetics
Element Biosciences is a California-based DNA sequencing platform that provides genome analysis, data insights and related solutions to scientists.
Business Model: unknown
Revenue: 4.5M
Employees: 140
Industry: Genetics
Berkeley Lights is a California-based digital cell biology company that develops and commercializes cellular therapies and biopharmaceuticals for the healthcare sector.
Business Model: unknown
Revenue: 87M
Employees: 290
Industry: Genetics
Tessera is a Massachusetts-based biotechnology company that develops and commercializes genome-based therapeutics for the treatment of genetic diseases.
Business Model: unknown
Revenue: 5M
Employees: 250
Industry: Genetics
Beam Therapeutics develops precision medicines through base editing technology to treat genetic diseases.
Business Model: unknown
Revenue: 92M
Employees: 410
Industry: Genetics
Moderna is a Massachusetts-based biotechnology company that researches and develops messenger mRNA therapeutics to treat diseases such as cardiovascular and auto-immune.
Business Model: unknown
Revenue: 21.4B
Employees: 3k
Industry: Genetics
Editas Medicine is a Massachusetts-based biotechnology company that develops and commercializes gene-edited therapeutics for the treatment of ocular diseases and cancer.
Business Model: unknown
Revenue: 25.6M
Employees: 260
Industry: Genetics
Karius develops a genome sequencing platform that detects and identifies microorganisms and pathogens.
Business Model: unknown
Revenue: 12.5M
Employees: 90
Industry: Genetics
Colossal is a Texas-based genetic engineering company that offers solutions such as extinct species restoration and research for bioscience applications.
Business Model: unknown
Revenue: 2M
Employees: 48
Industry: Genetics
Oryzon develops and commercializes epigenetic therapies for the treatment of oncology and neurodegenerative diseases.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Genetics
REGENXBIO research and develops adeno-associated viral gene therapies for treatment of lysosomal storage disorders and ocular diseases.
Business Model: unknown
Revenue: 483.4M
Employees: 370
Industry: Genetics
Generation Bio is a biotechnology company that researches and develops gene therapies for the treatment of skeletal muscle diseases and eye disorders.
Business Model: unknown
Revenue: 0 - 100000
Employees: 150
Industry: Genetics
AGTC is a Florida-based biotechnology company that researches and develops gene therapies for the treatment of ocular diseases.
Business Model: unknown
Revenue: 325k
Employees: 100
Industry: Genetics
Legacy is a Massachusetts-based digital fertility clinic that designs and manufactures sperm testing and freezing kits for the healthcare sector.
Business Model: unknown
Revenue: 1.1M
Employees: 20
Industry: Genetics
MedGenome is an India-based genomic diagnostics and research company that provides genetic testing and drug discovery solutions for clinicians.
Business Model: unknown
Revenue: 20.3M
Employees: 501
Industry: Genetics
Sarepta develops and commercializes ribonucleic acid targeted therapeutics for the treatment of neuromuscular diseases.
Business Model: unknown
Revenue: 876M
Employees: 840
Industry: Genetics
Entrada Therapeutics is a Massachusetts-based biotechnology company that researches and develops novel therapeutics for the treatment of neuromuscular diseases.
Business Model: unknown
Revenue: 0 - 100000
Employees: 120
Industry: Genetics
Orchard is a biopharmaceutical company that develops and commercializes gene therapies for the treatment of inherited diseases.
Business Model: unknown
Revenue: 16.9M
Employees: 259
Industry: Genetics
Oxford Nanopore is an England-based biotechnology company that provides solutions including gene analysis, DNA sequencing and testing for medical research centers.
Business Model: unknown
Revenue: 180.4M
Employees: 705
Industry: Genetics
Fulcrum is a Massachusetts-based biotechnology company that develops and commercializes small molecule therapies for the treatment of genetic diseases.
Business Model: unknown
Revenue: 10.7M
Employees: 100
Industry: Genetics
L7 Informatics is a Texas-based enterprise science platform that offers data intelligence solutions for life sciences and healthcare organizations.
Business Model: unknown
Revenue: 5M
Employees: 90
Industry: Genetics
Scipher Medicine is a Massachusetts-based precision immunology company that discovers and develops novel therapeutics for the treatment of autoimmune diseases.
Business Model: unknown
Revenue: 5M
Employees: 120
Industry: Genetics
Centogene is a Germany-based biochemical research company that provides genetic diagnostics and medical testing services for the treatment of hereditary diseases.
Business Model: unknown
Revenue: 264.1M
Employees: 530
Industry: Genetics
Denali is a California-based biotechnology company that develops molecular therapeutics for the treatment of neurodegenerative diseases.
Business Model: unknown
Revenue: 110.9M
Employees: 390
Industry: Genetics
Verge Genomics is a California-based AI drug discovery platform that generates human sample-based proprietary datasets to develop novel drugs for neurodegenerative disorders.
Business Model: unknown
Revenue: 6M
Employees: 32
Industry: Genetics
NGM Bio is a clinical stage biopharmaceutical company that develops biologic drugs for the treatment of cardio-metabolic and liver disease.
Business Model: unknown
Revenue: 58.1M
Employees: 220
Industry: Genetics
Sophia Genetics is a Switzerland-based healthcare technology company that offers genomic and radiomic analysis for hospitals to treat and diagnose diseases.
Business Model: unknown
Revenue: 45.1M
Employees: 462
Industry: Genetics
Relation is an England-based active-graph machine learning platform that provides drug discovery and development solutions for the pharmaceutical sector.
Business Model: unknown
Revenue: 1.3M
Employees: 15
Industry: Genetics
Counsyl is a provider of genetic testing and DNA screening services for men, women and children to aware about their genetic conditions.
Business Model: unknown
Revenue: 134M
Employees: 551
Industry: Genetics
Abeona Therapeutics is a New York-based biopharmaceutical company that develops and commercializes gene and cell therapies for the treatment of genetic diseases.
Business Model: unknown
Revenue: 4.3M
Employees: 90
Industry: Genetics
Xenon is a Canada-based biopharmaceutical company that researches and develops novel therapeutics for the treatment of neurological disorders.
Business Model: unknown
Revenue: 13.2M
Employees: 153
Industry: Genetics
CareDx is a California-based health-tech firm that provides solutions such as digital transplant administration and EMR integration for the healthcare industry.
Business Model: unknown
Revenue: 318.6M
Employees: 640
Industry: Genetics
Intellia Therapeutics is a Massachusetts-based biotechnology company that researches and develops genome editing therapies to treat genetic and oncological diseases.
Business Model: unknown
Revenue: 51.4M
Employees: 480
Industry: Genetics
Codagenix develops prophylactic vaccines and oncolytic virus therapies for influenza and respiratory syncytial diseases.
Business Model: unknown
Revenue: 3.4M
Employees: 13
Industry: Genetics
Genome Medical is a California-based digital health company that offers virtual genetic care services for patients.
Business Model: unknown
Revenue: 3M
Employees: 210
Industry: Genetics
GBT is a California-based biopharmaceutical company that develops and commercializes novel therapeutics for the treatment of sickle cell diseases.
Business Model: unknown
Revenue: 234.9M
Employees: 460
Industry: Genetics
eGenesis is a Massachusetts-based biotechnology company that researches and develops human-compatible organs tissues, and cells for xenotransplantation operations.
Business Model: unknown
Revenue: 20M
Employees: 130
Industry: Genetics
LifeMine is a Massachusetts-based clinical-stage biopharmaceutical company that develops genomically-enabled small molecule drugs for the treatment of chronic diseases.
Business Model: unknown
Revenue: 5.6M
Employees: 110
Industry: Genetics
DermTech develops and commercializes gene expression tests for diagnosis of dermatologic conditions, such as melanoma.
Business Model: unknown
Revenue: 14.7M
Employees: 260
Industry: Genetics
Celsius Therapeutics is a Massachusetts-based biotechnology company that develops and commercializes single-cell RNA therapies to treat cancer and autoimmunity diseases.
Business Model: unknown
Revenue: 2.2M
Employees: 40
Industry: Genetics
Massive Bio is a New York-based AI-driven platform that provides clinical trial matching and cancer analysis solutions for the biopharmaceutical industry.
Business Model: unknown
Revenue: 4.3M
Employees: 70
Industry: Genetics
Eurofins is a Luxembourg-based company that provides laboratory testing services for sectors including food and pharmaceutical.
Business Model: unknown
Revenue: 7.2B
Employees: 58k
Industry: Genetics
Gyroscope is an England-based pharmaceutical company that researches and develops gene therapies for the treatment of eye disorders.
Business Model: unknown
Revenue: 3M
Employees: 167
Industry: Genetics
BostonGene is a Massachusetts-based healthtech platform that offers solutions such as AI-based molecular profiling and analytics for physicians to treat patients with cancer.
Business Model: unknown
Revenue: 7M
Employees: 100
Industry: Genetics
Morphogenesis is a biotechnology company that develops novel cell and gene therapies for immuno-oncology and companion animal cancer treatments.
Business Model: unknown
Revenue: 29.8M
Employees: 148
Industry: Genetics
PGDx is a Maryland-based biopharmaceutical company that develops and commercializes liquid biopsy genome testing products for the treatment of cancer.
Business Model: unknown
Revenue: 16M
Employees: 200
Industry: Genetics
Personalis is a California-based cancer genomics company that provides solutions such as genomic sequencing and analytics for biomarker discovery applications.
Business Model: unknown
Revenue: 69M
Employees: 330
Industry: Genetics
uniQure is engaged in the development and commercialization of gene therapies for the treatment of cardiovascular and hemophilia diseases.
Business Model: unknown
Revenue: 61.4M
Employees: 463
Industry: Genetics
Prime Medicine is a Massachusetts-based biotechnology company that provides solutions including gene editing and DNA sequencing to medical research centers.
Business Model: unknown
Revenue: 0 - 100000
Employees: 150
Industry: Genetics
Encoded Therapeutics is a biotechnology company that develops and commercializes therapeutics for the treatment of genetic disorders.
Business Model: unknown
Revenue: 12M
Employees: 40
Industry: Genetics
Audentes Therapeutics doing business as Astellas Gene Therapies, Inc. is a biotechnology company that serves as the Gene Therapy Center of Excellence. The company is divided into three divisions that specialize in gene therapy research, including technical operations, medical and development, and future commercialization of gene therapy programs. Audentes Therapeutics was acquired by Astellas Pharma on January 15, 2020.
Business Model: unknown
Revenue: 0 - 100000
Employees: 201 - 500
Industry: Genetics
Viridian is a Massachusetts-based biopharmaceutical firm that researches and develops antibody therapeutics to treat thyroid eye and autoimmune diseases.
Business Model: unknown
Revenue: 1.9M
Employees: 50
Industry: Genetics
Standard BioTools, previously known as Fluidigm, is driven by a bold vision – unleashing tools to accelerate breakthroughs in human health. Standard BioTools has an established portfolio of essential, standardized next-generation technologies that help biomedical researchers develop medicines faster and better. As a leading solutions provider, the Company provides reliable and repeatable insights in health and disease using its proprietary mass cytometry and microfluidics technologies that help transform scientific discoveries into better patient outcomes. Standard BioTools works with leading academic, government, pharmaceutical, biotechnology, plant and animal research, and clinical laboratories worldwide, focusing on the most pressing needs in translational and clinical research, including oncology, immunology, and immunotherapy.
Business Model: unknown
Revenue: 0 - 100000
Employees: 201 - 500
Industry: Genetics
Shenzhen Huada Gene Technology Co. Ltd. operates as a biotech development company. The Company provides bioinformatics testing, genetic testing, agricultural genomics researching, proteomics researching, and other services. Shenzhen Huada Gene Technology conducts business in China.
Business Model: unknown
Revenue: 0 - 100000
Employees: 5001 - 10000
Industry: Genetics
Helix Nanotechnologies uses artificial intelligence to help cure genetic diseases. HelixNano is a Y Combinator and venture backed biotech startup. At HelixNano, we have spent the last two years developing cancer vaccines. Now we are adapting our synthetic biology arsenal to take on COVID-19. We’re moving fast but thinking long-term. We’re already testing COVID-19 vaccine candidates designed to be precise and safe. Our next goal is to create a vaccine that protects everyone not only from this virus, but all future coronaviruses.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
Oxford BioMedica is an England-based biopharmaceutical company that develops cell and gene therapies for the treatment of cancer, CNS and liver diseases.
Business Model: unknown
Revenue: 161.7M
Employees: 959
Industry: Genetics
Congenica is an England-based digital health company that offers solutions such as AI-powered clinical decision support and genomic data analysis for the healthcare industry.
Business Model: unknown
Revenue: 2.2M
Employees: 105
Industry: Genetics
Arcturus is a California-based biotechnology company that develops and commercializes RNA medicines and vaccines for the treatment of infectious diseases.
Business Model: unknown
Revenue: 15.5M
Employees: 180
Industry: Genetics
Cepheid is a molecular diagnostics company that develops, manufactures and markets pathogens and genetic testing systems for disease detection.
Business Model: unknown
Revenue: 2B
Employees: 2.5k
Industry: Genetics
2seventy Bio is a Massachusetts-based biotechnology company that develops and commercializes cellular therapies for the treatment of cancer.
Business Model: unknown
Revenue: 51.4M
Employees: 440
Industry: Genetics
Molecular Assemblies is a California-based life sciences company that produces sequence-specific DNA-based products for markets including agriculture and nanotechnology.
Business Model: unknown
Revenue: 5M
Employees: 40
Industry: Genetics
SalioGen is a Massachusetts-based biotechnology company that develops and commercializes genetic therapies for the treatment of inherited disorders.
Business Model: unknown
Revenue: 5M
Employees: 35
Industry: Genetics
Poseida is a California-based biopharmaceutical company that develops and commercializes gene therapies for the treatment of cancer and genetic diseases.
Business Model: unknown
Revenue: 151.7M
Employees: 280
Industry: Genetics
GenEdit is a California-based biotechnology company that develops and commercializes curative therapies for the treatment of genetic diseases.
Business Model: unknown
Revenue: 2.1M
Employees: 30
Industry: Genetics
SolveBio is a New York-based SaaS platform that offers solutions such as genomics and clinical data analytics for the biotech and pharma sectors.
Business Model: unknown
Revenue: 2.5M
Employees: 18
Industry: Genetics
Variantyx is a Massachusetts-based precision medicine firm that provides solutions such as diagnostic testing, genome screening, and NGS analysis for the healthcare sector.
Business Model: unknown
Revenue: 6.5M
Employees: 150
Industry: Genetics
Translate Bio is a Massachusetts-based biotechnology company that researches and develops mRNA therapeutics for the treatment of genetic diseases.
Business Model: unknown
Revenue: 225M
Employees: 122
Industry: Genetics
Tmunity is a Pennsylvania-based biotechnology company that researches and develops cell therapies for the treatment of cancer.
Business Model: unknown
Revenue: 5M
Employees: 50
Industry: Genetics
Sangamo focuses on research, development and commercialization of deoxyribonucleic acid binding proteins for therapeutic gene regulation.
Business Model: unknown
Revenue: 112.1M
Employees: 430
Industry: Genetics
Charlotte's Web is a Colorado-based cannabis company that produces and markets cannabidiol products such as oils, gummies and capsules.
Business Model: unknown
Revenue: 80.1M
Employees: 270
Industry: Genetics
Taysha is a Texas-based biotechnology company that researches and develops gene therapies for the treatment of monogenic central nervous system disorders.
Business Model: unknown
Revenue: 0 - 100000
Employees: 180
Industry: Genetics
64x Bio is a California-based synthetic biology company that develops and commercializes enhanced cell lines for biomanufacturing and therapeutics.
Business Model: unknown
Revenue: 5M
Employees: 10
Industry: Genetics
Homology is a Massachusetts-based clinical-stage genetic medicine company that develops and commercializes novel therapies for the treatment of genetic diseases.
Business Model: unknown
Revenue: 3.2M
Employees: 220
Industry: Genetics
Geneoscopy is a Missouri-bassed life sciences company that develops diagnostic tests for the detection of colorectal cancer.
Business Model: unknown
Revenue: 4.6M
Employees: 21
Industry: Genetics
Singlera Genomics is a fast growing company focusing on non-invasive genetic testing. Singlera’s main products and services include tumor diagnosis and personalized treatment, non-invasive prenatal diagnosis, pre-implantation genetic screening, and customized scientific research services. Singlera is dedicated to the development of precision medicine, striving to help the patients through early, accurate and informative diagnoses.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Genetics
Coave Therapeutics is active in the field of gene therapies in rare ocular and CNS (Central Nervous System) diseases.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Genetics
Loxo Oncology develops and markets genomic medicines for the treatment of cancer.
Business Model: unknown
Revenue: 124M
Employees: 400
Industry: Genetics
CBM is a Pennsylvania-based company that provides services such as viral vector manufacturing, plasmid production and GMP testing for the pharmaceutical industry.
Business Model: unknown
Revenue: 4.8M
Employees: 97
Industry: Genetics
Phosphorus designs, develops, builds and deploys a genomic data network that enables labs to deliver clinical genetic tests.
Business Model: unknown
Revenue: 10M
Employees: 26
Industry: Genetics
METiS is a Massachusetts-based discovery technology and therapeutics company that develops optimal therapies for patients with cancer and infectious diseases.
Business Model: unknown
Revenue: 3.2M
Employees: 70
Industry: Genetics
4DMT is a biotechnology company that researches, develops and commercializes gene therapeutics for the treatment of cancer.
Business Model: unknown
Revenue: 2M
Employees: 130
Industry: Genetics
Equinom is an Israel-based food-tech company that manufactures and supplies non-GMO plant-infused ingredients for the agriculture industry.
Business Model: unknown
Revenue: 4M
Employees: 51
Industry: Genetics
Constellation is a Massachusetts-based biopharmaceutical company that researches, develops and commercializes novel therapeutics for the treatment of cancer.
Business Model: unknown
Revenue: 3M
Employees: 154
Industry: Genetics
Bionano Genomics is a California-based biotechnology company that develops genome mapping and analytics tools for sectors such as pharma and healthcare.
Business Model: unknown
Revenue: 25.9M
Employees: 300
Industry: Genetics
Altor BioScience is a clinical-stage biopharmaceutical company that focuses on developing immunotherapies for the treatment of cancer and viral infections.
Business Model: unknown
Revenue: 6.2M
Employees: 130
Industry: Genetics
GNS Healthcare is a big data analytics company that focuses on discovering what works in the healthcare industry and for whom. They focus on advancing and applying industrial-scale data analytics to empower key healthcare stakeholders to solve complex care, treatment, and cost challenges.
Business Model: unknown
Revenue: 0 - 100000
Employees: 51 - 200
Industry: Genetics
Spark is a Pennsylvania-based biotechnology company that develops and commercializes therapeutics for the treatment of hemophilia and neurodegenerative diseases.
Business Model: unknown
Revenue: 93.5M
Employees: 800
Industry: Genetics
Parse Biosciences is a Washington-based biopharmaceutical company that develops and commercializes single-cell RNA sequencing solutions for the healthcare industry.
Business Model: unknown
Revenue: 6.1M
Employees: 40
Industry: Genetics
Ensoma is a Massachusetts-based biotechnology company that researches and develops gene therapies for the treatment of cancer and autoimmune diseases.
Business Model: unknown
Revenue: 2.3M
Employees: 45
Industry: Genetics
Capsida is a California-based biotechnology company that researches and develops tissue-targeted gene therapies for CNS diseases.
Business Model: unknown
Revenue: 2M
Employees: 60
Industry: Genetics
Prelude is a provider of genetic screening, embryo creation and transfer services.
Business Model: unknown
Revenue: 5.9M
Employees: 155
Industry: Genetics
VBL Therapeutics is a biopharmaceutical company that develops and commercializes medicines for the treatment of cancer.
Business Model: unknown
Revenue: 922k
Employees: 38
Industry: Genetics
TwinStrand is a Washington-based biotechnology firm that provides solutions including DNA sequencing and cancer detection for the healthcare sector.
Business Model: unknown
Revenue: 3M
Employees: 100
Industry: Genetics
Genomics is a healthcare company that researches and develops therapies for the treatment of genetic diseaeses.
Business Model: unknown
Revenue: 2M
Employees: 71
Industry: Genetics
Genomelink is a platform where people discover more with their DNA data and help businesses build, market and do research with it. The best founders in consumer genomics with real experience in the industry for many years, including M3, Inc. ($13B valued Meditech in Japan), a founding member of the Japanese version of 23andMe, and lead bioinformatician and software engineer at a joint-venture between Illumina and Sony. Raised $4M for Seed Round from Berkeley SkyDeck, SONY, and top-tier Japanese VCs. Supported by Illumina Accelerator, Carlos Bustamante Lab at Stanford University among others.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Genetics
CODA is a California-based biopharmaceutical company that develops and commercializes chemogenetic therapies for the treatment of neurological diseases.
Business Model: unknown
Revenue: 5.7M
Employees: 35
Industry: Genetics
Pathway Genomics provides physicians with genetic testing reports on diet, exercise, drug response, carrier status and health conditions.
Business Model: unknown
Revenue: 3M
Employees: 20
Industry: Genetics
AavantiBio is a Massachusetts-based biotechnology company that develops gene therapies for the treatment of cardiac and central nervous system dysfunctions.
Business Model: unknown
Revenue: 5.4M
Employees: 50
Industry: Genetics
DiaCarta develops and commercializes molecular diagnostics products for cancer and infectious diseases.
Business Model: unknown
Revenue: 4.4M
Employees: 75
Industry: Genetics
Lucence Health is a liquid biopsy company detecting the hallmarks of cancer for earlier detection and targeted treatment.
Business Model: unknown
Revenue: 0 - 100000
Employees: 51 - 200
Industry: Genetics
Exagen is a California-based commercial-stage life sciences company that provides services such as diagnosis and prognosis testing for chronic autoimmune diseases.
Business Model: unknown
Revenue: 46.8M
Employees: 220
Industry: Genetics
Ziopharm Oncology is a biotechnology company employing a novel gene expression and control technology to deliver DNA for the treatment of cancer. ZIOPHARM&s;s technology platform employs Intrexon Corporation&s;s RheoSwitch Therapeutic System® to turn on and off and precisely modulate gene expression at the cancer site in order to improve the therapeutic index. This technology is currently being evaluated in Phase 2 clinical studies of the immune system cytokine interleukin-12 for the treatment of breast cancer and advanced melanoma. Multiple new INDs for new targets using similar technology are expected in 2014 and 2015. ZIOPHARM is also developing novel small molecules as potential cancer therapeutics.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Genetics
OpGen is a Maryland-based biotechnology company that researches and develops molecular diagnostic therapeutics for the treatment of infectious diseases.
Business Model: unknown
Revenue: 3.4M
Employees: 100
Industry: Genetics
Inivata is a North Carolina-based biotechnology company that develops and distributes ctDNA genome-scale diagnostics tools for the treatment of cancer.
Business Model: unknown
Revenue: 5.5M
Employees: 77
Industry: Genetics
Abbott is an Illinois-based healthcare company that develops and distributes products such as medical devices and generic medicines for the treatment of a range of diseases.
Business Model: unknown
Revenue: 44.5B
Employees: 113k
Industry: Genetics
Voyager is a Massachusetts-based biopharmaceutical company that develops and commercializes gene therapies for the treatment of neurological disorders.
Business Model: unknown
Revenue: 70.5M
Employees: 100
Industry: Genetics
Gameto is a new breed of biotechnology firm dedicated to better understanding and treating infertility and menopause. The company aims to leverage the allogeneic human cellular derivatives of their platform to therapeutic applications for assisted fertility and menopause. Gameto was founded in 2020 and is based in New York.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
Gencove is an AI-based platform that offers genome sequencing solutions for educational institutions and biotechnology and pharmaceutical companies.
Business Model: unknown
Revenue: 1M
Employees: 12
Industry: Genetics
Codex DNA is a California-based biotechnology company that provides services including drug discovery, vaccine development and genome editing for healthcare organizations.
Business Model: unknown
Revenue: 21M
Employees: 210
Industry: Genetics
Strata Oncology is a Michigan-based biotechnology company that offers solutions such as molecular profiling and clinical trials for the treatment of cancer.
Business Model: unknown
Revenue: 9M
Employees: 60
Industry: Genetics
Dicerna is a Massachusetts-based biotechnology company that develops and commercializes RNAi therapies for the treatment of cardiometabolic and complement-mediated diseases.
Business Model: unknown
Revenue: 192.8M
Employees: 302
Industry: Genetics
EdiGene is a China-based biotechnology company that develops and commercializes novel therapeutics for the treatment of genetic and cancer diseases.
Business Model: unknown
Revenue: 1.8M
Employees: 100
Industry: Genetics
Tocagen researches, discovers, develops and commercializes gene therapies for the treatment of cancer.
Business Model: unknown
Revenue: 36k
Employees: 9
Industry: Genetics
HTG is an Arizona-based RNA platform that automates sample processing for molecular profiling applications.
Business Model: unknown
Revenue: 6.8M
Employees: 90
Industry: Genetics
Nabsys is a Rhode Island-based biotechnology firm that develops and supplies electronic whole-genome mapping and analysis products for sectors such as pharma and healthcare.
Business Model: unknown
Revenue: 5M
Employees: 30
Industry: Genetics
Kelonia is a Massachusetts-based biotechnology company that researches and develops cell and gene therapies for the treatment of blood cancer and infectious diseases.
Business Model: unknown
Revenue: 2M
Employees: 18
Industry: Genetics
Kytopen is a Massachusetts-based biotechnology company that develops microfluidics-based cell therapies for the treatment of cancer and genetic disorders.
Business Model: unknown
Revenue: 5.9M
Employees: 38
Industry: Genetics
Frequency Therapeutics researches and develops regenerative therapeutics for the treatment of sensorineural hearing loss.
Business Model: unknown
Revenue: 9.4M
Employees: 70
Industry: Genetics
23andMe is an online healthcare platform that provides DNA genetic testing for individuals and uses that information for health research.
Business Model: unknown
Revenue: 271.9M
Employees: 770
Industry: Genetics
Candel Therapeutics is a Massachusetts-based biotechnology company that develops and commercializes oncolytic viral immunotherapies to treat cancer.
Business Model: unknown
Revenue: 125k
Employees: 60
Industry: Genetics
Sionna is a Massachusetts-based life science company that researches and develops cystic fibrosis drugs for the treatment of rare diseases.
Business Model: unknown
Revenue: 10M
Employees: 30
Industry: Genetics
Veritas is a Massachusetts-based health-tech company that offers solutions such as genetic screening and whole genome sequencing for individuals.
Business Model: unknown
Revenue: 5M
Employees: 60
Industry: Genetics
Exosome is focused on developing and commercializing biofluid-based diagnostics solutions to deliver personalized precision healthcare.
Business Model: unknown
Revenue: 8M
Employees: 100
Industry: Genetics
AVROBIO develops and commercializes step-change cell and gene therapies for the treatment of cancer and rare diseases.
Business Model: unknown
Revenue: 1.2M
Employees: 120
Industry: Genetics
ArcherDX is a bioinformatics company that develops and commercializes NGS-based gene fusion detection assays for oncology applications.
Business Model: unknown
Revenue: 50.5M
Employees: 260
Industry: Genetics
Business Model: unknown
Revenue: 0 - 100000
Employees: 201 - 500
Industry: Genetics
Apton is a California-based biotech firm that manufactures and supplies single-molecule detection, sequencing imaging and related solutions for clinical applications.
Business Model: unknown
Revenue: 3.3M
Employees: 25
Industry: Genetics
Regulus Therapeutics is a California-based biopharmaceutical firm that develops and markets microRNA therapies for the treatment of inflammatory and metabolic disorders.
Business Model: unknown
Revenue: 10M
Employees: 30
Industry: Genetics
MicroByre is a biotechnology company that converts non-model species into genetically tractable strains and bacteria cultivation solutions.
Business Model: unknown
Revenue: 1M
Employees: 15
Industry: Genetics
Quantgene is a California-based molecular diagnostics company that provides human genome sequencing and related solutions for industries such as pharma and healthcare.
Business Model: unknown
Revenue: 8.3M
Employees: 55
Industry: Genetics
F2G is an England-based clinical-stage biopharmaceutical company that discovers and develops novel therapies for the treatment of rare fungal diseases.
Business Model: unknown
Revenue: 12.5M
Employees: 60
Industry: Genetics
LogicBio is a Massachusetts-based biotechnology company that researches and develops genetic medicines for the treatment of rare pediatric diseases.
Business Model: unknown
Revenue: 10.8M
Employees: 60
Industry: Genetics
Foundation Medicine is a Massachusetts-based biotechnology company that provides genomic profiling assays and clinical trail matching solutions for oncology research centers.
Business Model: unknown
Revenue: 350M
Employees: 2k
Industry: Genetics
AI Therapeutics was founded in 2013 with a mission to advance the clinical development of new therapies to treat Lymphangioleiomyomatosis (LAM) and other diseases. Working with a dedicated team of scientific, clinical, and drug development experts, AI Therapeutics expects to use its disease-specific focus and technological approach to identify and advance drugs that will provide significant therapeutic benefits for LAM patients. AI Therapeutics develops drugs for rare diseases and cancer. LAM takes advantage of the inflection point in biological understanding and computer science, leveraging big data from NextGen sequencing, genome editing, chemical genomics, and combinational drug screening, to develop precision therapeutics and companion diagnostics. LAM has advanced two drugs into the clinic: LAM-001 for lymphangioleiomyomatosis, and LAM-002 for B-cell non-Hodgkin lymphoma.
Business Model: unknown
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Genetics
CardioDx is a molecular diagnostics company that develops tests for coronary artery disease, cardiac arrhythmia and heart failure.
Business Model: unknown
Revenue: 10M
Employees: 139
Industry: Genetics
iECURE is a Pennsylvania-based gene editing company that researches and develops in vivo gene therapies for the treatment of liver disorders.
Business Model: unknown
Revenue: 2M
Employees: 50
Industry: Genetics
Agendia researches and develops genomic-based molecular diagnostics for the prevention, treatment and monitoring of cancer.
Business Model: unknown
Revenue: 15M
Employees: 250
Industry: Genetics
Arbutus is a biopharmaceutical firm that develops therapies for the treatment of hepatitis B virus infection.
Business Model: unknown
Revenue: 36M
Employees: 90
Industry: Genetics
Limula provides a unique platform technology enabling scale out of cell therapy production. By bringing manufacturing closer to the patients, our solution will broaden access to these highly personalised treatments. Our patented solution is composed of an automation unit and single use kits, allowing healthcare providers to safely manufacture CGT in a decentralized manner. We support companies at all stages of the cell therapy life cycle, from R&a;D to routine production.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
Solid Bio is a Massachusetts-based life sciences company that develops novel therapeutics for the treatment of Duchenne muscular dystrophy.
Business Model: unknown
Revenue: 11.2M
Employees: 100
Industry: Genetics
Raptor develops and commercializes therapeutics for the treatment of cystinosis, Huntington and Cystic Fibrosis diseases.
Business Model: unknown
Revenue: 110M
Employees: 158
Industry: Genetics
GenXys is a medication management platform that provides pharmacogenetic-based automated prescribing solutions for the healthcare industry.
Business Model: unknown
Revenue: 1M
Employees: 32
Industry: Genetics
Evogene is a biotechnology company that develops technology for enhancement of crop productivity and performance.
Business Model: unknown
Revenue: 1.3M
Employees: 141
Industry: Genetics
GenomeDx discovers, develops, and commercializes genomic-based laboratory tests for the personalized medicine revolution in cancer care. In partnership with physicians and scientists from leading academic medicine institutions, our mission is to bring cost-effective and high-resolution genomics for routine clinical use in cancer medicine.
Business Model: unknown
Revenue: 0 - 100000
Employees: 51 - 200
Industry: Genetics
ACTG is a Taiwan-based biotechnology company that researches and develops precision medicine for the treatment of cancer.
Business Model: unknown
Revenue: 15.5M
Employees: 60
Industry: Genetics
Newtopia is a Canada-based healthcare engagement platform that provides solutions including mental health, diabetes and weight management for employees.
Business Model: unknown
Revenue: 9.7M
Employees: 100
Industry: Genetics
Eloxx is a Massachusetts-based biopharmaceutical company that researches and develops RNA-targeted genetic therapies for the treatment of premature stop codon diseases.
Business Model: unknown
Revenue: 3.6M
Employees: 30
Industry: Genetics
Vyant Bio is a New Jersey-based biotechnology company that researches and develops proprietary genomic tests for cancer treatment.
Business Model: unknown
Revenue: 2.2M
Employees: 30
Industry: Genetics
Exicure is an Illinois-based biotechnology company that researches and develops nucleic acid therapeutics for the treatment of neurological diseases and genetic disorders.
Business Model: unknown
Revenue: 5.7M
Employees: 40
Industry: Genetics
Stilla develops a digital PCR platform that offers genetic analysis solutions for life science research applications.
Business Model: unknown
Revenue: 3.4M
Employees: 40
Industry: Genetics
MiNA is an England-based biotechnology company that develops and commercializes saRNA therapeutics for the treatment of cancer and genetic diseases.
Business Model: unknown
Revenue: 6M
Employees: 19
Industry: Genetics
Minoryx is a Spain-based biotechnology company that develops and commercializes novel therapeutics for the treatment of orphan central nervous system disorders.
Business Model: unknown
Revenue: 4.4M
Employees: 35
Industry: Genetics
Solena is a biotechnology company dedicated to the study of the microbiome of agricultural soils, with the aim of increasing the profitability of farmers by tailored biological inputs
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Genetics
Imara develops novel therapeutics for the treatment of sickle cell disease.
Business Model: unknown
Revenue: 0 - 100000
Employees: 40
Industry: Genetics
AGT is a Maryland-based biotechnology company that develops and commercializes gene therapies for the treatment of immuno-oncology and monogenic disorders.
Business Model: unknown
Revenue: 6.3M
Employees: 41
Industry: Genetics
3billion is a Korea-based biotechnology company that develops and commercializes medicines for the treatment of undiagnosed genetic diseases.
Business Model: unknown
Revenue: 0 - 100000
Employees: 51 - 200
Industry: Genetics
Huida Gene is a China-based biotechnology company that researches, develops and commercializes medicines for the treatment of genetic disorders.
Business Model: unknown
Revenue: 5M
Employees: 200
Industry: Genetics
GenSight Biologics is a France-based biopharmaceutical firm that researches and develops gene therapies to treat retinal neurodegenerative diseases and CNS disorders.
Business Model: unknown
Revenue: 8.7M
Employees: 44
Industry: Genetics
Eagle Genomics is an England-based biotech platform that provides solutions such as AI-driven knowledge discovery and workflow automation for the healthcare industry.
Business Model: unknown
Revenue: 5.6M
Employees: 138
Industry: Genetics
ReviR is a California-based biotechnology company that researches and develops RNA-based therapeutics for the treatment of tumors, infections and various diseases.
Business Model: unknown
Revenue: 1M
Employees: 10
Industry: Genetics
Fulgent focuses on developing and commercializing novel formulations of anti-cancer therapeutics.
Business Model: unknown
Revenue: 802.9M
Employees: 640
Industry: Genetics
Strand is an India-based that genomic diagnostics and research company that provides services such as predictive modeling and genetic diagnostic testing for clinicians.
Business Model: unknown
Revenue: 12.1M
Employees: 250
Industry: Genetics
Phylagen develops a cloud-based platform that provides microbiome data analysis solutions for healthcare, manufacturing and retail industries.
Business Model: unknown
Revenue: 3M
Employees: 20
Industry: Genetics
Roslin Tech is on a mission to improve protein production through disruptive technologies. Our core capability is in animal stem cells; we have developed the world’s perpetually self-renewing, pluripotent stem cells for animals (iPS cells) which will accelerate the development of cultivated meat for the consumer market.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Genetics
Genoox is a California-based NGS analysis platform that allows clinicians to manage sequencing processes.
Business Model: unknown
Revenue: 2.5M
Employees: 30
Industry: Genetics
Biofidelity is an England-based cancer diagnostic company that develops precision diagnosis and routine monitoring products for the healthcare industry.
Business Model: unknown
Revenue: 1.1M
Employees: 16
Industry: Genetics
AveXis develops and commercializes gene therapies for the treatment of neurological genetic disorders.
Business Model: unknown
Revenue: 15M
Employees: 1.1k
Industry: Genetics
Nebula Genomics is a human genome sequencing platform that helps researchers to analyze drug development and clinical trial data.
Business Model: unknown
Revenue: 5.7M
Employees: 9
Industry: Genetics
Ethris is a Germany-based biotechnology company that develops and commercializes mRNA-based therapeutics for the treatment of respiratory viral infections.
Business Model: unknown
Revenue: 9.5M
Employees: 40
Industry: Genetics
RainDance is a provider of genetic analysis solutions for the early detection of cancer and infectious diseases.
Business Model: unknown
Revenue: 20M
Employees: 93
Industry: Genetics
Blueprint Genetics is a provider of clinical sequencing and genetic testing services for the diagnosis of inherited diseases.
Business Model: unknown
Revenue: 17.7M
Employees: 170
Industry: Genetics
Phase Genomics is a Washington-based proximity ligation genomics platform that provides DNA sequencing solutions for microbiological applications.
Business Model: unknown
Revenue: 3M
Employees: 35
Industry: Genetics
Centrillion is a provider of DNA sequencing analysis, ancestry testing and genomics services.
Business Model: unknown
Revenue: 5M
Employees: 30
Industry: Genetics
Cofactor Genomics is a California-based biotechnology company that offers solutions such as predictive immune modeling and human genome sequencing for the pharama industry.
Business Model: unknown
Revenue: 3.2M
Employees: 21
Industry: Genetics
Atlas Biomed is a personalized health company applying the latest genetic technologies to inspire consumers into a positive lifestyle change, and lead them into a healthier future.
Business Model: unknown
Revenue: 0 - 100000
Employees: 51 - 200
Industry: Genetics
Linc&s;well is a health care company providing SaaS for medical institutions in order to improve medical inefficiencies with technology.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
Centauri is an England-based biotechnology company that develops and commercializes immunotherapies to treat cancer and infectious diseases.
Business Model: unknown
Revenue: 3.5M
Employees: 5
Industry: Genetics
The Salk Institute is a research based organization that specializes in fundamental research in biology and its relation to health.
Business Model: unknown
Revenue: 181.6M
Employees: 262
Industry: Genetics
Color is a California-based health-tech company that offers solutions such as genomic analysis and clinical testing for healthcare, life science and medical research centers.
Business Model: unknown
Revenue: 0 - 100000
Employees: 501 - 1000
Industry: Genetics
GigaGen is a biotechnology company that develops and commercializes single-cell technology-based antibody drugs to treat infectious diseases.
Business Model: unknown
Revenue: 5M
Employees: 35
Industry: Genetics
Porton Advanced Solutions (Porton Advanced) is a CDMO specializing in Cell and Gene Therapy (CGT). To meet the therapeutic product needs of our clients at the pre-clinical, clinical, and commercial stages, we offer end-to-end process development (PD), analytical development (AD), GMP manufacturing, and testing services.
Business Model: unknown
Revenue: 0 - 100000
Employees: 201 - 500
Industry: Genetics
Emedgene develops an automated genetic interpretation platform that uses AI to dramatically scale genetic interpretation.
Business Model: unknown
Revenue: 4.5M
Employees: 38
Industry: Genetics
Batavia is a Netherlands-based biotechnology firm that offers services such as cell line generation, upstream process development and product characterization.
Business Model: unknown
Revenue: 20M
Employees: 100
Industry: Genetics
PNI is a Canada-based biotechnology company that develops and commercializes genetic medicine development technologies and related products for the pharmaceutical industry.
Business Model: unknown
Revenue: 8.5M
Employees: 150
Industry: Genetics
Chameleon is changing the way they treat genetic diseases using gene therapy to deliver corrective genes using multiple systemic dose administrations. Research indicates that 20-30% of all infant fatalities are due to genetic disorders, and for those who survive, treatment options are often limited. Recent breakthroughs in gene therapy are saving lives, but there&s;s still a long way to go. At Chameleon, their goal is to ensure every child can be treated with lower doses and accurate target specificity over time as their condition requires. They are committed to every child and family who suffers from a genetic disorder. Their mission is to make sure every Belle, Abby and Marian live to their 10th birthdays, learn to drive, go to prom and someday have healthy children of their very own.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
Adendra is an England-based biotechnology company that develops and commercializes cell-based novel therapeutics for the treatment of solid tumors and autoimmune diseases.
Business Model: unknown
Revenue: 100k
Employees: 5
Industry: Genetics
Volta Labs is a Massachusetts-based bioautomation company that develops genomic sequencing workflow automation and sample preparation analytics for the biotechnology industry.
Business Model: unknown
Revenue: 3.4M
Employees: 20
Industry: Genetics
Lilac Insights is a Maharashtra-based medical laboratory that provides genetic diagnostics services for patients with cancer.
Business Model: unknown
Revenue: 5.7M
Employees: 250
Industry: Genetics
Immunexpress is a biotechnology company that develops and commercializes molecular blood biomarkers for detection and management of sepsis.
Business Model: unknown
Revenue: 5M
Employees: 25
Industry: Genetics
Developer of cell therapeutics created for autoimmune diseases and immune-related disorders. The company uses regulatory T (Treg) cells from a donor and makes Treg cells for hemophilia, multiple sclerosis and graft-versus-host disease from stem cell transplantation, enabling the healthcare industry to suppress the unwanted immune reactions without side effects in patients with autoimmune diseases.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Genetics
Epsilogen is a biotechnology firm that develops and commercializes immunoglobulin E antibodies for the treatment of cancer.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Genetics
Orphazyme is a Denmark-based biopharmaceutical company that develops and commercializes therapies for the treatment of neurodegenerative diseases.
Business Model: unknown
Revenue: 0 - 100000
Employees: 141
Industry: Genetics
Predictiv is the first DNA-base Digital Twin to predict and prevent over 22,000 diseases and simulate personalized reactions on 750+ drugs
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
NanoMosaic provides solutions for early illness detection, prognostic monitoring, and biomarker identification. Its protein interrogation powered by nanoneedles enables early disease detection, prognostic monitoring, and biomarker discovery on a single chip. .
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
Reviva develops is a California-based clinical-stage biopharmaceutical company that develops and commercialize therapeutics for inflammatory and cardiovascular diseases.
Business Model: unknown
Revenue: 0 - 100000
Employees: 5
Industry: Genetics
Desktop Genetics is an international biotechnology company established in 2012 to help researchers discover and treat the root genetic causes of human disease. Today, Desktop Genetics is a recognised leader in genome editing technology, staffed by dedicated team of genome editing experts, bioinformaticians and data scientists, driven by the real-world impact of CRISPR technology. They have invested four years developing their core technology, DESKGEN AI, trained on the largest database of genome editing data in the world. DESKGEN AI powers their flagship DESKGEN CRISPR Library product range, which enables the work of their pharma, biotech and academic customers working in drug discovery and functional genomics. Desktop Genetics&s; tools and technologies are used by over 1800 organisations all over the world, and their projects contribute directly to several key partnerships to bring CRISPR into the clinic. The company has received awards from Fast Company, Kairos 50 and SxSW Interactive.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Genetics
Phytoform Labs is a biotechnology company which aims to help breeders to cut down plant breeding times from decades to years using new gene editing technologies. Predictably evolving plants will maximise yields for breeders and improve the economics of breeding for customers.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
InformedDNA is a Florida-based healthcare firm that provides genetic counseling and testing services to patients and health insurers.
Business Model: unknown
Revenue: 15.8M
Employees: 135
Industry: Genetics
They aspire to control the immune system. By the time a patient is sitting in front of an oncologist, cancer has evaded their immune system. Chimeric antigen receptor T-cells (CARs) are reprogrammed immune cells, hot-wired to circumvent immune-evasion. Clinical trials for CARs against liquid tumor cancers, like acute lymphoblastic leukemia and lymphoma, have shown transformative results for patients unresponsive to standard therapy. However, limited efficacy against solid tumor cancers, life-threatening toxicities, and limited persistence are impediments to these therapies making a wider impact on cancer patients. Chimera Bioengineering solves the challenges of CARs with drug-responsive gene regulators, which allow us to re-program the "software" of the immune system. They design CAR behavior that promises to minimize toxicity, maximize efficacy and extend persistence so that CARs can lead to cures.w
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Genetics
JAX is a Maine-based nonprofit biomedical research institution that provides genetic research and data resources to laboratories.
Business Model: unknown
Revenue: 484.6M
Employees: 2.4k
Industry: Genetics
AltheaDx is a California-based commercial-stage molecular diagnostics company that offers pharmacogenomics testing services for patients and clinicians.
Business Model: unknown
Revenue: 12.3M
Employees: 148
Industry: Genetics
OriGene is a biotechnology company that provides research reagents and tools for the life science community.
Business Model: unknown
Revenue: 45M
Employees: 220
Industry: Genetics
Founded in 2015 in Palo Alto, California, USA, I Peace, Inc. is a leading CDMO (contract development and manufacturing organization) of clinical-grade cell products. The founder and CEO Dr. Koji Tanabe earned his doctorate at Kyoto University under Nobel laureate Dr. Shinya Yamanaka and was the second author of the groundbreaking article on the development of human iPSCs. I Peace’s mission is to ease the suffering of diseased patients and help healthy people maintain a high quality of life. With its proprietary manufacturing platform that enables parallel production of discrete iPSCs from multiple donors in a single room, I Peace can provide a large volume of high-quality clinical-grade iPSCs at competitive cost. Our goal is to create custom iPSCs for every individual to become their stem cells for life while supporting drug and cell therapy companies to accelerate their development to make cell therapy an affordable option.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Genetics
ASC is a biotechnology company that provides gene targeting, stem cell characterization and CRO services to life science and healthcare sectors.
Business Model: unknown
Revenue: 14.2M
Employees: 80
Industry: Genetics
Mammoth Biosciences is a California-based biotechnology company that develops a CRISPR-based platform for the detection and diagnosis of HPV and malaria.
Business Model: unknown
Revenue: 5M
Employees: 100
Industry: Genetics
NuGEN researches and develops NGS kits and genomic sample preparation reagents for DNA and RNA analysis.
Business Model: unknown
Revenue: 15M
Employees: 188
Industry: Genetics
Zhongbo Ruikang focuses on the research and development of domestic tools in the field of cell and gene therapy, mainly to assist customers in realizing the "continuous, closed, disposable, consistent, scalable, automated, modular, and medical deviceization of cell preparation industrialization.
Business Model: unknown
Revenue: 0 - 100000
Employees:
Industry: Genetics
Igentify is a bioinformatics company that develops a genomic-based preventative healthcare platform for the medical industry.
Business Model: unknown
Revenue: 0 - 100000
Employees: 40
Industry: Genetics
AVG is a California-based medical device company that designs and distributes laser systems for the treatment of age-related eye dysfunction and related ophthalmic disorder.
Business Model: unknown
Revenue: 0 - 100000
Employees: 51 - 200
Industry: Genetics
SAGA Diagnostics is a provider of molecular genetic tests and services for healthcare and biopharmaceutical companies.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Genetics
Cure Genetics is a China-based biopharmaceutical company that develops and commercializes gene and cell therapies to treat genetic diseases and tumors.
Business Model: unknown
Revenue: 5.7M
Employees: 56
Industry: Genetics
Calimmune is a biotechnology company that focuses on the development of ex vivo hematopoietic stem cell gene therapy for hematologic diseases.
Business Model: unknown
Revenue: 9M
Employees: 66
Industry: Genetics
Aperiomics is a biotechnology company that develops genomic sequencing solutions to identify infections for patients and the healthcare industry.
Business Model: unknown
Revenue: 2.3M
Employees: 50
Industry: Genetics
Luna is a genomic and medical research database that enables individuals to share and manage their health data.
Business Model: unknown
Revenue: 3M
Employees: 16
Industry: Genetics
Depixus develops a medical software that allows the physicians to manipulate the genetic and epigenetic information from DNA and RNA.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Genetics
PlusLife Biotech is devoted to developing revolutionary molecular diagnostic tools and gene treatment programs employing a new generation of gene technology. Founded in 2017 and is based in Guangzhou, China.
Business Model: unknown
Revenue: 0 - 100000
Employees:
Industry: Genetics
NantOmics is a molecular diagnostic firm that develops cloud-based molecular profiling tools that helps to guide cancer patients.
Business Model: unknown
Revenue: 1M
Employees: 30
Industry: Genetics
Shivom is a globally active healthcare data &a; analytics company, aiming at building the world’s largest genomics &a; precision medicine data ecosystem. The organization is using evidence-based methods to build products, using a combination of scientific methods, novel business models, and an agile approach, which helps the project remain adaptable, always responsive to emerging requirements and new innovations client requests. The London-based organization was contracted to design, build, and maintain the groundwork of a global healthcare token ecosystem. The $OMX token is intended to fuel the world’s healthcare systems, enabling people and organizations to tokenize healthcare, making it cheaper, faster, fairer, and more efficient. In 2020, Shivom successfully launched a precision medicine platform comprising intersecting environments: A genetics data and an AI bioinformatics (analytics) marketplace. Shivom announced phase II of the healthcare ecosystem, starting with the rollout of the world’s first genomic NFT (non-fungible token) marketplace and crypto e-commerce platform targeting all healthcare verticals (B2B and B2C). Shivom has already partnerships with global organizations including European Precision Medicine consortiums, universities, institutes,, and governmental organizations.
Business Model: unknown
Revenue: 1M
Employees: 31
Industry: Genetics
Refuge Biotech develops a genetic engineering platform that focuses on gene editing of immune cells for cancer immunotherapy.
Business Model: unknown
Revenue: 3M
Employees: 30
Industry: Genetics
Synthego is a California-based genome engineering platform that helps researchers to develop CRISPR-based gene therapies and diagnostic tests.
Business Model: unknown
Revenue: 31.5M
Employees: 400
Industry: Genetics
Lacerta is a clinical-stage gene therapy company that focuses on developing treatments for the central nervous system and lysosomal storage diseases.
Business Model: unknown
Revenue: 5M
Employees: 15
Industry: Genetics
Ribo Bio is a China-based biopharmaceutical company that develops and commercializes small nucleic acid drugs for the treatment of cancer and liver diseases.
Business Model: unknown
Revenue: 5.6M
Employees: 21
Industry: Genetics
Biognosys is a Switzerland-based SaaS platform that offers mass spectrometry-powered proteomics solutions for cell line engineering and protein quantification applications.
Business Model: unknown
Revenue: 6.8M
Employees: 60
Industry: Genetics
23mofang is an online platform that offers genetic testing and report analysis solutions for patients and healthcare providers.
Business Model: unknown
Revenue: 2M
Employees: 66
Industry: Genetics
Kraig Biocraft is a Michigan-based biotechnology company that develops and commercializes spider silk-based fibers and other polymers for the textile industry.
Business Model: unknown
Revenue: 803.2k
Employees: 11
Industry: Genetics
MediLink is a China-based biotechnology company that develops and commercializes antibody-drug conjugates for the healthcare industry.
Business Model: unknown
Revenue: 1.2M
Employees: 20
Industry: Genetics
At Nutri-Genetix (NGX), we have created the world’s first genetically personalised nutrition shake. In a world in which 2/3 of the population have food allergies or sensitivities, and as the demand for personalisation grows – NGX presents a convenient solution for active professionals looking to optimise their nutrition.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
Benchmark holdings manufactures animal health vaccines, medicines, biocides and diagnostics with a key focus on aquaculture.
Business Model: unknown
Revenue: 157M
Employees: 815
Industry: Genetics
Prokarium is an England-based biopharmaceutical firm that develops and commercializes microbial immunotherapies and vaccines for the treatment of cancer diseases.
Business Model: unknown
Revenue: 2.4M
Employees: 25
Industry: Genetics
AEENA Dx is developing a saliva-based platform for the detection of cancer and disease.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
iBio is a Texas-based biotechnology company that researches and develops plant-infused therapeutic proteins and vaccines for the treatment of fibrotic diseases.
Business Model: unknown
Revenue: 2.3M
Employees: 100
Industry: Genetics
Benitec Biopharma is engaged in the development of gene-silencing therapies for the treatment of chronic and life-threatening diseases.
Business Model: unknown
Revenue: 73k
Employees: 20
Industry: Genetics
enGene develops a proprietary non-viral gene therapy platform for localized delivery of nucleic acid payloads to mucosal tissues.
Business Model: unknown
Revenue: 3.5M
Employees: 58
Industry: Genetics
Ariel is a Pennsylvania-based precision medicine platform that helps physicians to monitor and treat complex chronic diseases and disorders.
Business Model: unknown
Revenue: 2.5M
Employees: 22
Industry: Genetics
Dynamic Code&s;s driving force is to translate the latest research into products that contribute to increased well-being and better health. Special expertise is to apply the latest scientific advances in DNA technology and other molecular biological research into useful products for consumers, municipalities, healthcare and companies. Their approach to product development is to create a product that is close to people&s;s needs and to help people seeking guidance on various symptoms or diseases. Several of the häsotest as Dynamic Code has been developed, giving customers a quick and useful answers. Analysis The answer is at least as safe as in health care, but faster. In some cases there has not been adequate diagnoses within the traditional health care system. An example of this is our home test for bacterial vaginosis.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
Genoplan provides customized products and services using biotechnology (BT) and information technology (IT). Genoplan is leading the way to create a world where everyone can use their genetic information. Best Company for Customized Genetic Service: Genoplan tells your genetic predisposition in an easy way. The algorithms developed by Genoplan help companies plan their customized services and products. Reasons for DNA Analysis: The DNA does not change for the rest of my life. In order to plan a healthier life, it is necessary to identify genetic information in advance and understand my tendency properly. Companies can offer personalized benefits to customers who want better lives. This will be a new competitive power than has never existed before. With the Best R&a;D Team: The Genoplan R&a;D team is made up of leading experts in biotechnology. Since its establishment, we have accumulated the greatest know-how by concentrating only on analysis of individual DNA. The entire analysis is conducted using state-of-the-art automated facilities, providing the fastest and the most accurate DNA analysis results.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Genetics
Horizon is a cell engineering company that provides gene editing, modulation and screening services for research and clinical applications.
Business Model: unknown
Revenue: 76.4M
Employees: 432
Industry: Genetics
Clinical Genomics is a biotechnology company that develops medical systems for colorectal cancer diagnosis and monitoring.
Business Model: unknown
Revenue: 13M
Employees: 90
Industry: Genetics
FerGene is a biopharmaceutical company that researches and develops gene therapies.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
Transgenomic provides genetic testing and research services for cardiology, neurology, mitochondrial disorders, oncology and inherited diseases.
Business Model: unknown
Revenue: 1M
Employees: 56
Industry: Genetics
FitnessGenes is a medical technology company that analyzes DNA and provides personalized fitness training and nutrition strategies.
Business Model: unknown
Revenue: 2M
Employees: 11 - 50
Industry: Genetics
Gen9 is engaged in the development of synthetic biology technologies for synthesizing and assembling DNA.
Business Model: unknown
Revenue: 8.5M
Employees: 41
Industry: Genetics
C2i Genomics is a New York-based cancer intelligence company that provides residual disease detection and management solutions to pharmaceutical and diagnostic organizations.
Business Model: unknown
Revenue: 19M
Employees: 40
Industry: Genetics
DNAlite is a preclinical biotechnology company that focuses on developing drugs for the treatment of diseases such as FAP and colorectal cancer.
Business Model: unknown
Revenue: 1M
Employees: 10
Industry: Genetics
GenePeeks is a genetic research company that develops a sperm donor screening technology to reduce the risk of heritable diseases.
Business Model: unknown
Revenue: 4.9M
Employees: 116
Industry: Genetics
Yikon Genomics is a biotechnology firm that provides reproductive health and cancer diagnostics solutions for physicians.
Business Model: unknown
Revenue: 2M
Employees: 29
Industry: Genetics
Spirovant is focused on changing the course of cystic fibrosis and other pulmonary diseases. Their gene therapy technologies are designed to overcome the historical barriers that have prevented effective genetic treatments for cystic fibrosis.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Genetics
Deep Genomics is a Canada-based AI drug discovery and development platform that offers lead optimization and toxicity assessment solutions for the healthcare sector.
Business Model: unknown
Revenue: 5M
Employees: 88
Industry: Genetics
Stratos is a genomic technology company that designs nanopore DNA sequencer for diagnosing infectious diseases.
Business Model: unknown
Revenue: 8M
Employees: 60
Industry: Genetics
Corvidia is a pharmaceutical firm that develops and commercializes novel therapeutics for the treatment of cardiorenal and chronic kidney disorders.
Business Model: unknown
Revenue: 7.2M
Employees: 25
Industry: Genetics
DalCor develops precision medicine for patients suffering from cardiovascular diseases.
Business Model: unknown
Revenue: 5M
Employees: 53
Industry: Genetics
AceRNA contributes to regenerative medicine and drug discovery through the discovery of novel miRNA functions. It began operation in April 2018, with its headquarters in Kyoto in Japan.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
Interleukin develops and markets proprietary genetic tests for the prevention and management of chronic inflammatory diseases.
Business Model: unknown
Revenue: 1.7M
Employees: 3
Industry: Genetics
Synpromics is a biotechnology company that provides synthetic bioinformatics platform for developing gene medicines.
Business Model: unknown
Revenue: 120M
Employees: 81
Industry: Genetics
Celldom is developing next generation, high throughput single cell analysis technology to advance research, drug discovery, and drug development by illuminating diversity in cell populations. The company’s TrapTx Analyzer System uniquely integrates both phenotypic and genomic data at massive scale (up to tens of thousands of cells per experiment) to identify and characterize rare cells that play critical roles in biological pathways and disease. Celldom is developing initial applications of the platform in the areas of oncology, immunology and stem cell biology.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
Xenothera is a France-based biotechnology company that develops and commercializes immunotherapies for the treatment of cancer and infectious diseases.
Business Model: unknown
Revenue: 2M
Employees: 17
Industry: Genetics
Carcell Biopharma is a pre-clinical biotech company. Carcell Biopharma develops cell and gene therapy products with an innovative cross-border business model.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
Oxford Genetics is a UK-based biotechnology company specializing in the production of versatile cloning plasmids for research in academic and biotechnology institutions. They also provide custom cloning and DNA synthesis. All of their products are free of intellectual property restrictions.
Business Model: unknown
Revenue: 0 - 100000
Employees: 51 - 200
Industry: Genetics
Allelica is a New York-based genomic software platform that provides polygenic risk score analysis and reporting to reduce the impact of chronic diseases for individuals.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
NovaSom develops and commercializes home testing devices for monitoring and diagnosing obstructive sleep apnea.
Business Model: unknown
Revenue: 20M
Employees: 230
Industry: Genetics
Mapmygenome provides molecular diagnostics for genetic traits, drug responses, inherited conditions and diseases.
Business Model: unknown
Revenue: 1.3M
Employees: 63
Industry: Genetics
Loop Genomics develops genetic analysis tools that transform molecular sequences for synthetic biological research.
Business Model: unknown
Revenue: 3.2M
Employees: 10
Industry: Genetics
At Shield, we’re ensuring that antibiotic resistance doesn’t become more deadly than cancer. In 2050 more people will be dying of antibiotic resistant pathogens than cancer. Infections that were once treatable with a simple oral antibiotics are now requiring complex, painful treatments and resulting in serious health complications for patients. Gonorrhea is one such infection, having become resistant to over 10 different antibiotics, they have only one treatment that is still effective and resistance to this has already begun to emerge. With 820,000 new infections every year in the US, antibiotic resistance will spread quickly, which is why the CDC has resistant gonorrhea at an urgent threat level, the highest level available. Shield&s;s novel genomic testing platform enables STI clinics to identify the antibiotic resistant strains of gonorrhea and other pathogens that their patients have, so they can select the correct antibiotics and halt the spread of antibiotic resistance.
Business Model: unknown
Revenue: 0 - 100000
Employees: 10
Industry: Genetics
BioStrand is a Belgium-based firm that provides solutions such as genomics, structural genetics, data analytics and visualization to businesses.
Business Model: unknown
Revenue: 2M
Employees: 20
Industry: Genetics
Courtagen provides proteomic and genomic products and services to the life sciences industry.
Business Model: unknown
Revenue: 25M
Employees: 97
Industry: Genetics
MNM is a scientific start-up created by an interdisciplinary group of enthusiasts. We are a multi-specialist team of experts from geneticists, to molecular biologists, bioinformaticians and AI specialists. We combine next-generation AI with the most advanced genomic approaches (whole genome and multiomics data) to save the lives of cancer patients through predictive modeling and drug target identification.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Genetics
MGC is a developer of gene-based microbial testing, strain identification, point-of-grow screening solutions for the cannabis industry.
Business Model: unknown
Revenue: 3.8M
Employees: 25
Industry: Genetics
Nucleome Therapeutics is decoding the dark matter of the human genome to uncover novel ways to treat disease. The dark genome holds more than 95% of disease-linked genetic variants whose value remains untapped, representing a significant opportunity for drug discovery and development. We have the unique ability to link these variants to gene function and map disease pathways. Our cell type-specific platform creates high resolution 3D genome structure maps and enables variant functional validation at scale in primary cell types. This enables us to discover and develop novel, better and safer drugs. The initial focus of the company is on lymphocytes and related autoimmune disease. Our ambition is to build a robust pipeline of drug assets, with corresponding biomarkers. Nucleome Therapeutics was founded by leading experts in gene regulation from the University of Oxford and backed by investment from Oxford Sciences Innovation. For more information, please visit www.nucleome.com.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
Cytena is a life science company that designs and develops single-cell dispensing systems for genomic applications.
Business Model: unknown
Revenue: 6.4M
Employees: 50
Industry: Genetics
Basecare develops and markets medical devices for embryonic preimplantation genetic screening and diagnosis.
Business Model: unknown
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Genetics
Coriell Institute for Medical Research is a non-profit biomedical research center that provides blood banking, cell culture and molecular biology.
Business Model: unknown
Revenue: 3.4M
Employees: 142
Industry: Genetics
Vigene is a Maryland-based biotechnology company that develops and commercializes viral vector-based gene therapy products for research and clinical applications.
Business Model: unknown
Revenue: 30M
Employees: 130
Industry: Genetics
Probably Genetic is on a mission to help get answers for those with rare genetic conditions that are commonly initially diagnosed as autism spectrum disorder. On average, a patient with a rare genetic condition waits up 7 years to find answers. In the meantime, they spend years bouncing around from doctors to specialists, often at an enormous personal financial cost, to understand if there is more to their, or their child&s;s symptoms. They believe this is too long! Probably Genetic offers educational material and DNA sequencing tests to make it easy to find out if there is more to your symptoms. Their aim is to help those who fall through the cracks of the current healthcare system.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
Geneticure is a pharmaceutical firm that develops drugs by pharmacogenomics for chronic diseases.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
Serotiny partners is a life science company that develops therapies and tools for the treatment of cancer.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
Bluebee is a genomics analysis platform that provides diagnostic tools and components to clinicians and research labs.
Business Model: unknown
Revenue: 3.1M
Employees: 35
Industry: Genetics
Recombine is a clinical genetic testing company that facilitates informed medical decisions for patients and providers.
Business Model: unknown
Revenue: 17.4M
Employees: 54
Industry: Genetics
Ring Code Bio is a biomedical company that develops nucleic acid drugs based on a unique circular RNA technology platform.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Genetics
Dark Heart is California’s leading cannabis genetics company serving retail consumers and commercial growers with cutting edge genetics in a variety of form factors. Our business is powered by our leading cannabis ag biotech platform. With core competencies in tissue culture, genetics, and plant pathology.
Business Model: unknown
Revenue: 0 - 100000
Employees: 51 - 200
Industry: Genetics
Retro Sense Therapeutics delivers novel therapies to specific diseases of the eye.
Business Model: unknown
Revenue: 2.8M
Employees: 220
Industry: Genetics
Coral is a biotechnology firm that offers clinical genetic testing services for the treatment of chronic disease.
Business Model: unknown
Revenue: 500k
Employees: 20
Industry: Genetics
Renova Therapeutics engaged in the development of treatments for congestive heart failure and other chronic diseases.
Business Model: unknown
Revenue: 18.1M
Employees: 41
Industry: Genetics
ImmunoVec develops gene therapy treatments to cure terminal genetic diseases of the immune system. Its gene therapy is intended for hematopoietic diseases.
Business Model: unknown
Revenue: 0 - 100000
Employees:
Industry: Genetics
NYGC is a genome sequencing and research center that offers bioinformatics and data management services.
Business Model: unknown
Revenue: 13M
Employees: 191
Industry: Genetics
Helex uses its own genomics data, bioinformatics, and intelligent data-driven platform to create, verify, and distribute therapy-specific gRNAs. Founded in 2021 and is based in New York.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
Integra Therapeutics is a developer of next-generation of gene editing tools to cure diseases.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
Business Model: unknown
Revenue: 0 - 100000
Employees: 201 - 500
Industry: Genetics
Panacea Life Sciences is a Colorado-based company that produces and retails cannabinoid-based products such as tablets, oils and pain relief patches for the commercial market.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Genetics
GeneMatters is a Minnesota-based digital health company that provides genetic counseling services for hospitals and biopharmaceutical companies.
Business Model: unknown
Revenue: 3M
Employees: 35
Industry: Genetics
Veritas is a Spain-based health-tech company that offers solutions such as genetic screening and whole genome sequencing for individuals.
Business Model: unknown
Revenue: 3M
Employees: 40
Industry: Genetics
LaserGen is a biotechnology company that focuses on the research and development of technologies for DNA sequencing.
Business Model: unknown
Revenue: 5M
Employees: 45
Industry: Genetics
GenomSys is a SaaS-based firm that provides genomics information handling solutions for businesses.
Business Model: unknown
Revenue: 1.9M
Employees: 29
Industry: Genetics
Perthera is a Massachusetts-based biotechnology company that develops and commercializes personalized molecular analysis for advanced-stage cancer.
Business Model: unknown
Revenue: 4M
Employees: 30
Industry: Genetics
Edico Genome develops an automation platform that analyzes sequencing data for newborns, cancer patients, scientists and drug developers.
Business Model: unknown
Revenue: 2.4M
Employees: 50
Industry: Genetics
Zymtronix develops technology for enzyme immobilization. It provides a platform to immobilize enzymes and screen for immobilized enzyme performance, the unlocked potential of oxidative enzymes for biocatalysis, and new materials and customer-oriented processes for small molecule conversion. The company is optimizing enzyme immobilization to create unique, and sustainable and responsible processes for high-performance biocatalysis. Stéphane Corgié founded Zymtronix in 2013. It has its headquarters in Ithaca in New York.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Genetics
Genomics Medicine Ireland is an Irish life sciences company leading a large-scale research study across Ireland looking at the human genome to examine the relationship between genetics, health and disease.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Genetics
Clear Genetics develops a SaaS-based platform that offers medical genetic testing solutions to the healthcare industry.
Business Model: unknown
Revenue: 2.2M
Employees: 18
Industry: Genetics
Lamar Health connects patients with genetic diseases to new treatments or research. Lamar Health was founded in 2020 by Eesha Sharma and Serhiy Serhiy Shekhovtsov.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
Qlucore is a Sweden-based bioinformatics software development company that provides multi-omics companion and precision diagnostics solutions for the biotechnology sector.
Business Model: unknown
Revenue: 10M
Employees: 56
Industry: Genetics
Jiksak Bioengineering is a biotechnology company. Jiksak Bioengineering provide an efficient screening service using a three-dimensional cell tissue "Nerve Organoid". We will mainly develop screening technologies specifically for neurodegenerative diseases and search for drugs that are effective for amyotrophic lateral sclerosis (ALS).
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
Lifebit is an England-based genomic data analytics platform that offers clinical research and biomedical data visualization solutions for pharmaceutical researchers.
Business Model: unknown
Revenue: 1.5M
Employees: 65
Industry: Genetics
Ebb Therapeutics is a medical device company that develops regional cerebral thermal therapy devices for insomnia and sleep disorders.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Genetics
WaferGen is a biotechnology company that offers genomic technology solutions for single-cell analysis and clinical research.
Business Model: unknown
Revenue: 9.2M
Employees: 54
Industry: Genetics
Ranomics provides database of genetic variations and their associated disease risk.
Business Model: unknown
Revenue: 4M
Employees: 30
Industry: Genetics
Lineagen is a genetic testing firm that provides proprietary molecular diagnostics solutions for patients with ASD and neurodevelopmental disorders.
Business Model: unknown
Revenue: 6.3M
Employees: 70
Industry: Genetics
AVECRIS platform extends the capabilities of mRNA / RNA approaches. AVECRIS provides the following services: cell-type specific gene expression / Protein expression that is stable and long-lasting / Non-integrating, unlikely to elicit innate immunity / Redosable and titratable / Unprecedented ability to deliver mitochondrial gene therapy / A DNA-based backbone construct that is universal, unmodified, and has a modular coding region that allows for rapid and infinite application programming / Manufacturing that is quick, dependable, highly scalable, and low-cost.
Business Model: unknown
Revenue: 0 - 100000
Employees:
Industry: Genetics
Genia Technologies develops DNA sequencing system.
Business Model: unknown
Revenue: 3.6M
Employees: 30
Industry: Genetics
Inso Bio is a New York-based biotechnology firm that develops and supplies products such as genome sampling, DNA sequencing and multi-omic analysis for the healthcare sector.
Business Model: unknown
Revenue: 520k
Employees: 3
Industry: Genetics
MedAnswers is an online healthcare application that allows infertility patients to connect with embryologists, andrologists, and geneticists.
Business Model: unknown
Revenue: 1.2M
Employees: 15
Industry: Genetics
Sequenom is a molecular diagnostic testing and genetics analysis firm that provides diagnostic testing, applications and genetic analysis products.
Business Model: unknown
Revenue: 119M
Employees: 454
Industry: Genetics
KromaTiD is a Colorado-based bioscience company that provides services such as gene editing, undiagnosed disease screening, single cell analysis and radiation biodosimetry.
Business Model: unknown
Revenue: 14.1M
Employees: 35
Industry: Genetics
NuCicer is a crop genetics company pioneering ultra-high protein varieties of chickpea. The company was founded in 2019 and is based in Davis, California.
Business Model: unknown
Revenue: 0 - 100000
Employees:
Industry: Genetics
Gini is a Canada-based health and wellness platform that provides DNA-based diet and fitness training plans for individuals.
Business Model: unknown
Revenue: 2.5M
Employees: 40
Industry: Genetics
Appistry designs, develops and provides analytics and data management software to corporations.
Business Model: unknown
Revenue: 0 - 100000
Employees: 30
Industry: Genetics
The company delivers genetic tests that help people to live healthier (predisposition tests), save lives (inherited deseases) and help in family planning (carrier screening).
Business Model: unknown
Revenue: 0 - 100000
Employees: 51 - 200
Industry: Genetics
Atossa Therapeutics is a biopharmaceutical company that develops novel, proprietary therapeutics for breast cancer and conditions.
Business Model: unknown
Revenue: 0 - 100000
Employees: 7
Industry: Genetics
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Genetics
Business Model: unknown
Revenue: 0 - 100000
Employees: 51 - 200
Industry: Genetics
Arctic Therapeutics (AT) uses bioinformatic approaches and AI to eliminate major risks associated with traditional drug development, as well as sharply reducing the enormous cost and time to bring effective treatments to millions of patients. AT leverages over 20 years of international genomics research, pioneering a novel approach to guide its drug development. The company collaborates closely with The Center for Applied Genomics (CAG) at the Children’s Hospital of Philadelphia to repurpose and develop ground-breaking new medical treatments. A conservative valuation of AT’s pipeline exceeds $100 billion, and the company‘s Alzheimer‘s drug candidate has the potential to become the first cure for dementia, not only treating the disease but preventing it AT&s;s creation was inspired by one of the leading minds in applied genomics, Dr. Hakon Hakonarson, who launched CAG in 2006 and established it as the largest paediatric biobank and genomic database in the world Time Magazine listed Dr. Hakonarson’s autism gene discovery project, reported in Nature in 2009, among the top ten medical breakthroughs of that year. Dr. Hakonarson’ s Nat Med paper on a novel precision-based therapy in lymphatic disorders was awarded among the top 10 clinical/translational papers in 2020 by The Clinical Research Forum. Dr. Hakonarson was recently ranked among “The World’s Most Influential Scientific Minds” by Thomson Reuters, with over 1000 publications and h-index of 171.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
Paradigm Diagnostics is a precision medicine company that provides genetic and molecular testing services for the treatment of cancer.
Business Model: unknown
Revenue: 5M
Employees: 48
Industry: Genetics
Cure Forward develops, builds and operates as a digital platform that enables cancer patients to identify targeted therapies and clinical trials.
Business Model: unknown
Revenue: 1.3M
Employees: 98
Industry: Genetics
Resolve BioSciences is a Germany-based molecular cartography platform that offers single-molecule detection solutions for clinical pharmaceutical scientists.
Business Model: unknown
Revenue: 0 - 100000
Employees: 51 - 200
Industry: Genetics
ActX is a Washington-based health-tech company that provides services such as personalized medical prescriptions and health record management for patients and hospitals.
Business Model: unknown
Revenue: 18M
Employees: 200
Industry: Genetics
Positive Sequence Biology is a biotech company with new gene system-based editing, focused on biotech innovation &a; breakthrough therapies.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
KEW provides genomic testing services that enable oncologists to make evidence-driven personalized treatment decisions for cancer patients.
Business Model: unknown
Revenue: 3M
Employees: 20
Industry: Genetics
Asuragen is a molecular diagnostic product company that provides oncology, and clinical testing services for cancer diagnosis.
Business Model: unknown
Revenue: 30M
Employees: 200
Industry: Genetics
MiLaboratories&s; key product - MiXCR is a top-notch solution to analyze immunology sequencing data. Software is used in the vaccine, cancer, antibodies, and autoimmune diseases drug development pipelines. The original idea is based on a Nature Journal article published in 2015 and developed by founders into a cutting-edge software solution based on competitors&s; reviews by top Pharma and the academic community.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Genetics
JCVI is a nonprofit organization that researches and develops human genomic medicine.
Business Model: unknown
Revenue: 9.6M
Employees: 207
Industry: Genetics
Curetis is a molecular diagnostics company that develops tools to test infectious diseases.
Business Model: unknown
Revenue: 2M
Employees: 100
Industry: Genetics
AltraTech designs and develops biosensors and semiconductor molecular testing chips to detect infectious viral diseases.
Business Model: unknown
Revenue: 1M
Employees: 271
Industry: Genetics
TapImmune engages in the discovery and development of immunotherapeutics for the treatment of cancer, infectious diseases, autoimmune disorders, and transplant tissue rejection. The company focuses on conducting studies using its transporters of antigen processing (TAP) gene technology in combination with an adeno virus. Its products include TAP cancer vaccine used for the treatment of breast cancer, prostate cancer, lung cancer, liver cancer, melanoma, renal cancer, and colorectal cancer. The company also develops vaccines for infectious diseases using its TAP gene technology. TapImmune has strategic relationships with University of British Columbia, Crucell Holland B.V., SAFC Pharma, Inc., and National Institute of Allergy and Infectious Diseases. The company was founded in 1999 and is based in Vancouver, Canada.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Genetics
Gene Box is a health management platform that delivers fitness insights and personalized diet plan solutions for healthcare and insurance sectors.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Genetics
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Genetics
Genomenon is a Michigan-based AI platform that provides solutions such as drug discovery and genomic data analytics for sectors including healthcare and pharmaceutical.
Business Model: unknown
Revenue: 2M
Employees: 42
Industry: Genetics
Genisphere research and development service for the nanotechnology based products.
Business Model: unknown
Revenue: 29.6M
Employees: 206
Industry: Genetics
Circulomics is a Maryland-based biotechnology company that develops PicoSep instruments, separation cartridges, and assay kits for biomarker analysis and clinical diagnostics.
Business Model: unknown
Revenue: 8.1M
Employees: 25
Industry: Genetics
Xcode is a pioneer in personal genomics, specializing in preventative healthcare. We are dedicated to empowering physicians, wellness professionals and individuals with the most validated actionable genomic information, to positively impact health and improve the quality of life. Using advances in genomics, informatics, computing, and domain specific knowledge, Xcode is building comprehensive personalized solutions for clients across clinical and non-clinical segments. The genetic tests are performed using saliva screens for presence or absence of these mutations through a technique known as genotyping. In the genetic reports, we present information about your genotype and its associations for specific conditions. The association information has been curated by us from hundreds of scientific publications from India and abroad. The test protocols and the equipment we use are world class, and the procedure and method of testing are as per international standards.
Business Model: unknown
Revenue: 0 - 100000
Employees: 60
Industry: Genetics
Genomcore is a professional bioinformatics framework with focus on privacy, compliance and collaborative analysis designed for a broad implementation of precision medicine in a clinical context. Made of Genes is a personal genomics service spined-off from Genomcore.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Genetics
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Genetics
BG Medicine is a life sciences company focused commercialization of novel molecular diagnostics based on biomarkers to improve patient outcomes.
Business Model: unknown
Revenue: 1.6M
Employees: 5
Industry: Genetics
SGB is a fully-integrated bioenergy crop company using molecular breeding and biotechnology to develop and produce elite hybrid seeds of Jatropha as a low-cost feedstock for biodiesel, bio-jet fuel, and specialty chemicals. With the largest and most diverse library of Jatropha genetic material, SGB is turning the opportunities of Jatropha into reality through a world-class leadership team, leading-edge science and genetics, and expertise in agronomy and plantation management. SGB has been named one of the Top 5 Renewable Jet Fuel Supply Chain Companies in the World by The Carbon War Room (2011), one of the Top 50 Companies in Bioenergy for three consecutive years (2009, 2010, and 2011), and the 2010 Feedstock Domestication Project of the Year by Biofuels Digest and one of the Top 200 Going Green Private Companies in the World by Always On.
Business Model: unknown
Revenue: 7.9M
Employees: 51
Industry: Genetics
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Genetics
DxTerity has developed the DxDirect genomic platform that enables measurement of genomic biomarkers from a single drop of blood.
Business Model: unknown
Revenue: 11.5M
Employees: 55
Industry: Genetics
MyGene focuses on providing clinical diagnostics and treatment guidelines for doctors and cancer patients.
Business Model: unknown
Revenue: 3M
Employees: 120
Industry: Genetics
Acrigen Biosciences is dedicated to making gene editing safe. It develops technologies to improve efficiency and enhance the safety of CRISPR-Cas based gene editing. CRISPR-Cas system which enables the precise enzymatic editing of genes is one of the most exciting and promising techniques to be developed in the last few years with the capability to prevent or cure many devastating diseases. It was founded in 2019 and is headquartered in Berkeley, California.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
Tongshu Gene is a high-tech enterprise that focuses on the field of tumor precision medicine. The company provides gene testing services and develops diagnostic molecular pathology projects and ctDNA precision detection systems based on high-throughput gene sequencing technology and biological information analysis to provide clinicians with consulting services including precision medication, efficacy monitoring, postoperative recurrence monitoring, and risk prediction and early detection.
Business Model: unknown
Revenue: 0 - 100000
Employees:
Industry: Genetics
Raided by the FBI for alleged fraudulent billing practices, uBiome uses a clinical screening platform to sequence human microbiomes for consumers.
Business Model: unknown
Revenue: 32M
Employees: 96
Industry: Genetics
Humane Genomics is a virus development platform that develops artificial viruses to cure diseases. The company was founded in 2019 and is headquartered in New York, United States.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
Biomedican is a biotechnology company that conducts research into synthetic biology and cellular agriculture. The company is working on research and development to commercialize its disruptive intellectual property that is focused on emerging industries. Biomedican has marshaled experts across the globe, leaders in their respective fields, to ensure the speed and success of these efforts. Biomedican is based in Berkeley, California.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
Ceram Pharmaceuticals is a biotech firm that uses epigenetics to carry out R&a;D of drugs and diagnostic treatments for cancer and diseases.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Genetics
Lifecode provides concise, accurate and actionable molecular information for patients with cancer diseases.
Business Model: unknown
Revenue: 1.7M
Employees: 26
Industry: Genetics
KinDex Pharmaceuticals is a developer of novel therapeutics used to help patients suffering from metabolic disorders. It was established to focus on the discovery and development of molecules that improve women’s health and impact chronic disease. KinDex Pharmaceuticals is developing therapeutics that work through the Bitter Taste Receptors (TAS2Rs), a family of GPCR receptors that target inflammation and metabolic dysfunction.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
Primordial Genetics is developing Function Generator™, a novel combinatorial gain-of-function genetic technology designed to enhance product tolerances, productivities (rate, titer and yield) and growth characteristics of microbial organisms used for renewable production of chemicals, fuels, pharmaceuticals and other commercially valuable compounds. The technology will find widespread applications in multiple industries.
Business Model: unknown
Revenue: 7.9M
Employees: 40
Industry: Genetics
We apply our end-to-end solutions to hand genetic reports at the clinical desk. We make Genomics accessible!
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Genetics
Antegenes’ novel genetic tests assess a patient’s personal cancer risks, and include clinical recommendations for personalized cancer prevention. The tests are based on innovative polygenic risk score technology which helps to clarify a person’s genetic predispositions to cancer. It therefore allows for more accurate prevention and early detection measures – crucial in the fight with cancer. The tests are currently being used to determine the genetic risk for four cancers: breast cancer, prostate cancer, colon cancer, and skin melanoma.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
Anandia Labs is a biotechnology company focused exclusively on cannabis, with the aim of bringing the best of modern science to the cannabis industry for the benefit of growers and consumers. Anandia Labs provides industry leading analytical testing services including potency, pesticides, microbes and terpenes to Licenced Producers and patients. In addition, Anandia Labs uses its cannabis-specific scientific expertise to assist its customers in the analysis of their testing results and resolution of any detected non-conformities.
Business Model: unknown
Revenue: 0 - 100000
Employees: 51 - 200
Industry: Genetics
Bamboo Therapeutics researches, discovers, develops, produces and commercialises gene therapies for the treatment of neurological diseases.
Business Model: unknown
Revenue: 1.2M
Employees: 33
Industry: Genetics
Business Model: unknown
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Genetics
IdentiGEN is a biotechnology firm that provides DNA-based animal traceability solutions for the agri-food industry.
Business Model: unknown
Revenue: 24.3M
Employees: 142
Industry: Genetics
Biotechnology in BioPharma, Genetics, Medical Research and Delivery | Integration of AI patented technologies in medicine and biotechnology Engaging in Research and Development in AI, Nanotechnology, Biotechnology, and Biotechnology- Genetics towards the advancement of medicine.
Business Model: unknown
Revenue: 0 - 100000
Employees: 51 - 200
Industry: Genetics
Transplant Genomics is a biotech company that focuses on improving organ transplant outcomes with noninvasive serial monitoring guided by genomics. Its extensive development pipeline includes diagnostic and predictive tests for kidney and liver graft dysfunction, the use of multiple sample types and technology platforms, companion diagnostics for immune suppressants and immune status tests.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
EnEvolv develops a microbial screening platform that utilizes sensor systems for the development of enzymes and molecules.
Business Model: unknown
Revenue: 3.5M
Employees: 25
Industry: Genetics
Cytox have developed a simple genetic based blood test for the assessment of risk and diagnosis of Alzheimer&s;s Disease in the very early stages. Alzheimer&s;s Disease affects over 26 million people world-wide and is a growing condition as people live longer. There is currently no cure for Alzheimer&s;s Disease, but there are large international initiatives underway to find treatments with many drugs in clinical development. Cytox are commercially launching their tests in conjunction with Affymetrix (part of Thermo Fisher Scientific) to support Pharmaceutical and Biotechnology companies developing novel therapeutics.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
HaploX develops a genetic sequencing technology that helps to detect the circulation of tumor DNA sequencing for personalized cancer therapy.
Business Model: unknown
Revenue: 2.5M
Employees: 34
Industry: Genetics
Claritas Genomics engages in providing genetic testing services for the diagnosis of pediatric disorders.
Business Model: unknown
Revenue: 4.4M
Employees: 20
Industry: Genetics
Flomics uses circulating transcriptomic analysis to provide novel non-invasive, fast and affordable diagnostics for complex diseases.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
Ambulero is a Florida-based biotechnology company that develops and commercializes cell and gene therapies for the treatment of vascular disease.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Genetics
ImmunoMind improves the design of T-cell therapies by precisely identifying T-cell subpopulations and their immune profile. ImmunoMind’s Augmented Intelligence platform guides translational and clinical research to improve the product’s quality, safety and efficacy with single-cell precision. The platform is based on proprietary single-cell multi-omics technologies to automatically evaluate cell differentiation, estimate exhaustion rate of subpopulations and identify off-tumor targets. UC Berkeley SkyDeck’20 Alumnus.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Genetics
RNAgri is a biotech company that develops and commercializes RNA based chemical products for the fertilizer industry.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
Empire Genomics is a New York-based company that designs, manufactures and distributes molecular biomarkers for clinical laboratories and biotechnology companies.
Business Model: unknown
Revenue: 15.8M
Employees: 60
Industry: Genetics
Somos is a Mexican company of genetic solutions that offers you evidence of global ancestry and Latin American ancestry with an important differentiator: ancestry of Latin American groups, which makes it the first test to offer this kind of information.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
Jungla develops AI-based computational and cellular modeling to improve clinical genetic tests in the healthcare industry.
Business Model: unknown
Revenue: 10M
Employees: 1 - 10
Industry: Genetics
Fusion Genomics develops highly sensitive and massively multiplex DNA/RNA sequencing based diagnostics for infectious diseases. We seek to change the paradigm in both treatment of the individual (optimum genomic information for effective personalized therapy) and public health (information for development of transmission dynamic models, outbreak predictions &a; optimal vaccines). Fusion Genomics ONETest platform enables accurate and simultaneous detection and discrimination of hundreds of pathogens. The ONETest platform consists of our patent-pending DNA/RNA capture technology called Quantum Probes. These are paired with fully optimized reagents into a ONETest kit for library preparation which is then used to sequence the sample on NGS machines (Illumina/Life). Results from the sequencing are analyzed using Fusion’s proprietary Fusion Cloud database and analytics suite. The ONETest platform captures actionable genomic data at par with meta-genomic sequencing at a fraction of the cost. The advantages of the platform over PCR are: 1) Limits of detection up to 1,000x better; 2) High sensitivity and specificity; 3) Detail pathogen data including virulence and resistance markers; and 4) high number of organisms and variants targeted. Our Cloud and proprietary database enable us to not only give all relevant clinical data but also to do detail strain level analysis and combine other data (such as such as geo-tags) for surveillance, epidemiology and transmission dynamics studies. Fusion Genomics develops tests for both the surveillance/research and clinical markets. Our two present test – Influenza ONETest and Avian Influenza Environmental DNA ONETest – have gained traction in the surveillance market in Canada and the EU. The AI eDNA ONETest proves our claims on high limit-of-detection, sensitivity and specificity by being the only test to date that can detect and genotype avian influenza from wetland sediments in wild bird habitats. Our upcoming Hepatitis C tests is similarly designed to give much improved clinically actionable data in a single test and we have a pipeline of other tests such as HPV, MDR/XDR Tuberculosis, blood screening multiplex, sepsis, etc.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Genetics
HumanCode develops and provides a personal genomics application that allows users to understand about their genetics.
Business Model: unknown
Revenue: 1.5M
Employees: 11 - 50
Industry: Genetics
Beta Bugs is a cutting edge biotechnology company that produces enhanced insect strains for the growing insect farming industry. The domesticated, optimised strains we produce provide benefits at all levels of the production chain ensuring the industry is both more profitable and sustainable. We accelerate the evolution of the organisms to create traits that ensure greatly superior final products.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
Deyun Kangrui is a bio-medical high-tech enterprise that integrates R&a;D and the production of full-chain single-cell multi-omics technology.
Business Model: unknown
Revenue: 0 - 100000
Employees:
Industry: Genetics
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
One Codex is a data platform for applied microbial genomics, enabling new and valuable applications in clinical diagnostics, food safety, and biosecurity.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
MOgene LC, a Limited Liability Company has been in operations since February 2004. The company has established solid reputation as a genomics service provider to academic, government and industrial research groups and institutions. Several papers have been published in leading scientific journals, based on the genomic services provided by MOgene. Company’s management and employees have a vast range of expertise and experience.
Business Model: unknown
Revenue: 6.5M
Employees: 38
Industry: Genetics
Agribody Technologies is a agricultural biotechnology company with patented technology that pinpoints and knocks down the gene that causes quick decay in perishable crops, resulting in 3X - 4X longer shelf life, more tolerance to stress, and up to 40% higher yields. CRISPR genome editing is the technical breakthrough enabling our precise novel plant trait development at low cost and high scalability, providing solutions for agricultural crop loss and food waste. We license and co-develop our technology.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
Engender has developed a proprietary process to separate X (female) and Y (male) bearing bull sperm cells, enabling dairy farmers to accelerate genetic gain and improve productivity. Engender has secured scientific and laboratory facilities from one of the world’s largest AI companies in exchange for an option for it to non-exclusively license Engender’s technology.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
Nextcode Health provides genomics diagnosis, treatment and solutions.
Business Model: unknown
Revenue: 0 - 100000
Employees: 31
Industry: Genetics
Genz is a biotech research &a; development company, developing novel diagnostic solutions for complex diseases, like cancer, coronavirus pandemic. Genz provides solutions for medical centers and/or end-users in cooperation with genetic disease and diagnostic centers. To date, Genz received 4 R&a;D grants and approval by Turkish Ministry of Health for 3 genetic tests.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Genetics
Rthm guides you to time your life to your Body Clock. Use Rthm to discover the best times to eat, think, exercise, and more. Our DeepHeart feature – based on decades of published research and 2 million unique recordings – is the only technology capable of analyzing your heart health and nervous system using only your iPhone. Combined with our mobile genetic analysis software – riDNA – Rthm is the only product in the world that provides users with a truly holistic snapshot of their health, encompassing their Circadian Rhythm, heart and nervous system health, and genetics.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Genetics
Conformiq delivers model-based testing (MBT) tools, solutions, and services for the automated design of functional tests, derived from high-level functional models of the software and systems to be tested. Its Conformiq 360○ Test Automation technology enables the next generation of testing transforming, streamlining, and automating even the most complex system-level testing environments.
Business Model: unknown
Revenue: 0 - 100000
Employees: 25
Industry: Genetics
Gen-t is a platform capable of providing the map of genomic research. Gen-t was founded in 2021 and was headquartered in Sao Paulo, Brazil.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Genetics
TellmeGen helps people identify possible future illnesses and sensitivities inherent in their genes. TellmeGen was established 2014 in Valencia, Spain.
Business Model: unknown
Revenue: 3.8M
Employees: 45
Industry: Genetics
PathoGene, Inc. is a private, seed-stage precision MedTech startup headquartered in Los Angeles, with R&a;D operations located in Monrovia, California. We are developing a sample-to-answer in vitro diagnostic medical device that detects and identifies all known microscopic human pathogens along with their antimicrobial resistance profiles on a single 6-hour test panel. To do this, we leverage robotic automation, third-generation DNA and RNA sequencing, and cloud computing technologies to report a molecular diagnosis to care providers and disease surveillance systems in real-time. Our goal is to deliver the necessary diagnostic tools for doctors and medical staff to make optimal treatment decisions that can ultimately improve public health as a whole, and we believe that our sample-to-answer technology can become the global standard of care for diagnosing infectious diseases.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
GA is a molecular diagnostic company that provides microbiota analysis for testing bacterial imbalance in IBS and IBD patients.
Business Model: unknown
Revenue: 821.8k
Employees: 11 - 50
Industry: Genetics
Predictive Fitness is a health and fitness technology company that uses big data, advanced analytics, and artificial intelligence to prescribe and optimize health and fitness activities for individuals based on their individual biometrics, genetics, and activity data. The company&s;s patent-pending algorithms discover key data trends, patterns, and relationships that impact results. It was founded by Jeff Booher, in 2003 Predictive Fitness is based in Southlake, Texas.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Genetics
Wildlife engages in developing gene therapy for the treatment of rare diseases.
Business Model: unknown
Revenue: 4M
Employees: 10
Industry: Genetics
WASAI Technology is a big data acceleration platform that accelerates system architecture and infrastructure. It delivers expert patented solutions to problems for large data centers with high quality and performance. It focuses on FPGA accelerators for Hadoop, Spark, Hive, and DNA sequencing algorithms. WASAI Technology creates highly competitive and unique products to meet the customers’ needs. WASAI Technology was founded on 2015 and is headquartered in Taipei, Taiwan.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Genetics
AzarGen is focused on developing human therapeutic proteins using genetic engineering and synthetic biology techniques in plants.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
Jiabao Renhe provides genetic testing solutions in the field of assisted reproduction.
Business Model: unknown
Revenue: 0 - 100000
Employees: 51 - 200
Industry: Genetics
Genomics and Artificial Intelligence are two of the most promising technologies today. Individually, each provide unapparelled insight into millions of datapoints, and the combination of the two are leading to some of the greatest discoveries of our lifetime. In the U.S. alone, there are over 25 million people affected by rare genetic diseases and it is estimated that every year more than 400,000 children are born with one of these conditions. Genetic testing is quickly becoming the go-to procedure to effectively identify these conditions, allowing for improved patient outcomes and potential lives saved. Unfortunately, once a SNP Array test is prescribed and sequenced, Geneticists all over the world have traditionally spent millions of man-hours manually sifting through databases in order to identify and correlate a case to more than 7,000 rare diseases. That is, until now. Our SIVOTEC BioInformatics name derives from “Signatures in Vivo Through Technology” and our GENA™ AI platform provides commercial labs, hospitals and academic centers with the necessary tools to shorten their discovery cycle by over 95% (from days to just minutes) thus accelerating the time from testing-to-diagnosis and saving thousands of dollars per each sample sequenced thanks to improvements in workflow and the quality of results.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
Business Model: unknown
Revenue: 0 - 100000
Employees: 51 - 200
Industry: Genetics
eXIthera is a biotech company that is focused on developing small molecule pharmaceuticals to inhibit Factor Xla.
Business Model: unknown
Revenue: 3.4M
Employees: 20
Industry: Genetics
B-MoGen provides gene editing solutions for immunotherapy treatments.
Business Model: unknown
Revenue: 1M
Employees: 28
Industry: Genetics
Dante Labs is a direct-to-consumer genomic testing platform that provides whole genome sequencing tests, DNA Tests and data analysis solutions.
Business Model: unknown
Revenue: 100M
Employees: 325
Industry: Genetics
Inbiomotion is a personalized medicine company develops biomarkers that predict bone metastasis to improve cancer patients life.
Business Model: unknown
Revenue: 7.4M
Employees: 91
Industry: Genetics
CircaGene is building the future of genetic testing. Direct to Consumer platform where users can order personal genetic tests through total privacy (Patented new encryption Number 1907358.4) with actionable results to reduce health Risk and enhance lifestyle and health. CircaGene provides End-to-end Encryption guaranteeing that only the user can have access to his results, protecting Genetic Privacy. Sequencing Services that put in relation Consumers with the best Genetic Research algorithms, easy to navigate reports, and connection to third parties with consistent healthcare. CircaGene can be described as the “Uber” of Genetic testing.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
Jupiter Orphan Therapeutics, Inc. (JOT) is a specialty pharmaceutical company developing therapies for rare diseases linked to single gene deficiencies. JOT, a Delaware Corporation with it&s;s principal office located in Jupiter, FL, USA, was founded in the summer of 2015. In its short period of operations, JOT has assembled a very strong management and scientific team as well as defined three pipeline products which of one is already in Phase II.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
Democratizing access to genetic technologies for cannabis and hemp.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Genetics
Neoprospecta, a contract research company, uses high-throughput genomic sequencing and large scale bioinformatics to find new genes, enzymes, and other proteins from the biodiversity. It specializes in bioprospecting of new enzymes, peptides, and other proteins. Neoprospecta offers custom metagenomic bioprospection, contract research, enzyme development, and conservation biology services. Luiz Fernando Valter de Oliveira, Luiz Felipe Valter de Oliveira, Ronaldo Mota, and Marcos Carvalho founded it on January 21, 2011, with its headquarters in Florianópolis in Brazil.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Genetics
Genetic disease risk analysis service through M-CHECK (My Genome Check), a system for analyzing individual genes and biomarkers of Korean and various races developed by the head office, will be a guide to disease prevention and health life extension. is.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Genetics
CellScape Corporation (formerly Saryna Medical Corp) is a privately funded company headquartered in Newark, California, in the heart of the biotech corridor of the San Francisco Bay Area. The Company has developed whole fetal cell technology to transform prenatal genetic testing using a simple blood test. Their vision is to make comprehensive prenatal genetic testing available to every woman without requiring an invasive procedure that might put the fetus at risk. Their leadership team is accomplished in bringing innovative, cost-effective medical and molecular diagnostics to market.
Business Model: unknown
Revenue: 19M
Employees: 90
Industry: Genetics
Developing the next generation of antibiotics with novel mechanisms of action.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
Amylon focuses on developing central nervous system therapies for the treatment of Katwijk disease.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
KellBenx is a biotechnology company that develops patented tests to advance the science of women's health.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
Athletigen is an online genetic testing platform that helps athletic to customize personalized training and fitness programs to improve performance.
Business Model: unknown
Revenue: 2.5M
Employees: 25
Industry: Genetics
Cognigenics transforms mental health in the genetic age through cognitive neuroengineering. The company’s business is cognitive neuroengineering, which is the genetic engineering of desirable cognitive traits, such as mindfulness, relaxation, and mental acuity. These cognitive assets can enhance human performance in normal individuals or offset cognitive deficits in people suffering from mental health issues such as stress, anxiety, and depression (which are the initial applications).
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
EpigenCare is connecting consumers with skincare companies through a direct-to-consumer skincare test and web platform on the Ethereum network. Consumers receive actionable recommendations of optimized skincare products to use, as well as assess the progress of their skincare routines, based on their skin&s;s epigenetic profiles. The recommendation engine looks at the functional state of a panel of epigenetic markers strongly correlated with skin quality indicators (e.g., aging, moisture retention, elasticity, etc.), and how skincare product ingredients affect them. It offers SKINTELLI, a direct-to-consumer personal epigenomics test that measures DNA methylation levels of a proprietary panel of genes responsible for key skin quality factors (e.g., aging, elasticity, moisture retention, etc.). The SKINTELLI web platform empowers you with the knowledge of which products truly work for your skin. EpigenCare was founded in 2017 and based in Farmingdale, New York.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
Pathogenetix develops biological sensors for the identification of pathogens and biomarkers in air, human serum, and other biological materials.
Business Model: unknown
Revenue: 24.1M
Employees: 101
Industry: Genetics
Beijing Compson Agricultural Technology Co., Ltd., established in 2018 with a registered capital of 10 million yuan, is a wholly-owned subsidiary of Beijing Compson Biotechnology Co., Ltd. It has been rated as a Zhongguancun high-tech enterprise and a national high-tech enterprise. Co-sponsor unit of "Pig Genome Selection and Breeding Beijing Alliance", "Shanxi Jin Pig Industry Technology Innovation Strategic Alliance", "Sheep Chip Breeding Alliance", "Broiler Whole Genome Selective Breeding Alliance" and a member unit of the Information Branch of China Animal Husbandry Association . The company focuses on molecular breeding, uses genetic technology to solve breeding problems, and adheres to the corporate mission of "genes help new agriculture".
Business Model: unknown
Revenue: 0 - 100000
Employees:
Industry: Genetics
Ngx Bio is a biotechnology firm that specializes in offering sample preparation, design and genomic data analysis for sequencing projects.
Business Model: unknown
Revenue: 1M
Employees: 5
Industry: Genetics
GenScript is a New Jersey-based biotech company that discovers, develops and commercializes industrial synthetic products and cell therapeutic solutions.
Business Model: unknown
Revenue: 511.1M
Employees: 4.6k
Industry: Genetics
Chengdu Genevector Biotechnology Co., Ltd. (Genevector, Genevector) is a biotechnology company engaged in the research and development of new drugs for adeno-associated virus (AAV) gene therapy. The company is committed to the development of new AAV gene therapy drugs for ophthalmic diseases, neuromuscular diseases, genetic and metabolic diseases, etc.
Business Model: unknown
Revenue: 0 - 100000
Employees:
Industry: Genetics
Cadex Genomics is a biotechnology company that develops molecular diagnostic tests to treat cancer patients.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
Linkage Biosciences is a molecular diagnostics company that focuses on the development of real-time PCR genotyping technologies.
Business Model: unknown
Revenue: 25M
Employees: 45
Industry: Genetics
Nova Satra engages in the research, development and commercialization of blood-based diagnostic tests for the detection of cancer.
Business Model: unknown
Revenue: 2M
Employees: 176
Industry: Genetics
PNA Innovations provides customized reagents for biotechnological and biomedical applications.
Business Model: unknown
Revenue: 6.5M
Employees: 24
Industry: Genetics
Rapid Diagnostek formerly Intellignostics, has developed a patented, inexpensive, easy to use sensor appropriate for detecting bacteria, viruses, spores and disease biomarkers. Markets of opportunity include human and veterinary diagnostic, environmental, biohazard, bioterrorism, agricultural commodity, and food safety testing. Its technology offers remarkably faster and less expensive results than existing methods. Current diagnostic tests can take hours to days from the time a sample is taken to delivery of results. Rapid Diagnostek&s;s IntelliProbe Immunosensor (IPI) platform can deliver results at the point of sampling in under 60 seconds. The sensor has performed as intended in the laboratory and the company is now developing a fully functioning device and initial assays to aggressively move towards commercialization.
Business Model: unknown
Revenue: 11.8M
Employees: 66
Industry: Genetics
The Zenome is a non-profit organization that aims at raising awareness on genomic medicine and providing the platform for DNA exchange. The most fundamental duty of Zenome is to ensure ownership of personal genomic information and equal access to the market of genomic information. Being a distributed genomic market, based on P2P network and blockchain, Zenome puts users in control of their genetic data. The fairness of data exchanges is enforced by smart-contracts and utilization of dedicated tokens (ZNA). Together with genetic services of any kind the platform is expected to provide one-stop ecosystem for genetic data.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Genetics
Indee Labs designs and develops microfluidic vortex shedding hardware for gene therapy.
Business Model: unknown
Revenue: 310k
Employees: 11
Industry: Genetics
Discuva is a pharmaceutical company that is involved in developing anti-microbial drugs for new emerging and drug-resistant pathogens.
Business Model: unknown
Revenue: 5.8M
Employees: 30
Industry: Genetics
Protabit engineers proteins for industrial, agricultural, and healthcare applications. Its platform technology is being developed via a strategic partnership with the Monsanto Company and the California Institute of Technology. Protabit’s protein engineering approach combines computational modeling with high-throughput screening and directed evolution to expand the diversity of protein sequences that can be explored to produce novel proteins.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
LoneStar Heart focuses on developing cardiac restorative therapies for patients with heart failure.
Business Model: unknown
Revenue: 2M
Employees: 465
Industry: Genetics
NHGRI is a research platform that collaborates with medicals communities to analyze genomic breakthroughs and treats specific diseases.
Business Model: unknown
Revenue: 10M
Employees: 10
Industry: Genetics
DestiNA Genomics Ltd (DGL) is a University of Edinburgh spin-out company, formed to commercialise a revolutionary chemical based system for detecting nucleic acids and single nucleotide polymorphisms (SNP’s). DGL has entered into an exclusive Licence Agreement with the University of Edinburgh, covering the development and commercialisation arising from the patent “Nucleobase Characterisation”. The technology is unique and distinguishable from ALL existing enzymatic methods of nucleic acid analysis. DGL intends to develop and launch a completely ‘PCR free’ system for nucleic acid analysis, using the unique properties of the nucleobase chemistry. In particular, DGL has identified that its reagents are particularly suited for direct detection of micro-RNA’s.DestiNA is working with trade partners to integrate their technology within colorimetric, fluorescent and electrochemical-based detection platforms. DestiNA Genomics Ltd has incorporated a Spanish company called DestiNA Genomica SL with the goal of exploit our technology in Spain with different partners such as Master Diagnostica. DestiNA Genomica SL. was awarded a grant from the Technological Fund of Invest in Spain (1-2011/55 €239,000). The Technological Fund of Invest in Spain is a special area of ERDF funds from the European Union created to promote business R&a;D&a;I in Spain for the 2007-2013 period.
Business Model: unknown
Revenue: 3.8M
Employees: 42
Industry: Genetics
Sequentia Biotech was founded in 2013 by Walter Sanseverino (CEO) and Riccardo Aiese Cigliano (CSO), two young researchers with a real passion for genetics and omics sciences, and is based at the UAB Research Park. Sequentia is a bioinformatics company that offers services and tools that transform genomic data into knowledge in academic research, plant and animal breeding and biomedicine. In just four years, Sequentia has achieved a large highly diversified portfolio of clients and partners, consisting of over 30 public and private research centers, companies and hospitals. The company is taking part in more than 160 R &a; D public and private projects, and it has two open source biodata banks; and an award-winning R&a;D line, Tricopharming, which was established in 2014. Cofounders Walter Sanseverino and Riccardo Aiese have published more than 40 scientific articles in high impact journals such as Nature Genetics, Scientific Report or DNA Research.
Business Model: unknown
Revenue: 10M
Employees: 40
Industry: Genetics
Rubicon Genomics engages in the development and commercialization of nucleic acid samples for clinical research and diagnostic applications.
Business Model: unknown
Revenue: 7M
Employees: 114
Industry: Genetics
Insight is a molecular diagnostic company that discovers, develops and commercializes therapies for the treatment of cancer.
Business Model: unknown
Revenue: 4.2M
Employees: 55
Industry: Genetics
SynVaccine is a pharmaceutical company that develops potent vaccines and immunotherapies targeting infectious diseases and cancer.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
Naitive Traits develops native genetic traits that makes corn higher-yielding, resistant to drought, and tolerant of temperature extremes. Native traits have many advantages compared to genetically-engineered (GMO) traits. EaSY is the flagship product of our proprietary NT RECOVERY technology. The Company is currently negotiating licensing agreements with prominent seed companies. It was founded in 2013 and is headquartered in Kalamazoo, Michigan.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Genetics
InterpretOmics is a integrated genomics company that provides genome-scale data analysis and interpretation services for healthcare.
Business Model: unknown
Revenue: 4.4M
Employees: 80
Industry: Genetics
Metalytics Is a biotechnology company that provides cell factory analysis. Metalytics CoreMFATM is its technology-enabled packaged services offering which enables customers to optimize cell line selection, as well as determines optimal conditions for cell line production. The company was founded in 2016 and is headquartered in Morrisville, NC.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Genetics
Tupac Bio &l;www.tupac.bio&g; is a startup developing design and analysis software tools for synthetic biology companies. Our biodesign cloud software, Tupac Bio Designer, allows researchers to quickly generate and analyze gene variants and through software designed synthetic DNA. The Tupac Bio Designer is the first in an ecosystem of intuitive, collaborative and essential biodesign tools. The company currently has six members but will be growing fast in the near future.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
Mitomics engages in the research and development of mitochondrial genome-based products.
Business Model: unknown
Revenue: 11.6M
Employees: 99
Industry: Genetics
Foodimprover develops a platform technology to genetically modify fruits.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
DNAtix is an Israeli start up developing a genetic platform providing anonymous and secured DNA testing &a; storage, using distributed ledger technologies (Blockchain). DNATIX PLATFORM A cutting-edge dedicated infrastructure for genetics providing anonymous and encrypted genetic services including: analysis, storage, and transfer of digitized DNA sequence through a direct-to-consumer platform. Key Highlights - DNAtix proprietary DNA compression algorithm compresses human DNA sequences by up to 99% of their original size DNAtix is the first company to ever transfer DNA sequence on a blockchain.
Business Model: unknown
Revenue: 3M
Employees: 17
Industry: Genetics
GeneTether develops DNA Template-Nuclease-Tethering or TNT™ platform that allows to conjugate or tether donor DNA templates to CRISPR/Cas9 and other nucleases. The platform improves the efficiency of programming and modifying genes. GeneTether was co-founded by Har Grover, R. Geoffrey Sargent, William J. Garner, and Daren Graham in 2018 and is headquartered in San Lorenzo, California.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
Our mission is to empower every human being to take charge of their own health and make informed decisions based on reliable health data.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
Prosensa engages in the development and commercialization of ribonucleic acid modulating therapeutics.
Business Model: unknown
Revenue: 12.3M
Employees: 89
Industry: Genetics
Business Model: unknown
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Genetics
The business of Riboxx consists of two distinct product lines: LIFE SCIENCES and PHARMA. Riboxx LIFE SCIENCES develops customized and tailor-made molecular tools for gene silencing in vitro and in vivo through RNA interference: small interfering RNA (siRNA) and microRNA (miRNA). RNA interference is a new technology broadly used in life science. With the help of RNA interference, genotype-phenotype correlation studies as well as identification of gene expression patterns are possible. The core expertise of Riboxx LIFE SCIENCES is RNA synthesis and analytics. The direct applications of this technology are in the field of RNA interference, more precisely in vivo. Here, Riboxx has developed innovative molecular tools for gene silencing in vivo such as the IVORI® siRNA, the CONTRAmir® and CONmir®. The Riboxx RNAi-technology is robust, easy-to-use and reliable. Riboxx PHARMA has developed two families of TLR &a; RLR agonists with indications in the fields of oncology, virus infections and autoimmune disorders. The development pipeline at Riboxx comprises: - RIBOXXIM® compounds, for treatment of cancer or virus infections - RIBOXXON® compounds, for treatment of cancer and autoimmune diseases RIBOXXIM® and RIBOXXON® include more than 20 proprietary Active Pharmaceutical Ingredients (API) that possess unique properties as to potency, analytical purity, bioavailability, and safety.
Business Model: unknown
Revenue: 6.7M
Employees: 62
Industry: Genetics
Genesis DNA is taking a fundamentally new approach to gene synthesis, the process of turning digital text like ACTG into physical DNA. Their proprietary method circumvents the cost, turnaround time, and sequence limiting factors of existing synthesis methods. Genesis was founded by a team of students at Stanford and MIT that have experienced the pain of current DNA construction methods first hand. They started Genesis DNA with the vision that every researcher should have fast, affordable, and secure access to any DNA sequence they need. They believe the next technology revolution will be a biological one.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
Continuity Pharma is creating modern, efficient, and portable continuous flow manufacturing systems for synthesizing essential generic medicines. We&s;re here to ensure the availability of essential medicines for patients.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
Insitome helps people understand their DNA by combining the latest genetic analysis technologies with story telling and consumer centric design.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
Countagen offers consumable reagent kits that allow users to analyze gene editing efficiency and specificity with the same high precision as high-end instrumentation.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
Clontech develops, manufactures and distributes genetic engineering research reagents, products and services.
Business Model: unknown
Revenue: 10.4M
Employees: 172
Industry: Genetics
Parabase Genomics is a privately held molecular diagnostics company focused on changing the way newborns and children with genetic disorders are diagnosed and treated. The Company’s NewbornDx™ test is designed to guide the differential diagnosis of common symptomology found in neonates. It allows a physician to utilize one test to provide an accurate molecular profile on 500+ newborn related genes using dried blood spots within 10 days. Physicians no longer need to depend on severe phenotypes to nominate a single gene test for a given disorder.
Business Model: unknown
Revenue: 26M
Employees: 70
Industry: Genetics
Our MISSION is to facilitate the widespread adoption and routine use of non-invasive imaging technologies by increasing awareness and acceptance of their value and power.
Business Model: unknown
Revenue: 2.4M
Employees: 36
Industry: Genetics
Genetic Internet is an iOS application, global genetic platform, and new communications structure for the internet. The company genetically engineers information for internet search, advertising, and copyright. Genetic Internet supports internet users, advertisers, and copyright managers with the ability to network people, information, and applications. It was launched in 2014 in Cambridge, Massachusetts.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
Turn is a California-based biotechnology company that discovers and develops novel therapeutics for the treatment of age-associated diseases.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
Plasmonix manufactures and sells products that enhance fluorescence and luminescence signals in life sciences and in diagnostic applications.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
DoubleHelix offers practical solutions based on cutting edge scientific technologies to verify the accuracy of timber and timber product claims of species and origin. Established in 2008 and headquartered in Singapore, our customers include suppliers, buyers and retailers in over 20 countries worldwide across the Americas, Africa, Europe and Asia. We partner with governments, foundations and scientific centres of excellence, working together to support the responsible and sustainable use of forest resources.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Genetics
Equinome, a spin out from UCD was incorporated in May 2009. The technology was developed in Dr. Emmeline Hill’s laboratory in UCD. Equinome is a world leader in the development and provision of genomic selection tools for the bloodstock and racing industry. The product, ’The Speed Gene test‘ genetically identifies (through a blood test) whether a racehorse will be more suited as a short, medium or long distance runner. It will influence the breeding strategies of farms who will select certain mares and stallions to produce progeny with desired genetic profiles for particular racing distances. The company was co-founded by Dr. Hill and Mr. Jim Bolger, the renowned Irish horse breeder. Still in its first year of operation, Equinome has already secured customers in Ireland, UK, France, USA, Australia, New Zealand and Singapore.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Genetics
CureSeq’s mission is to revolutionize next-generation sequencing in the oncology space by making it more affordable, offering faster time to results with a comprehensive solution. They offer products to advance your research endeavors, and will open their services shortly. Turnaround time using their products is 48 hours from extraction through generating clinically relevant mutations. CureSeq’s technology is born out of the Applied Genomics Thoracic Oncology Lab of Dr. Il-Jin Kim at UCSF.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Genetics
Selah Genomics develops nanotechnology products for the biomedical industry.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Genetics
Karmagenes offers DNA-based personality test that links specific genetic regions with 14 major behavioral characteristics.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Genetics
e-NIOS develops a platform for unsupervised analysis and interpretation of Genomics data of multiple sources (multi -omics), with applications in Biotechnology, Drug Discovery and Personalized Medicine.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
Genecorp addresses a person’s optimum food and exercise plan according to their genes. It helps in understanding one&s;s genetic predisposition to certain diseases and helps prevent it by adjusting food intake. With just a saliva sample, Genecorp will know a person&s;s body-specific requirements. The service includes genotyping, customized reports, and health counseling based on research and stringent standards of scientific evidence. Genecorp is headquartered in Mumbai, India.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
Shire is a biopharmaceutical company that develops therapeutics for rare diseases and also offers patient advocacy services.
Business Model: unknown
Revenue: 15.2B
Employees: 23k
Industry: Genetics
LGC is an England-based firm that provides quality assurance, drug development and genomic analysis tools for the healthcare and food and beverage industries.
Business Model: unknown
Revenue: 568.5M
Employees: 3.2k
Industry: Genetics
Inno-Gene SA is a Poland-based holding company engaged in management of a portfolio of companies active in life-science sector through the technology, research and development. Inno-Gene SA’s portfolio comprises of Centrum Badan DNA Sp. z o.o., a company that provides services in the field of genetic medical diagnostics, including microbiological diagnosis of infection and the suitability of human congenital diseases using tests performed on DNA microarray technology.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Genetics
DNActive is a web platform that offers health advisory services for diabetes, osteoporosis, and celiac disease.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Genetics
Molecular Devices is a California-based company that develops and supplies bioanalytical measurement systems for sectors including life sciences and pharmaceuticals.
Business Model: unknown
Revenue: 190M
Employees: 1k
Industry: Genetics
Sangon Biotech Co. (生工生物) is engaged in the research and development of chemical synthesis of DNA. It is a high-tech Sino-foreign joint venture established in 2003. After ten years of development, Sangon has become a professional biotechnology company that integrates research and development. Chemical synthesis DNA earned reputation for Sangon in the global market. In 2006, Sangon invested 50 million to build a manufacturing and industrial base in Songjiang Industrial Park, which has been put into use. Sangon produces various products such as DNA synthesis, DNA sequencing, Gene Synthesis, peptide synthesis, chemical agents, enzymes, molecular biology kit, cultivation medium, lab consumptive material, and miniature instruments.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Genetics
Life Technologies is a provider of biotechnology solutions.
Business Model: unknown
Revenue: 410.6M
Employees: 1.4k
Industry: Genetics
Gero is an AI-based platform that offers drug discovery and repurposing solutions for complex diseases and aging.
Business Model: unknown
Revenue: 2.5M
Employees: 50
Industry: Genetics
Complete Genomics engaged in developing DeoxyriboNucleic Acid sequencing for human genome sequencing and analysis.
Business Model: unknown
Revenue: 25M
Employees: 125
Industry: Genetics
Genomic Health is a biotechnology company that provides genomic-based diagnostic test services relating to the treatment of early-stage cancer.
Business Model: unknown
Revenue: 441.9M
Employees: 829
Industry: Genetics
IDT is an Iowa-based biotechnology company that develops and markets nucleic acid products for the life sciences industry.
Business Model: unknown
Revenue: 350M
Employees: 1.4k
Industry: Genetics
yRisk is genetic test which allows people to know their oncological risks, including breast cancer, stomach cancer and 18 more, using NGS.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
Hemera Biosciences is a gene therapy company that specializes in treating retinal diseases.
Business Model: unknown
Revenue: 5.5M
Employees: 10
Industry: Genetics
GenomeNext develops automated genomic analysis solutions for researchers and clinicians to enhance the treatment and prevention of complex diseases.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
The chemicals Yel002 and CJ010 were isolated from 16,000 chemicals from a chemical library as treatments against radiation induced genotoxicity and genetic instability. After radiation with a lethal dose that killed 100% of the mice and the first injection of Yel002 24 hours after radiation we could rescue 100%. Yel002 is also active against UV, and toxic chemicals and carcinogens EMS, MMS, nitrogen mustard, radioactive iodine and cigarette smoke extract induced DNA damage. Yel002 and CJ010 reduced radiation induced leukemia from 90% to 40% and the spontaneous frequency from 10% to 0%. Weekly subcutaneous injections of Yel002 also extended the life expectancy of cancer prone Atm deficient mice of which usually 90% die from lymphoma for 16 weeks which is about 12 years of human life expectancy. Yel002 also extended the life span in a senescence assay after radiation 2 fold and spontaneous senescence 15%. The mechanism of action seems to be induction of DNA repair, namely ATM signalling, homologous recombination, and end joining, base excision repair and chromosome segregation functions.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Genetics
Genzyme is a pharmaceutical company that develops and commercializes drugs for rare diseases and multiple sclerosis.
Business Model: unknown
Revenue: 1B
Employees: 4.7k
Industry: Genetics
At DtoR they have developed the PCR of gene expression—a disruptive technology that will revolutionize the tools used to “tune” protein production in any organism. In one step, and for any cell type, they can identify all of the switches regulating expression of the genome, as well as how active they are. They can also rapidly evolve or synthesize new switches to adapt to any application. Applications developed using their platform will lead to improved product yields in bioreactors, engineered specialty crops, optimized cancer therapeutics, and much more. The possibilities are limited only by their partners&s; imaginations.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
OyaGen focuses on the discovery, development and commercialization of pharmaceutical therapies to exploit RNA editing and DNA editing enzymes.
Business Model: unknown
Revenue: 5M
Employees: 11
Industry: Genetics
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Genetics
Warp Drive Bio develops microbiome-based therapeutics for the treatment of oncology diseases.
Business Model: unknown
Revenue: 4.6M
Employees: 60
Industry: Genetics
Brammer Bio provides commercial GMP manufacturing services for cell and gene therapies.
Business Model: unknown
Revenue: 250M
Employees: 700
Industry: Genetics
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
FDNA is a Florida-based biotechnology company that develops facial dysmorphology novel analysis technology products for healthcare professionals.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Genetics
Biomiic is a fast and accurate microbiome sequencing service for the masses. They utilize high-throughput metagenomic (shotgun) sequencing to deliver high-dimensional, high-coverage genomic information about bacteria and viruses present in the human body
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
Any Lab Test Now is a direct access lab testing services company that allows individuals to take control of their health.
Business Model: unknown
Revenue: 4.3M
Employees: 141
Industry: Genetics
SIRION Biotech is a Germany-based company that designs and supplies viral vectors for genetic cell modeling, target validation, and preclinical development.
Business Model: unknown
Revenue: 11.2M
Employees: 50
Industry: Genetics
Business Model: unknown
Revenue: 0 - 100000
Employees: 51 - 200
Industry: Genetics
Vical&s;s core technology grew out of a chance discovery and provided the cornerstones for two new biopharmaceutical industry sectors: DNA vaccines and non-viral gene therapy. Vical&s;s management systematically leveraged that technology into a broad portfolio of independent and partnered product development programs. The first products for animal health are on the market. The first human products are approaching.
Business Model: unknown
Revenue: 0 - 100000
Employees: 201 - 500
Industry: Genetics
GENEWIZ provides DNA sequencing, gene synthesis, molecular biology, bioinformatics and regulatory compliance services.
Business Model: unknown
Revenue: 220.7M
Employees: 70
Industry: Genetics
DNA Gensee is a biotechnological laboratory working on plant DNA to offer you the possibility to identify the plant species that are present in your raw materials, ingredients or final products. Such genetic analyses allow you to guarantee the botanical and geographical authenticity of the natural extracts you are using and to ensure traceability, security and quality. DNA Gensee uses innovative molecular biological facilities allowing blind analyses on highly processed products thanks to the unique genetic signature of each plant. Playing a central role in a technical, scientific and botanical environment, DNA Gensee offers a complete range of services to give keys to solve your industrial problems.
Business Model: unknown
Revenue: 0 - 100000
Employees: 51 - 200
Industry: Genetics
Exiqon supplies products for miRNA research for academia, biotechnology and pharmaceutical industry researchers.
Business Model: unknown
Revenue: 21.6M
Employees: 250
Industry: Genetics
CuraGen Corporation is a biopharmaceutical development company that develops novel therapeutics for the treatment of cancer in the United States and Europe. Its therapeutics is based on novel targets from the human genome that play a role in proven mechanisms underlying disease. The Company&s;s strategy continues to be focused on advancing its pipeline of pipeline of protein, antibody, and small molecule drugs in the areas of oncology, inflammatory diseases, and diabetes, promising therapeutics through clinical and preclinical development. CuraGen Corporation was founded in 1991 and is headquartered in Branford, Connecticut. As of October 1, 2009, CuraGen Corporation operates as a subsidiary of Celldex Therapeutics, Inc.
Business Model: unknown
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Genetics
Algen Biotechnologies is a therapeutic discovery company that builds a platform to decode functional gene networks. The company was founded in 2018 and is based in San Francisco, California, United States.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
StemCyte, Inc. operates as an umbilical cord blood stem cell transplantation and therapeutic products company. It provides cord blood products to transplant centers for life-threatening diseases. The company&s;s products are used to treat patients suffering from various blood cancers, and immune and genetic disorders. StemCyte, Inc. was founded in 1997 and is headquartered in Covina, California. It operates umbilical cord blood storage facilities in California and Taiwan. The company has locations in the United States, India, and Taiwan.
Business Model: unknown
Revenue: 4M
Employees: 76
Industry: Genetics
Sequence Bio operates as a data-driven drug discovery and biotechnology firm that leads a genome research project to improve patient care.
Business Model: unknown
Revenue: 0 - 100000
Employees: 51 - 200
Industry: Genetics
Integene International LLC. is a privately held Florida Corporation. The Company has developed platform technology for diabetes and it&s;s complications. Targets include Peripheral Artery Disease (PAD) Obesity and Hyperglycemia. Integene International has developed a unique protocol GenstemX for the treatment of Ischemic diseases. Primary patented treatment is for Criticial Lower Limb Ischemia (CLI). The combined gene and stem cell treatment has proven successful in pre-clinical testing.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
At Rosetta Genomics we discover, develop and commercialize next generation diagnostic tests for personalized medicine.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Genetics
Wisdom Panel™ dog DNA tests - backed by the Wisdom Health™ scientific research - can help pet parents plan better, care smarter, and love longer. For more than a decade, Wisdom Health™ scientific research contributed to develop state-of-the-art genetic tests for companion animals, revolutionizing personalized pet care. By unlocking the secrets of their dog or cat&s;s DNA, pet parents and veterinarians can work together to tailor wellness programs that fit the one-of-a-kind needs of their pets.
Business Model: unknown
Revenue: 20M
Employees: 72
Industry: Genetics
Juneau Biosciences offers medical diagnostic services such as diagnostic services for women’s health issues and medical diagnostic testing services. The firm dedicated to improving the lives of millions of women through our genetic research and innovative health care solutions. Juneau is applying population genetics and genomics approaches to rapidly identify the fundamental, molecular bases of major diseases that predominantly affect women.
Business Model: unknown
Revenue: 16.9M
Employees: 78
Industry: Genetics
Apceth develops cell and gene therapies for the treatment of chronic inflammation and autoimmune diseases.
Business Model: unknown
Revenue: 4.4M
Employees: 22
Industry: Genetics
Decode Health is a healthcare AI company that powers an ecosystem of industry-leading diagnostic and pharmaceutical companies to unlock discoveries with data. Current projects include genomic data creation, RNA diagnostics, and population health analytics. Over the course of a decade, the team leading Decode has built a framework leveraging a variety of advanced machine learning approaches. The company’s flexible, scalable approach layers clinical data with SDoH and non-clinical data to fuel innovation and advance precision medicine. Decode’s data assets, products, and services improve patient outcomes, lower costs, and promote health equity.
Business Model: unknown
Revenue: 4.2M
Employees: 32
Industry: Genetics
H3 Biomedicine is engaged in the development of small-molecule for the treatment of cancer.
Business Model: unknown
Revenue: 8M
Employees: 130
Industry: Genetics
Genencor International, Inc. (NASDAQ-NM: GCOR) is a diversified biotechnology company with over $350 million in 2002 revenues. Genencor focuses on two markets: bioproducts and health care. For the bioproducts market, Genencor discovers, develops and sells biocatalysts and other biochemicals for the industrial, consumer and agri-processing markets. For the health care market, Genencor has drug development platforms in protein therapeutics and immunotherapeutics targeting viral infectious diseases and cancer. Genencor leverages its technology platforms across both markets. These platforms include: gene discovery and functional genomics, molecular evolution and design, metabolic pathway engineering, immunology, and biomaterial production and formulation delivery systems. With many industry firsts, Genencor has shown the power of its technology by delivering innovative products to the marketplace.
Business Model: unknown
Revenue: 0 - 100000
Employees: 201 - 500
Industry: Genetics
Protillion Biosciences is a biotech company commercializing disruptive technology for therapeutic antibody and drug discovery and accelerating biologic research and development productivity.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
PharmaGen, s.a. provides integrated molecular products and biotechnology services including gene research and development. The company’s manufactures various products such as diagnostic kits and reagents, laboratory equipment, and applications such as emetic fingerprinting in forensic and veterinary medicine. In addition, it offers technology transfer, laboratory installation and technical support services, and training courses for laboratory, clinical, and forensics professionals. PharmaGen is based in Silver Spring, Maryland.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Genetics
Metamark Genetics is a developer of prognostic and predictive diagnostic tests for cancer treatment.
Business Model: unknown
Revenue: 14M
Employees: 24
Industry: Genetics
Geneticlab is a reference diagnostic center at European level in the field of Genetics and Molecular Biology, which stands out for its high level of competence and for its cutting-edge instrumental equipment. Through the two operative offices of Noventa Vicentina (VI) and at the Technological Pole of Pordenone (PN), Geneticlab operates in Italy and abroad performing the Laboratory Service activities with diagnostic methods of great sensitivity, specificity, and efficiency. The company is structured internally to respond quickly and effectively to all the needs of its customers, through a team of highly specialized professionals, using sophisticated analytical methods and constantly updated scientific and technological. Geneticlab does not offer its customers a simple customer-supplier relationship but offers a full-service 360-degree partnership that includes consulting, design, assistance and creation of customized solutions. This operating mode allows you to have a single reference for all your needs and greatly simplifies all procedures (eg single billing, single reporting, etc ...). Anticipating the future starting from the present has always been our guiding principle: this is why we aim to be an indispensable reference point for all healthcare facilities. This operating mode allows you to have a single reference for all your needs and greatly simplifies all procedures (eg single billing, single reporting, etc ...). Anticipating the future starting from the present has always been our guiding principle: this is why we aim to be an indispensable reference point for all healthcare facilities. This operating mode allows you to have a single reference for all your needs and greatly simplifies all procedures (eg single billing, single reporting, etc ...). Anticipating the future starting from the present has always been our guiding principle: this is why we aim to be an indispensable reference point for all healthcare facilities.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Genetics
Iverson Genetic Diagnostics designs and manufactures genetic testing tools for the detection and treatment of chronic diseases.
Business Model: unknown
Revenue: 1.5M
Employees: 52
Industry: Genetics
Bind Health provides information and professional guidance on genetic testing during pregnancy.
Business Model: unknown
Revenue: 13.8M
Employees: 124
Industry: Genetics
Takara Bio offers research tools for the life sciences.
Business Model: unknown
Revenue: 286.8M
Employees: 1k
Industry: Genetics
Canexia Health is a biotechnology firm that offers genomic biomarker testing solutions for cancer disease.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Genetics
Mendel is a Mexico-based financial technology company that provides solutions such as expense management and budgeting for businesses.
Business Model: unknown
Revenue: 18.7M
Employees: 74
Industry: Genetics
CD Genomics provides sequencing, genotyping and microarray services for pharmaceutical and biotechnology sectors.
Business Model: unknown
Revenue: 1M
Employees: 200
Industry: Genetics
Xenogen Corporation is a biotechnology company offering an integrated suite of biophotonic real-time in vivo imaging and genetic modification technologies that can help expedite drug discovery and development, and significantly reduce the cost and time to market for new therapies. Xenogen&s;s VivoVision(TM) Systems non-invasively illuminate and monitor biological processes within living mammals, at the molecular level, in real time. The technology is designed to provide higher quality in vivo data earlier in the drug discovery and development process. VivoVision(TM) Solutions are designed to improve discovery and pre-clinical research in multiple therapeutic areas. VivoVision(TM) Biosciences represents more than 15 years of experience in the creation and characterization of animal models, including genetic modifications, comprehensive phenotyping, compound profiling and custom design and production of light producing cells, microorganisms and animals.
Business Model: unknown
Revenue: 0 - 100000
Employees: 51 - 200
Industry: Genetics
Population Genetics develops a novel approach for the identification of rare genetic variants.
Business Model: unknown
Revenue: 0 - 100000
Employees:
Industry: Genetics
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Genetics
Platinum BioSciences offers pharmacist-compounded nutraceutical products infused with THC-free cannabidiol (CBD), enhanced with scientifically specific terpenes to deliver optimal results in the health and wellness line of products. Platinum Biosciences’ line of CBD infused nutraceutical products have been developed for discriminating customers who are looking for the best product quality and efficacy that nature and science can offer. Platinum BioSciences formulates and produces the highest quality CBD-infused nutraceuticals available. Platinum BioSciences’ products begin with industry proven formulations and they enhance the efficacy of these existing product formulations using known and proven nutraceutical ingredients, and they also add terpene-enriched CBD to potentiate the overall success of their finished products. The company is headquartered in Prosper, Texas, United States.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
WellGenetics was founded in July 2014. WellGenetics is dedicated to providing researchers professional services in generating transgenes and gene knockout/knockin in fly and mosquito models. They are an independent company from any academic research institutes. With strong and solid background in Drosophila genetics, their team are composed of experts in molecular biology and in microinjection for generating variety of genetic tools, such as gene deletion, point mutation, gene reporters, tag knockin and RMCE knockin with/without selection marker to level-up your research quality. Each project will be designed, executed, and supervised by postdoctoral scientists, thus to ensure the quality and reliability of entire experiment process.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
Genomics USA, Inc. develops and fabricates micro array technologies to bypass DNA purification and quantitation by allowing human leukocyte antigen (HLA) typing directly from raw blood (rehydrated) dried blood spots on Guthrie cards and from raw buccalswabs. It offers HLA Chip technology based on HLA typing for tissue transplantation and stem cell therapeutics, as well as based on HLA analysis for vaccine development, personalized vaccine delivery, personalized treatment for autoimmune diseases, and personalized treatment of microbial infection. Genomics USA was incorporated in 2004 and is based in Inverness, Illinois.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
Biomatters creates applications for omics analysis. Our WebApp Development Group builds production quality, public- and private cloud based responsive web applications to deliver the highest usability and visualized insight for applied genomics workflows. By collaborating with clinical and molecular diagnostics developers, we build the platforms that crunch their data and deliver results reports to their customers. We turn genomic research workflows into production-ready, regulatory-compliant diagnostic pipelines. Geneious, our desktop app for research biologists, features tools for DNA/RNA/protein sequence analysis, data management, database searching, and publication-quality image generation. Geneious is used by university, government, and medical research labs worldwide in disciplines such as agricultural genomics, evolutionary biology, biofuels, synthetic biology, microbiology, virology, and next-gen sequence analysis.
Business Model: unknown
Revenue: 4M
Employees: 50
Industry: Genetics
Amnis Corporation engages in the development, manufacture, and marketing of cell analysis systems for the imaging and analysis of cells in flow. It provides ImageStream, an instrument that combines the functionalities of microscopy and flow cytometry in a single platform for various applications in drug discovery, basic biomedical research, and diagnostics. The company also offers upgrades for ImageStream system to add additional functionality, including violet and red lasers, and an extended depth of field technology (EDF) option. In addition, it provides IDEAS, a cell image analysis software that is used for the quantitative analysis of cell images, as well as for the evaluation of image-based data in various cell populations. Further, the company provides a calibration reagent for the operation of ImageStream system that allows the instrument to track flow rate and core position; and a sheath solution for the functioning of ImageStream system. Its systems are used in apoptosis, immune synapse analysis, nuclear translocation, leukocyte classification, cell cycle analysis, cell morphology analysis, intracellular molecular trafficking, surface markers co-localization, and gene expression quantitation applications. The company offers its products to academic, biotechnology, and pharmaceutical customers. Amnis Corporation was founded in 1998 and is headquartered in Seattle, Washington.
Business Model: unknown
Revenue: 16.2M
Employees: 80
Industry: Genetics
Circularis is a California-based biotechnology firm that offers solutions as circular RNA promoter discovery, enhancement and analysis for the pharmaceutical industry.
Business Model: unknown
Revenue: 4M
Employees: 15
Industry: Genetics
Bioneer is a biotech company that develops molecular biology products and technologies including oligonucleotides, thermostable polymerases, and instruments of gene manipulation. From its inception, Bioneer has invested in the integration of recombinant DNA technology, fermentation, biochemistry and nucleic acid chemistry in addition to mechanics, photonics and electronics. The company is positioned to fully-integrate its capability to develop next-generation technologies in the post-genome era through the invention of new biochemistry and instruments. Bioneer was established in 1992 and is based in Daejeon, South Korea.
Business Model: unknown
Revenue: 31.2M
Employees: 74
Industry: Genetics
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Genetics
BioReliance provides nonclinical testing and manufacturing services for pharmaceutical and biotechnology industries.
Business Model: unknown
Revenue: 150M
Employees: 91
Industry: Genetics
Igenomix is a Spain-based biotechnology company that offers women reproductive genetic, diagnostic and related fertility treatment services for IVF clinics.
Business Model: unknown
Revenue: 145.2M
Employees: 560
Industry: Genetics
NewLink Genetics discovering, developing, and commercializing novel immunotherapeutic products.
Business Model: unknown
Revenue: 733k
Employees: 21
Industry: Genetics
Santa Cruz Biotechnology focuses on the ongoing development of research monoclonal antibodies, biochemicals, labware and CRISPR products.
Business Model: unknown
Revenue: 7.1M
Employees: 486
Industry: Genetics
EdiTy Therapeutics is a biotechnology company that develops a gene-editing technology designed for in-vivo gene-editing of target cells. It utilizes T-cells machinery to directly deliver gene-editing agents to target cells in-vivo. Yoav Manaster established the Ness Ziona, HaMerkaz, Israel-based company in 2020.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
Gene By Gene provides DNA testing for genealogical, clinical genetic tests, chromosomal microarrays, genome sequencing & carrier screening services.
Business Model: unknown
Revenue: 20M
Employees: 180
Industry: Genetics
DuPont Pioneer produces hybrid and genetically modified seeds for agriculture.
Business Model: unknown
Revenue: 4B
Employees: 12.3k
Industry: Genetics
Santaris Pharma focuses on the discovery and development of RNA-targeted therapies internationally.
Business Model: unknown
Revenue: 0 - 100000
Employees: 10001 - 1
Industry: Genetics
Business Model: unknown
Revenue: 4.7M
Employees: 47
Industry: Genetics
Based in Lafayette, Colo., Dharmacon, Inc. is a leading provider of reliable and high quality RNA oligonucleotides, small interfering RNA (siRNA) and related RNA-interference (RNAi) products and technologies to the life-sciences industry. Using its core expertise in chemistry, biology, bioinformatics and production, Dharmacon has pioneered a custom siRNA design service for maximizing the efficiency of gene silencing, a powerful and increasingly widely-used new technology based on siRNA.
Business Model: unknown
Revenue: 0 - 100000
Employees: 201 - 500
Industry: Genetics
DNA2.0 is a biotechnology company that engages in gene synthesis and bioengineering solutions.
Business Model: unknown
Revenue: 18M
Employees: 52
Industry: Genetics
Actio Biosciences involves in the development of precision medicines for homogenous rare patient populations. They develop a pipeline of new medicines with the goal to enhance the probability of clinical success and deliver medicines for all patients.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Genetics
Drift Biotechnologies develops bioinformatics software for infectious disease genetic sequencing. The company was headquartered in San Francisco, California in 2020.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
NRGene Technologies is a biotechnological company that is focused on developing software and algorithms for crop plants breeding.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Genetics
Innogenetics NV develops and markets diagnostic products for therapy management and patient health. Its diagnostics business focuses on developing products for infectious diseases, genetic testing, tissue typing, neurodegeneration, and oncology. Its products in the area of infectious diseases include screening and confirmation tests for HIV, HCV, HTLV, and syphilis; genotyping tests for hepatitis B virus (HBV), human papillomavirus, and mycobacterium sp; and drug-resistance tests for TB and HBV. Innogenetics also offers genetic testing products comprising detection tests for cystic fibrosis, as well as MBL2 and APO E genetic variants associated with genetic risks; tissue typing tests to determine the type of HLA; and neurodegeneration products, which include tests for Alzheimer&s;s disease. In the Oncology area, the company distributes AdnaGen AG’s diagnostics products for breast and colon cancer. Its therapeutics business engages in the development of therapeutic vaccines for the treatment of infectious diseases caused by hepatitis C, hepatitis B, and human papillomaviruses. The company’s therapeutic portfolio includes GNI-102, a polyepitope vaccine candidate, which is in phase I clinical trial targeting HBV; GNI-104, which are anti-HCV neutralizing human monoclonal antibodies; and GNI-105, a HPV polyepitope vaccine candidate. It has collaborative research, development, distribution, or licensing agreements with Solvay Pharmaceuticals BV; sanofi-aventis; Takeda Chemical Industries; Immuno-Biological Laboratories Co; Roche Group of companies; AdnaGen AG; Siemens Healthcare Diagnostics; Danisco A/S; Pharmexa-Epimmune, Inc.; and PamGene International BV. It sells its products primarily in Germany, Italy, France, Spain, the United States, Brazil, Switzerland, Austria, the Benelux, and Eastern Europe. It was founded in 1985 and is based in Gent, Belgium. As of November 20, 2008, Innogenetics NV operates as a subsidiary of Solvay Pharmaceuticals S.A.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Genetics
Creative Biogene provides kits, reagents and services that help researchers explore questions about gene discovery, regulation and function.
Business Model: unknown
Revenue: 9.6M
Employees: 154
Industry: Genetics
Business Model: unknown
Revenue: 17.3M
Employees: 78
Industry: Genetics
Genus is a provider of genetical pig breeding stock products for the livestock farming and food producers.
Business Model: unknown
Revenue: 721.5M
Employees: 3.4k
Industry: Genetics
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Genetics
SCIENION designs, manufactures and distributes biosensors, immunoassays and liquid dispensing systems for the life sciences industry.
Business Model: unknown
Revenue: 24.1M
Employees: 145
Industry: Genetics
Avesthagen is a life science company pioneering the convergence between Food, Pharma and Population Genetics leading to Predictive Preventive Personalized Healthcare. The business model of Avesthagen is to combine IP &a; product development through in-house research and collaborations. Avesthagen has built and continues to build an integrated, systems biology approach of capabilities, products, infrastructure and technology that allows for and facilitates ‘cross talk’ between numerous disciplines, leading to unique and innovative solutions. They employ 450 people worldwide and are headquartered in Bangalore, India.
Business Model: unknown
Revenue: 10M
Employees: 10
Industry: Genetics
In the biotech space, cell and gene therapy and clean meat are two of the most promising industries. Yet both are facing the same issue: large-scale cell culture remains the blocking point to scale up and make both cell and gene therapies and clean meat accessible and affordable. To that end, Kolibri is building a proprietary cell-engineering platform, combining cutting edge techniques in acoustics and biology, allowing for a 90x higher yield while decreasing production costs up to 50x.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
At Bitcare, we pioneer more effective ways to provide patients with greater accessibility to the healthcare products and services they need to live healthier and happier lives. By combining traditional approaches to care with modern technologies, we are disrupting the healthcare landscape for the better.
Business Model: unknown
Revenue: 0 - 100000
Employees: 51 - 200
Industry: Genetics
Claret Bioscience is an early-stage biotech startup that provides artisanal, hand-crafted 100% GMO libraries. It specializes in NGS library preparation tools for fragmented samples with an emphasis on cfDNA. Its Single Reaction Single-stranded DNA Library Prep Kit (SRSLY) is a simple and efficient ligation-based single-stranded DNA library preparation method that is engineered to produce complex libraries from samples with limited inputs. It recovers complete double-stranded DNA molecules, even when they contain nicks, plus single-stranded DNA molecules inaccessible to most NGS prep kits. Furthermore, the freedom of choice during DNA cleanup allows the user flexibility to decide whether they want to retain or discourage a substantial portion of short fragments. The company was founded in 2017 and is headquartered in Santa Cruz, California.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
AATI develops, manufactures and markets capillary electrophoresis instruments for nucleic acid analysis.
Business Model: unknown
Revenue: 5M
Employees: 105
Industry: Genetics
Genterpret is a startup, backed by Blueprint Health, that is crowdsourcing genetic and clinical datasets to advance personalized medicine.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
Plantik Biosciences develops new plant breeding technology to create future plants faster.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
Roche NimbleGen is a manufacturer and supplier of a proprietary suite of DNA microarrays, consumables, instruments and services.
Business Model: unknown
Revenue: 2.9M
Employees: 60
Industry: Genetics
Ravel Biotechnology markets an analytic technology platform capable of early detection of disease from cell-free DNA. The technology platform enables the accelerated development and validation of screening tests for a wide range of diseases from a single analyte, cell-free DNA. Thus providing the opportunity to screen for a multitude of diseases from a single blood draw. The company was co-founded by Erik Gafni and Nathan Boley in 2018 and is based in San Francisco, California.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
ImClone Systems develops and manufactures biologic medicines for treatment of cancer.
Business Model: unknown
Revenue: 0 - 100000
Employees: 5001 - 10000
Industry: Genetics
Cardion is a biopharmaceutical company that integrates synergistic local gene delivery, stem cell engineering, and tolerance induction capabilities to build cardiovascular gene therapy products. Cardion was founded in 1996 and is based in Erkrath, Nordrhein-Westfalen.
Business Model: unknown
Revenue: 0 - 100000
Employees:
Industry: Genetics
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
VariAD developed a unique patent-pending test to detect pre-disposition for Crohn’s Disease. The test, code named – deNoVA, analyzes the genetic makeup of the patient and determines the likelihood of the patient to develop Crohn’s as well as the severity level of the pre-disposition. Since this is a genetic test, samples are extracted from the patient through a simple, non-invasive procedure. Evaluated by an independent panel using clinical data, the deNoVa tool demonstrated high-accuracy, correctly identifying 96% of Crohn&s;s patients based on their genome data alone.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
GenePath Dx is a diagnostics company, providing state-of-the-art in vitro diagnostic techniques such as molecular diagnostics to the medical, healthcare, and allied communities. It is committed to providing accurate and affordable diagnostics that are relevant and actionable. The company’s portfolio includes DNA and RNA based tests for Infectious Diseases, Oncology, Endocrinology, Transplantation typing, Haematology, Pharmacogenetics, and Pre-natal and pre-implantation genetic diagnostics. GenePath Dx uses advanced, but proven, platform technologies such as quantitative or real-time polymerase chain reaction, multiplex ligation-dependent probe amplification, and Sanger and Next Generation Sequencing. Its molecular tests are more rapid compared to conventional microbiology and more sensitive than immunology based tests. For an increasing number of conditions, it is the only way to carry out a diagnosis. GenePath Dx is an innovation-centric company with an emphasis on continuous R&a;D. The company is constantly evolving in pace with global developments in the field and have the ability to develop new tests where needed. It was founded in 2012 by [Nikhil Phadke](https://www.crunchbase.com/person/nikhil-phadke) and is headquartered in Pune, India.
Business Model: unknown
Revenue: 32.6M
Employees: 129
Industry: Genetics
Datar Genetics is a provider of inherited cancer risk screening programs.
Business Model: unknown
Revenue: 427.3k
Employees: 11
Industry: Genetics
AnGes is engaged in the development of genetic medicines.
Business Model: unknown
Revenue: 10.1M
Employees: 52
Industry: Genetics
Helicos BioSciences provides a genetic analysis system which analyses, single molecules of DNA and RNA, as well as related tools and software.
Business Model: unknown
Revenue: 2.5M
Employees: 10
Industry: Genetics
FamilyTreeDNA is a Texas-based healthcare firm that provides DNA testing services for individuals.
Business Model: unknown
Revenue: 15.7M
Employees: 180
Industry: Genetics
Business Model: unknown
Revenue: 10M
Employees: 20
Industry: Genetics
Navigenics provides personal genetic testing and analysis services.
Business Model: unknown
Revenue: 11.5M
Employees: 92
Industry: Genetics
Biomatik is a supplier of competitive research products and custom services.
Business Model: unknown
Revenue: 6M
Employees: 28
Industry: Genetics
Imagene Labs Pte Ltd empowers consumers to optimise their health by providing customised wellness and lifestyle solutions tailored to their unique DNA profiles. Led by medical doctors and scientists, the company provides an entire ecosystem of genomics-based solutions ranging from wellness DNA tests, personalised lifestyle recommendations, bespoke skin serums and nutritional supplements, and mobile health apps that help people live, look and feel their best.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Genetics
Gala Biotech, a Catalent Pharma Solutions Company, was established in 1996 from technology developed at the University of Wisconsin. Located in Middleton, Wisconsin, this rapidly growing company (currently over 40 employees, including 16 PhD’s) has a wide range of capabilities in the fields of molecular biology, vector biology, cell line development, biopharmaceutical manufacturing, protein biochemistry, and quality systems. Gala’s core proprietary technology is GPEx® (Gene Product Expression), a gene insertion/expression technology that allows rapid creation of stable, high-expressing mammalian cell lines for a wide variety of gene products. "Gala" is Greek for milk, and the company&s;s original mission was to produce pharmaceutical proteins in the milk of transgenic cows. The gene insertion technology that Gala developed to generate transgenic animals became the basis of Gala&s;s Gene Product Expression or GPEx® technology for production of recombinant proteins in mammalian cell culture. The genomics revolution has led to the identification of thousands of new genes, and the race is now on to discover, characterize and stably express the protein products of these genes in order to develop new therapeutic proteins. Gala&s;s GPEx® technology, when applied to mammalian cell culture, accelerates this process for its biopharmaceutical partners. Once new therapeutic proteins have been identified for clinical development, production support becomes a major challenge. Gala&s;s mission is to meet this need, and the company has recently established a 43,000 square-foot facility in Middleton, Wisconsin devoted to GPEx®-based cell line development and cGMP-compliant protein production.
Business Model: unknown
Revenue: 29.5M
Employees: 103
Industry: Genetics
AnaSpec provides integrated proteomic and genomic solutions for life science research.
Business Model: unknown
Revenue: 9.6M
Employees: 93
Industry: Genetics
BioDiscovery is a California-based SaaS firm that offers solutions such as genomics data analysis, interpretation and reporting for healthcare and biotechnology sectors.
Business Model: unknown
Revenue: 4.4M
Employees: 50
Industry: Genetics
Oxford Gene engages in developing and providing molecular genetics research and biomarker solutions for clinical and academic research institutions.
Business Model: unknown
Revenue: 19.1M
Employees: 100
Industry: Genetics
Venture Catalysts is a company focused on commercialization of technologies through entrepreneurship. By supporting visionary researchers and entrepreneurs releasing the full potential of their technologies, the company acts as a catalyst on the development of new technology–based ventures
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
Kapa Biosystems offers enzymes solution for next-generation sequencing and real-time polymerase chain reaction applications.
Business Model: unknown
Revenue: 4M
Employees: 125
Industry: Genetics
Simmunome is an artificial intelligence-based contract research organization. They develop industry-ready computational models of pathogenesis and immunogenesis of various diseases with a particular focus on oncology and the nervous system. Our models are achieved by annotating cellular interactions at an in-depth, comprehensive molecular level to attain physiological accuracy
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
RheumaGen is a gene-editing technology that has the potential to cure rheumatoid arthritis. It offers an HLA gene-editing platform that uses stem-cell-enriched blood to alter DNA to suppress the immune system to stop rheumatoid arthritis&s;s abnormal immune response. The company was founded in 2019 and is based in Denver, Colorado.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
Haystack develops an AI-based platform that offers drug discovery and development solutions to the pharmaceutical sector.
Business Model: unknown
Revenue: 1.2M
Employees: 24
Industry: Genetics
Epinomics provides scientific research, deep analytics and clinical application development services for measurement and understanding of epigenome.
Business Model: unknown
Revenue: 2M
Employees: 1 - 10
Industry: Genetics
Compendia Bioscience is dedicated to applying the global collection of cancer genomic data to impact patient treatment by enabling the discovery and development and better cancer diagnostics and treatments.
Business Model: unknown
Revenue: 10.1M
Employees: 46
Industry: Genetics
Atgenomix is a cloud-native biomedical informatics platform that scales genomics-centric data analysis workflows to deliver on the promise of precision medicine by empowering healthcare organizations to build their own fully-managed precision medicine operation. Atgenomix platform implements GA4GH APIs that orchestrate industry standards, OpenWDL specification, and cloud computing technologies, allowing clinical laboratories to manage dataset integration, workflow automation, regulatory compliance, and to ensure code, data, and execution integrity.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
DCRI provides clinical database design and management, medical education and clinical trial services.
Business Model: unknown
Revenue: 250M
Employees: 1.3k
Industry: Genetics
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Genetics
In May 2007, Protedyne became a wholly owned subsidiary of Laboratory Corporation of America www.labcorp.com. Protedyne brings serious laboratory automation to LabCorp’s diagnostic testing facilities nationwide. Using the design principles of industrial automation, Protedyne’s automation systems combine powerful laboratory robotic hardware with a software infrastructure that ensures complete data management and process tracking. Protedyne is ISO 13485:2003 Registered with BSI Management Systems.
Business Model: unknown
Revenue: 6.7M
Employees: 27
Industry: Genetics
TATUM bioscience is a synthetic biology startup developing synthetic advanced biologics capable of multi-tasking therapeutic activities, packing all the advantages of combination therapy in a single agent to provide safer and more efficient treatments.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
Eurobio Scientific is a France-based manufacturer and supplier of products such as in-vitro diagnostic devices and testing equipment for the healthcare industry.
Business Model: unknown
Revenue: 208.5M
Employees: 148
Industry: Genetics
24genetics.com is a biotechnology company specialized in Direct to Consumer Genetic Test. It has one of the broadest portfolios in the market with DNA test for health prevention, pharmacogenomics, nutrigenetics, sports, ancestors, skin care, etc. Some of his tests stand out especially as his ancestry test with more than 400 geographical areas is the most detailed of the market. His health test with more than 250 traits is also one of his most famous reports. 24Genetics operates in more than 30 countries.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
ViaGen – a division of Trans Ova Genetics is the industry’s premier source of cloning technology for all non-primate species. Breeding elite animals requires knowledge, strategy and patience. Today, the use of advanced reproductive technologies like cloning not only capitalizes on scientific advancements in breeding, it allows breeders to further utilize the best tools available to achieve and improve their genetic goals. ViaGen can help advance genetic opportunities by multiplying the very best in your herd. Breeders of elite animals can use genetic preservation and cloning as the newest tools in their strategic breeding programs. Cloning is a safe, progressive and beneficial means to preserve and extend the best genetics to positively influence future generations. Please utilize this website as a resource to learn more about making the irreplaceable…..replaceable. ViaGen was founded in Austin, Texas in January 2002 to provide commercial bovine, equine, and porcine genetic preservation and cloning services. In 2003, ViaGen acquired ProLinia of Athens, Georgia. This acquisition doubled our cloning capacity, gave us the ability to produce clones from cells obtained from carcasses, and provided rights to cloning technologies developed by the Roslin Institute of Edinburgh, Scotland. In 2007, ViaGen joined forces with Trans Ova Genetics to form the joint venture Bovance, to promote bovine cloning in North America. Trans Ova Genetics has been providing ART (assisted reproductive technologies) to the bovine industry since 1980. In late 2012, Trans Ova Genetics acquired ViaGen and it became a wholly owned subsidiary of Trans Ova Genetics. Today, all genetic preservation and cloning services, for all non-primate species now falls under ViaGen – a division of Trans Ova Genetics. ViaGen L.C. is recognized as the global leader in animal genetic preservation and cloning services.
Business Model: unknown
Revenue: 7.2M
Employees: 58
Industry: Genetics
DGI Resolution discovers genetic risk factors for diseases from cardiovascular disease to cancer.
Business Model: unknown
Revenue: 39.4M
Employees: 331
Industry: Genetics
BugSeq is leveraging advanced sequencing technologies to revolutionize infectious disease testing and pathogen surveillance. BugSeq’s analysis suite delivers unparalleled data analytics and industry-leading expertise to convert sequencing data into actionable results. By profiling tens of thousands of microorganisms and markers of antimicrobial resistance from any specimen, BugSeq enables broad adoption of sequencing to improve health.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
Okairos AG, a bio-pharmaceutical company, focuses on the discovery and development of genetic T-cell vaccines, including hepatitis C virus. The company also provides health and allied services. It has operations in Rome and Naples, Italy. The company is based in Basel, Switzerland. Okairos AG was former subsidiary of Istituto Di Ricerche Di Biologia Molecolare P. Angeletti Spa.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
Pathwork Diagnostics develops genomics-based molecular diagnostics for oncology applications.
Business Model: unknown
Revenue: 6.2M
Employees: 46
Industry: Genetics
FTF Pharma is a research-oriented company aiming at the development of high quality pharmaceutical products both in the field of generics and formulations.
Business Model: unknown
Revenue: 0 - 100000
Employees: 51 - 200
Industry: Genetics
Gentris is a provider of pharmacogenomic testing and biorepository services.
Business Model: unknown
Revenue: 39.2M
Employees: 134
Industry: Genetics
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Genetics
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Genetics
DNA Romance uses the science of genomics to revolutionize online dating by forecasting "chemistry" between single individuals online. DNA Romance is the first platform to matchmake people based on all three elements of human attraction: appearance, personality &a; "chemistry".
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
Anhui Anke Biotechnology (Group) Co., Ltd. (安科生物) is one of the largest biopharmaceutical high-tech enterprises in China. Founded in 1994, Anhui Anke Biotechnology has been concentrating on the research and development of bio-technical pharmaceuticals such as cell engineering and gene engineering. It has taken more than 10 programs successively such as The National 863 Plan, The National Key Science and Technology and The National Key Torch Program, and number of national-level independently developed new drugs of the company is nearly ten. Among them the dominant products include recombinant human interferon A2B Anterfron and its series of preparations, recombinant human growth hormone Ansomone and anti-sperm antibody detection (MAR method) kit An Sibao which are in great demand nationwide and exported to more than ten countries and regions.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1001 - 5000
Industry: Genetics
Single Helix Genomics is a collection of engineers, scientists and executives determined to provide cGMP-compliant products of custom and pre-designed RNA for drug discovery and distributed manufacturing of mRNA therapeutics and vaccines accomplished on a proprietary single-use microfluidic biochip. It has developed an automated and portable therapeutics-on-demand device that enables consistent, small-scale current good-manufacturing-practice manufacturing of therapeutics-grade mRNA on a timescale of hours.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
Customarray provides customized oligonucleotide pools and microarrays for academic and industrial applications.
Business Model: unknown
Revenue: 5M
Employees: 35
Industry: Genetics
Sniper Medical is a biotechnology company dedicated to developing a new generation of digital quantitative PCR systems based on the original droplet generation technology platform. The company is headquartered in Suzhou, Jiangsu, China.
Business Model: unknown
Revenue: 0 - 100000
Employees:
Industry: Genetics
Business Model: unknown
Revenue: 1.9M
Employees: 23
Industry: Genetics
wellOwise is an engagement platform to predict, prevent and provide personalised management of chronic diseases. Leveraging machine learning, we are developing predictive models based on genomic, pathological and lifestyle data points to understand health risk of an individual. We integrate next generation technologies with healthcare services for providing personalised plans to improve overall wellness.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
Imegen is a research laboratory that provides human genetic diagnosis testing services.
Business Model: unknown
Revenue: 7.5M
Employees: 72
Industry: Genetics
With over 50,000 phlebotomists and medical assistants nationwide, Phlebotek is the largest phlebotomy and medical assistant staffing and solutions company in the USA. Phlebotek provides phlebotomists and medical assistants to all sectors of the healthcare industry including, hospitals, laboratories, blood banks, doctor&s;s offices, research centers, pharmaceutical trials, genetic testing, health screenings and more. Phlebotek also markets phlebotomy jobs and locate phlebotomists for to fill any position, including single patient in home visits. Phlebotomists and medical assistants are available for any amount of time and for any number of patients.
Business Model: unknown
Revenue: 140.5k
Employees: 7
Industry: Genetics
Business Model: unknown
Revenue: 0 - 100000
Employees: 51 - 200
Industry: Genetics
GenVault is dedicated to stabilizing biosamples and to the integration of biosample transport, storage and retrieval, in a way that meshes seamlessly with day-to-day lab operations: thus simplifying sample sharing for customers in genomic medicine, discovery and identification. Today, we are empowering over 150 pharmaceutical companies, medical centers, academic institutions and law enforcement agencies, to more fully leverage the rapidly growing genomics industry. GenVault’s proprietary dry-state storage platform enables the extraction, preservation, recovery and distribution of DNA at room temperature. Currently work is proceeding on equivalent storage technologies for protein and RNA. The need for such sample management solutions is growing at an exponential rate, as more and more samples are collected worldwide for disease diagnosis, research, identification and criminal investigations
Business Model: unknown
Revenue: 10M
Employees: 10
Industry: Genetics
SyAqua provides shrimp breeding, as delivering hatchery feed, genomic selection, quantitative genetics, and breeding science employing technologies. Their genetics and nutritional research have resulted in several well-known products and programs that are used by hatcheries and farms all over the world. They put the families up against disease resistance, as well as AHPNS and White Spot Syndrome Virus, which are the two most common global shrimp diseases. They use a genetic selection strategy for growth performance and they recognize the need for a fast-growing post larva.
Business Model: unknown
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Genetics
Enopace Biomedical is a Biotechnology company that focuses on developing a medical device to treat heart failure. Its medical device utilizes a minimally invasive, implantable neurostimulation device that increases cardiac efficiency by reducing the left ventricular workload.
Business Model: unknown
Revenue: 4.8M
Employees: 24
Industry: Genetics
PrimeraDx is a molecular diagnostics company that has developed a clinical platform which combines PCRn with capillary electrophoresis.
Business Model: unknown
Revenue: 10.3M
Employees: 50
Industry: Genetics
Claros Diagnostics, Inc. is creating products to move in-vitro medical diagnostic tests out of the laboratory and into the hands of physicians and patients.
Business Model: unknown
Revenue: 0 - 100000
Employees: 51 - 200
Industry: Genetics
Aelian Biotechnology allows researchers to assess much more complex phenotypes, thus effectively broadening the scope of these screens. The company combines CRISPR screening with single-cell sequencing, leveraging two transformative technologies to enable genetic screening for complex phenotypes. Aelian Biotechnology&s;s powerful approach has broad applications in identifying novel drug targets or elucidating unknown mechanisms of actions of drugs. They utilize and use the CRISPR screening workflow to map the impact of thousands of genetic perturbations on the global transcriptome at single-cell resolution, thus effectively establishing a paradigm for next-generation CRISPR screens. Aelian Biotechnology was founded in February 2018 and is headquartered in Vienna, Austria.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
XTAL is a Massachusetts-based contract research organization that provides structural biology services for industries including pharmaceutical and biotechnology.
Business Model: unknown
Revenue: 1.1M
Employees: 18
Industry: Genetics
Phlox Therapeutics specializes in the development of gene therapy to alleviate and cure cardiomyopathies.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
It can take a genetic lab up to 5 hours to prepare the results of a genetic test. In this time, their staff is reviewing variants in the genetic profile and cross referencing it with medical literature on the variants. Signifikance has developed software to automate the generation of a genetic test report, allowing them to process more genetic tests and generate additional revenue.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
P4 Medical Laboratory is Ireland’s first ever precision medicine company. We aim to revolutionise the way we think about health by promoting the maintenance of wellness and the prevention of disease.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
PTC Laboratories was formed in 1996 and operates internationally out of Columbia, Missouri, USA. The laboratory offers state of the art genetic testing in multiple areas of expertise including relationship, forensic, medication metabolism and disaster management. PTC handles DNA cases from over 2,000 collection locations throughout the United States, and performs DNA paternity testing worldwide through contracts with private entities, government agencies and individuals internationally.
Business Model: unknown
Revenue: 43.9M
Employees: 141
Industry: Genetics
VisiGen Biotechnologies, Inc., a sequencing technology company, develops an approach for DNA sequencing that enables whole genome sequencing. The company develops VisiGen sequencing system, a platform technology for single-molecule genetic analysis; and VisiATP, a biomolecule labeling product to label DNA, RNA, or oligos with a fluorescent dye for use in various applications.
Business Model: unknown
Revenue: 0 - 100000
Employees:
Industry: Genetics
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
BioTrove, Inc. provides micro and nano-scale technology platforms for life science and drug discovery research applications. The company offers OpenArray, a technology platform for relative gene expression analysis that advances genomic research in various life science fields, including agriculture, disease research, and public health; RapidFire, a technology platform that enables the screening of intractable drug targets via mass spectrometry based assay development; and RapidFire mass spectrometry hardware system, a native detection technology for drug screening and in vitro ADME applications.
Business Model: unknown
Revenue: 0 - 100000
Employees: 51 - 200
Industry: Genetics
Genetics Associates goal is to provide efficient, economical, and state-of-the-art cytogenetic diagnostic services. The owners bring numerous years of experience to Genetics Associates and work side by side with their team of cytogenetic technologists and support staff.
Business Model: unknown
Revenue: 24.3M
Employees: 65
Industry: Genetics
GnuBio is a life sciences company that develops a droplet-based DNA sequencing technology solutions.
Business Model: unknown
Revenue: 5.5M
Employees: 100
Industry: Genetics
Business Model: unknown
Revenue: 31.6M
Employees: 85
Industry: Genetics
Business Model: unknown
Revenue: 0 - 100000
Employees: 501 - 1000
Industry: Genetics
Bento Lab is a personal DNA analysis lab that enables scientists, artists and all curious minds to engage with biology and biotechnology.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
Synbionik is an innovative European biotech company that designs metabolic pathways, optimizes production organisms, and optimizes production processes.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Genetics
Business Model: unknown
Revenue: 8M
Employees: 31
Industry: Genetics
Clear Gene detects remaining solid tumors using genomics and machine learning. Residual Illness Cancer that persists after therapy is known as residual illness. A succession of technological breakthroughs in residual disease identification has assisted patients with liquid tumors. To detect a remaining solid tumor, they employed genomics and machine learning. Patients with solid tumors like breast cancer, on the other hand, have been left behind. Until now, that is. Cancer that persists after therapy is known as residual illness. Life-changing innovations need an atmosphere that encourages unconventional thinking while still rewarding rigorous product development. They work on both the high and low end of the innovation spectrum.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
Altogen Labs provides biotechnology research services for pharmaceutical, biotechnology and academic institutions.
Business Model: unknown
Revenue: 10M
Employees: 10
Industry: Genetics
B.O.S.S. Retirement is a Utah-based financial consultant that provides services such as wealth management and retirement planning for individuals and businesses.
Business Model: unknown
Revenue: 12.6M
Employees: 35
Industry: Genetics
Crystal Genetics, Inc. is an early-stage genetic test company, with the primary focus on achieving the highest possible clinical-grade accuracy and comprehensiveness for detecting mutations in human genes. When it comes to detecting mutations that are strongly correlated with life-threatening diseases, the detection accuracy of every single mutation counts: A single false positive error could cause severe anxiety for the patient. A single false negative error could potentially cost the life of the patient.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Genetics
Clinical Data, Inc. is focused on the development and commercialization of therapeutics, with two compounds in the areas of central nervous system and cardiovascular disorders. The Company&s;s late-stage drug candidate is vilazodone, a dual-acting selective and potent serotonin reuptake inhibitor and serotonin receptor 1A (5-HT1A) partial agonist for the treatment of major depressive disorder (MDD). The Company&s;s second late-stage drug candidate is apadenoson, trademarked Stedivaze, a selective adenosine receptor 2A (AR2A) agonist and coronary vasodilator in Phase III of clinical development for use in nuclear Single Photo Emission Computed Topography (SPECT) myocardial perfusion imaging. The Company also provides the FAMILION family of genetic tests for inherited cardiac syndromes, including cardiac channelopathies and cardiomyopathies. On September 30, 2009, the Company purchased all the assets of Epix Pharmaceuticals, Inc. (Epix).
Business Model: unknown
Revenue: 10M
Employees: 10
Industry: Genetics
BLOCKStrain Technology Corp. (TSX-V: DNAX.V), a full-service software company headquartered in Vancouver, BC, Canada, has developed the first integrated blockchain platform that registers and tracks cannabis intellectual property (“IP”) from genome to sale. It is proprietary, immutable and cryptographically secure, thereby establishing a single source of truth for cannabis strains and their ownership.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Genetics
Sysnsight specializes in molecular modeling, bioinformatic and structural biology fields. It offers high quality services to improve and accelerate research for pharmaceutical and cosmetic industries. Its services is integratable into more important research programs as a CRO such as protein design, diagnostic kit conception or drug discovery.
Business Model: unknown
Revenue: 0 - 100000
Employees: 7
Industry: Genetics
Neurologix, Inc., a development stage company, engages in the discovery and development of therapeutic treatments for disorders of the brain and central nervous system. The company&s;s treatments are designed as alternatives to conventional surgical and pharmacological treatments. It primarily focuses on gene therapy for treating Parkinson&s;s disease, a neurodegenerative disorder; and epilepsy, a group of diseases associated with recurrent seizures, which is caused by periodic episodes of repetitive, abnormal electrochemical disturbance in the central nervous system, beginning in the brain. The company also focuses on the development of gene transfers for the treatment of neurodegenerative and metabolic disorders, including Huntington&s;s disease, depression, and metabolic syndrome or genetically-based obesity. Neurologix, Inc. was founded in 1999 and is based in Fort Lee, New Jersey.
Business Model: unknown
Revenue: 10M
Employees: 10
Industry: Genetics
Igenbio.Inc they provides functional genomic data, metabolic reconstructions, expression profiling, biochemical and microbiological data.
Business Model: unknown
Revenue: 3.6M
Employees: 30
Industry: Genetics
Genos offers Deoxyribonucleic acid sequencing solutions for researchers.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Genetics
Forage Genetics is engaged in the production and development of alfalfa seed.
Business Model: unknown
Revenue: 20M
Employees: 90
Industry: Genetics
Business Model: unknown
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Genetics
Business Model: unknown
Revenue: 4.5M
Employees: 60
Industry: Genetics
Manalo K9 produces excellent, intelligent, and skilled dogs to serve as companions, protectors, and agents for safety. The CGD handles the breeding program that enables us to produce the best working dogs of different breeds. Integrity, Excellence, and Service are the core values of Manalo K9.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Genetics
GEDmatch is an online platform that allows users to compare their genetic profiles to individuals tested at other companies.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
Epigentek is a biotechnology firm that provides genetics kits, antibodies, reagents and services for research agencies.
Business Model: unknown
Revenue: 5M
Employees: 40
Industry: Genetics
DNA Direct was founded in 2005 to address the growing need for genetic expertise and guidance across the healthcare continuum. It was born out of a deep passion and belief that healthcare providers and patients deserve the most current information available to make more informed decisions to improve outcomes.
Business Model: unknown
Revenue: 16.9M
Employees: 59
Industry: Genetics
Single-cell whole genome sequencing service using the patented MALBAC single-cell whole genome amplification technology that amplifies pico-gram level nucleic acids to microgram prior to downstream genomic and Avrio Genetics provides life-changing reproductive and personalized genetic testing products and solutions to physicians and patients throughout the world. analyses.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Genetics
The Centre for Genomic Regulation (CRG) is an innovative centre for basic research created in December 2000 by initiative of the former Department of Universities, Research and Information Society (DURSI) of the Catalan Government. The CRG is legally constituted as a non-profit foundation and has the participation from the Catalan Government through the Economy and Knowledge Department (DECO) and the Health Department (DS), as well as from the Pompeu Fabra University (UPF), and the Spanish Ministry of Economy &a; Competitiveness (MINECO). It is an international biomedical research institute of excellence whose mission is to discover and advance knowledge for the benefit of society, public health and economic prosperity. The CRG believes that the medicine of the future depends on the groundbreaking science of today. This requires an interdisciplinary scientific team focused on understanding the complexity of life from the genome to the cell to a whole organism and its interaction with the environment, offering an integrated view of genetic diseases. The CRG is a unique centre in Spain, based in an innovative organization research model. Group leaders at the CRG are recruited internationally and receive support from the centre to set up and run their groups. An external Scientific Advisory Board, made up of 13 world leaders in the different areas, evaluates them. The result of evaluations conditions the future of the CRG scientists, no matter whether they have open-ended or time-limited contracts. This ensures the mobility and the renewal of the workforce.
Business Model: unknown
Revenue: 0 - 100000
Employees:
Industry: Genetics
Laragen provides service use to sequences from microsatellite-enriched libraries. They provide services for Sanger sequencing, mouse genotyping, Miseq sequencing, cell line id, fragment analysis, and microbial id. They provide inquiries through online applications, email, and phone calls.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
Genable researches, develops and commercializes gene-based therapies for the treatment of inherent diseases.
Business Model: unknown
Revenue: 0 - 100000
Employees: 66
Industry: Genetics
Cilian is an emerging biotechnology company developing and marketing a novel expression system. The Company uses a species of Ciliates, a eukaryotic single-cell organism, for the production of enzymes and therapeutic proteins. While Ciliates secrete a number of therapeutically relevant enzymes with high expression rates by nature, recombinant proteins are produced by Ciliates using genetically modified cells. Leveraging the unique capabilities of the Ciliates, the Company aims to produce proteins at an unmatched quality and price, thereby fulfilling its mission to improve human health by facilitating access to biopharmaceuticals.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
EpicGenetics is looking into fibromyalgia-related issues. Their analytics concludes a method to shorten the time and expense patients spend looking for a confirmed and objective diagnosis of their condition, whether the epidemic of chronic pain is a result of fibromyalgia. And also delivers the details about the urologic condition interstitial cystitis as a result of fibromyalgia and verifies there are discoverable DNA-based pathways that explain why and how a person develops fibromyalgia.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Genetics
Amaxa Biosystems GmbH develops and commercializes gene transfer technologies and products. The company offers Nucleofector Technology, a transfection solution which enables the transfer of various substrates, such as DNA, RNA, or peptides into cells. It also offers transfection services; HiFect transfection reagent, the transfection reagent for standard cell lines; antibiotics for the treatment and prevention of mycoplasma and other microbial contaminants; Expression Vectors for the expression of bright fluorescent proteins and individual customer constructs in mammalian cells; and peptide Nucleofection and transfection control solutions. Amaxa Biosystems offers its solutions in Canada, China, Croatia, Greece, Hong Kong, Indonesia, Japan, Korea, Malaysia, Mexico, Portugal, Singapore, Spain, Taiwan, and Turkey. The company was founded in 1998 and is based in Cologne, Germany. As of July 2, 2008, Amaxa Biosystems GmbH operates as a subsidiary of Lonza Group AG.
Business Model: unknown
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Genetics
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
Synbio Technologies provides DNA solutions that empower scientific discoveries by providing synthetic biology services and products for researchers. They develops DNA reading, DNA writing, and DNA editing capabilities for various applications, including diagnostic DNA probes, precision medicine, protein production, antibody discovery, vaccine development, novel enzymes, molecular breeding, biofuel implication, and more.
Business Model: unknown
Revenue: 0 - 100000
Employees: 51 - 200
Industry: Genetics
Anesiva, Inc., a biopharmaceutical company, engages in the development and commercialization of novel therapeutic treatments for pain management worldwide. Its lead product candidate includes Adlea, which completed multiple Phase II and Phase III trials for post-surgical, musculoskeletal, and neuropathic pain. The company was formerly known as AlgoRx Pharmaceuticals, Inc., it changed its name to Anesiva, Inc. in 2006. Anesiva, Inc. was founded in 1999 and is headquartered in South San Francisco, California. On January 15, 2010, Anesiva, Inc. filed a voluntary petition for liquidation under Chapter 7 in the U.S. Bankruptcy Court for the Northern District of California. On June 10, 2014 filed for Chapter 7 bankruptcy.
Business Model: unknown
Revenue: 0 - 100000
Employees: 51 - 200
Industry: Genetics
An innovative healthcare venture capital firm. Genetics, pharma and wider biotech. America &a; Asia HQ. Founded in 2010. @OrionModern #OrionModern
Business Model: unknown
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Genetics
DNA Compass is a provider of genomic data management software to the healthcare sector.
Business Model: unknown
Revenue: 0 - 100000
Employees: 5
Industry: Genetics
IDEA Bio-Medical is a commercial-stage company that specializes in solutions for biological cell-imaging research, drug-discovery automation, and diagnostics. It designs its product platforms are built for biological cell research and diagnosis, and its systems to improve the output of drug-discovery processes and reduce the costs of biomedical and pharmaceutical research and development. Its WiScan Hermes is a high-definition, ultra-fast biological cell-imaging system. It has joined forces with European research teams to develop solutions in super-resolution microscopy, regenerative medicine, immunology, and bio-medicine in keeping with the framework of the seventh program of the European Union. Shlomo Turgeman founded it through a partnership between YEDA; the Weizmann Institute&s;s commercialization arm; and IDEA Machine Development, Design and Production, an innovation hub.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Genetics
Population Diagnostics develops and market DNA based diagnosis for the early detection of diseases.
Business Model: unknown
Revenue: 14.8M
Employees: 68
Industry: Genetics
Tacere Therapeutics, Inc. specializes in the development of novel therapeutics for the treatment of serious infectious diseases such as Hepatitis C (HCV). Combining expertise in RNA interference (RNAi), gene medicine, and novel biologicals, Tacere possesses proprietary skill in the identification and development of RNAi therapeutics.
Business Model: unknown
Revenue: 16.8M
Employees: 72
Industry: Genetics
Biomax Genetics is a biotechnology company that specializes in the field of nucleic acid extractions. It provides clients with the tools and solutions to enable users to advance their research, develop new products and meet the needs of their own client base. The company was founded in 2015 and is headquartered in Midrand, South Africa.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
Rules-Based Medicine, a Q squared solutions company (RBM), the world&s;s leading multiplexed biomarker testing laboratory, provides comprehensive protein biomarker products and services based on its Multi-Analyte Profiling (MAP) technology platform. RBM&s;s biomarker testing service provides pre-clinical and clinical researchers with reproducible, quantitative, multiplexed immunoassay data for hundreds of proteins in a cost-effective manner, from a small sample volume and from multiple species. Their biomarker testing laboratory is CLIA certified and supports GLP studies.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1001 - 5000
Industry: Genetics
Q2 Solutions is the provider of clinical trial laboratory services for the pharma companies.
Business Model: unknown
Revenue: 41M
Employees: 2k
Industry: Genetics
Blacksmith Medicines is a California-based biotechnology company that develops and commercializes medicines for the treatment of cancer and inflammatory diseases.
Business Model: unknown
Revenue: 1k
Employees: 5
Industry: Genetics
Cypher Genomics is a genomics based informatics driven company that provides human genomic interpretation software solutions.
Business Model: unknown
Revenue: 0 - 100000
Employees: 19
Industry: Genetics
Ardais Corporation is a clinical genomics company, is dedicated to enhancing and accelerating biomedical research by introducing actual human disease into the pharmaceutical discovery research process. To achieve its goals, Ardais has incorporated multi-disciplinary scientific expertise into its operations, including pathology, molecular biology and genomics, statistical genomics, bioinformatics and medical informatics, as well as process management skills such as logistics, industrial engineering, and robotics. The result of this unique integration is a state-of-the-art, proprietary discovery platform that is dramatically transforming genomic research and leading the way to novel diagnostic and therapeutic solutions.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Genetics
Taueret Laboratories is a provider of clinical DNA testing and genomic testing services.
Business Model: unknown
Revenue: 16.5M
Employees: 83
Industry: Genetics
Morvus Technology Ltd., a pharmaceutical company, engages in the discovery, development, and commercialization of drugs and technologies in the oncology field. Its clinical candidates include MTL-005, a therapy for cancers treated with conventional radiotherapy; MTL-007, a novel anti-cancer prodrug; and MTL-003, an anti-angiogenic cancer therapy. The company&s;s research portfolio comprises MorTar platform technology that identifies new proteins and genes that share the ability to inhibit apoptosis; HAI-X, an anti-angiogenic treatment for prostate cancer; and MorGen, a novel prodrug-activating system. The company also engages in the development of anti-cancer treatments using genetic modification techniques. In addition, it offers MorAnt, an anti-parasitic drug; and MorRid, a rodenticide. Morvus Technology Ltd. was founded in 2004 and is based in Carmarthen, the United Kingdom.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Genetics
IntegraGen is a molecular research firm that develops and commercializes molecular diagnostic tests for autism and oncology.
Business Model: unknown
Revenue: 12.8M
Employees: 46
Industry: Genetics
GnTech is a biotechnology company that focuses on the production of medical reports from human genetic sequencing. Its mission is to increase people&s;s quality of life by enabling more efficient medical treatment through access to high-quality genetic information, easy interpretation, high accuracy, and clinical applicability. The company was founded in 2012 and is based in Florianopolis, Brazil.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Genetics
gMendel is providing the diagnosis of genetic disorders. The company provides research and develops medical technology solutions. They provide diagnostic tools that identify gene mutations and chromosomal aberrations from a normal karyotype and recognize genetic disorders.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Genetics
Lipogen is a biotechnology company that innovates and manufactures phospholipids. The company was the first to introduce phosphatidylserine (PS) globally and clinically test soy-lecithin-based PS. Lipogen raw ingredients, used as ingredients in a variety of products, have been shown safe and effective in extensive clinical research. Lipogen delivers high quality products at competitive prices. Patented Lipogen formulas have applications in cognitive function, stress management, enhancing well-being, women&s;s health and improving quality of life.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
CymoGen Dx, LLC, a genomic diagnostic technology company, provides genomic-based reagents and fluorescent in-situ hybridization probes research products and solutions for the diagnosis and monitoring of cancers and human genetic disorders for clinical, biopharmaceutical, and research customers. It engages in the development, manufacture, and application of fluorescence-based DNA detection technology. The company provides tools for identifying genomic aberrations in cancer cells found in tissue and bone marrow specimens. CymoGen Dx, LLC was formerly known as CymoGen, LLC. The company was incorporated in 2010 and is based in New Windsor, New York.
Business Model: unknown
Revenue: 9.9M
Employees: 60
Industry: Genetics
Genomic vision develops novel diagnostic and drug discovery solutions based on nanotechnology for DNA analysis for cancer and acute diseases.
Business Model: unknown
Revenue: 2.7M
Employees: 30
Industry: Genetics
Business Model: unknown
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Genetics
DGI is focusing on gene therapies for diseases of the blood.
Business Model: unknown
Revenue: 9.2M
Employees: 47
Industry: Genetics
DRISHTI Discoveries is a treatment developing research. Their services include research and development in the physical, engineering, and life sciences, biotechnology, and developing transformative treatments through RNA targeting genetic therapies.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
Enzypep designs and develops oligopeptides for pharmaceutical products. The Enzypep technology is expected to become the state-of-the-art in design and preparation of complex peptides. Compared with standard synthesis it results in pharmaceutical products with a much higher purity, at a much lower cost and in a sustainable, environmentally-friendly manner. It began operation in 2012, with its headquarters in Geleen in the Netherlands.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
SemBioSys Genetics Inc., a Canadian biotechnology company, announced today that it has signed a feasibility agreement with Dow AgroSciences LLC, of Indianapolis, Indiana, for the Stratosome(TM) Biologics System and its application to animal health biologics. Under the terms of the agreement, SemBioSys and Dow AgroSciences will engage in collaborative research with the aim of determining if the Stratosome(TM) Biologics System can enable the commercialisation of a Dow AgroSciences plant-made vaccine. Under the terms of the agreement, SemBioSys will receive upfront and milestone payments. Further terms of the agreement were not disclosed. &a;quot; We believe that our Stratosome(TM) Biologics System, with its economic and functional benefits, makes it an outstanding platform for animal health products. We are extremely pleased to be working with Dow AgroSciences in developing their vaccine,&a;quot; said Andrew Baum, president and CEO of SemBioSys. &a;quot;We are very pleased to be working with SemBioSys in evaluating the Stratosome(TM) technology and its application to plant-made biologics for the animal health industry,&a;quot; stated Butch Mercer, Global Business Leader, Animal Health and Nutrition for Dow AgroSciences This is the third funded development agreement announced by SemBioSys in the last six months. In December, SemBioSys announced that it had executed a development agreement with Martek Biosciences Corporation (Nasdaq: MATK) to co- develop value-added specialty oil products (DHA containing safflower oil) with potential pharmaceutical and nutraceutical applications. In February, SemBioSys announced that it had entered into an agreement with Syngenta for access to SemBioSys&s; proprietary oilbody based Stratosome(TM) Biologics and StratoCapture(TM) Purification Systems for the development of Syngenta&s;s biologic products. About SemBioSys Genetics Inc. (www.sembiosys.com) Calgary, Alberta-based SemBioSys Genetics Inc. is a privately held biotechnology company focused on the development of therapeutic proteins and oils using its proprietary oilbody-based technology - the Stratosome(TM) Biologics System. Spun out of the University of Calgary in 1994, the company&s;s investors include Bay City Capital, Dow AgroSciences Canada, Inc., Ventures West Management Inc., BDC Venture Capital, University Technologies International Inc., RBC Capital Partners and Maurice Moloney Ph.D. scientific founder and chief scientific officer. In addition to these investors, SemBioSys has received repayable contributions of CAD$5.5MM from Technology Partnerships Canada, an agency of Industry Canada, and CAD$4.9MM from AVAC Ltd. SemBioSys has partnerships with Syngenta Participations AG and Martek Biosciences for the use of its Stratosome(TM) technology for the development of therapeutic products.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Genetics
Maven Biotechnologies develops label free internal reflection ellipsometry analysis systems for microplates and slide disposables that measure molecular binding in real-time on microarrays spotted in wells or on slides. It offers Polaron, a platform for developing and performing immunoassays, rapid diagnostic screening, cell-based screening, drug-target kinetics, and protein and genomic microarrays; and LFIRE, a high density imaging system for quantitative biomarker analysis. The company serves diagnostics, pharmaceuticals, research, and industrial applications. Maven Biotechnologies, LLC was founded in 2000 and is based in Pasadena, California.
Business Model: unknown
Revenue: 22.8M
Employees: 77
Industry: Genetics
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Genetics
Novocraft Technologies Sdn. Bhd. is a Bioinformatics company incorporated in 2008. We are an avid group of Bioinformaticians, software developers and statisticians working with the full range of nextgeneration sequencing platforms. Our team is a culmination of over 8 years of experience in software development and performance tuning; bioinformatics research and high-performance computing. We build proprietary software for bioinformatics solutions, bioinformatics analysis platforms as well as provide consultancy and training.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Genetics
Lighthouse Biotech offers a liquid biopsy tool that helps to extract live and intact circulating tumor cells from a simple blood sample, to avoid repetition with altered metabolism, helping medical staff and doctors to trace and treat tumor cells in the very early stages of the disease.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
BIOPATH Laboratoires is an independent group of medical biology laboratories. Their focus is on connecting health partners with patients (doctors, pharmacists, private nurses, retirement homes, occupational doctors), with expertise in Biochemistry, Hematology, Immunology, Microbiology, Genetics, Medically Assisted Procreation, and Molecular Biology.
Business Model: unknown
Revenue: 0 - 100000
Employees: 501 - 1000
Industry: Genetics
XLabs builds AI to amplify humans. We build meaningful futuristic moonshots powered by artificial intelligence, quantum computing and neurotech. Each of our breakthroughs cascade on top of a core meta-learning AI. An evolution on Silicon Valley’s past models, we use next-gen technologies to change 3 future slices of the world: culture, genetics and the internet.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
Dhiti Omics is a precision molecular diagnostics service provider based in Bangalore, India offering tests using state-of-the-art genomics technologies such as Next-Generation sequencing, Sanger sequencing, Microarray, PCR, RT-PCR etc. We deliver ethical and actionable Molecular Diagnostics, Genetic testing, and R&a;D services, currently in following specialisations. 1. Rare Diseases 2. Inherited Disorders 3. Oncology 4. Pharmacogenomics 5. Infectious Diseases The team at Dhiti Omics aims to provide deeper insight into diagnosis for rare and difficult diseases through clinical genomics, collaborating with subject matter experts, and provide personalised research to help patients and clinicians predict, prevent and pre-empt diseases better, to help make an informed choice for patients.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Genetics
Cogenics provides genomics solutions to healthcare and life sciences industries. It offers nucleic acid extraction, sequencing, molecular biology, gene expression, bio repository, clinical and non-clinical genotyping, bio manufacturing support, and bio banking for research and regulated environments. Its customers include pharmaceutical and biotechnology companies, agricultural companies and agencies, and government and academic researchers in the international life science community. Cogenics, Inc. was incorporated as Genaissance Pharmaceuticals, Inc. in 1992 and changed its name to Cogenics, Inc. in December 2006. Cogenics, Inc. was formerly a subsidiary of Clinical Data, Inc. The company is based in Morrisville, North Carolina. It has operations in Texas and North Carolina, as well as in the United Kingdom, France, and Germany.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
TheraGenetics was spun out of King&s;s College London in April 2006. Their technology is based upon pharmacogenetics; the study of genetic factors involved in influencing an individual&s;s response to drug treatments. The strong foundation of TheraGenetics stems from the founding team&s;s long commitment to pharmacogenetics that has situated us at the cutting edge of personalised medicine. Under the umbrella of the Institute of Psychiatry at King&s;s College London, the founding team translated 15 years of research into the commercial world by developing the first pharmacogenetic test for response prediction in psychiatry. In 2005, this test which focuses on the schizophrenia treatment clozapine, was successfully licensed by King&s;s College London to a major UK laboratory who have successfully brought the test to market in 2006. Based on this achievement and the overwhelming enthusiasm for personalised medicine solutions, King&s;s College London, the academic founders and the London based venture firm IPGroup PLC launched TheraGenetics in April 2006. TheraGenetics unique knowledge and experience in CNS disorders extends from the bench to the bedside. The ultimate clinical utility has been a priority consideration at all stages of their test development; their clinical team knows what is required at the patient care interface and they develop tests accordingly. The TheraGenetic&s;s team has a threshold of knowledge and experience spanning the whole test development process that is now allowing us to rapidly advance their work in the field of pharmacogenetic response prediction.
Business Model: unknown
Revenue: 0 - 100000
Employees: 201 - 500
Industry: Genetics
Founded out of Yale University, CGI (formerly Cellular Genomics Inc.) began operations in 2000. CGI, in conjunction with several biotech and pharmaceutical partners (Pfizer, Serono, Lilly, Affymetrix, and Schering AG), utilized a unique chemical-genetics approach known as “ASKA” (Analog Sensitive Kinase Alleles) to understand kinase function. CGI Pharmaceuticals is dedicated to the discovery and development of breakthrough small molecule therapeutics for a broad range of oncology and allergy/autoimmune/inflammatory disease (AAID) indications. The Company’s fully integrated drug discovery infrastructure comprises proprietary kinase biology and chemistry, extensive lead generation and optimization capabilities, as well as drug metabolism/pharmacokinetics (DMPK) expertise. Utilizing its comprehensive chemistry capabilities, CGI has generated a proprietary small molecule kinase inhibitor library of over 50,000 compounds (all compounds designed and synthesized by CGI). To date, CGI has been awarded 8 U.S. patents covering its novel collection of kinase inhibitors. Moreover, all three of CGI’s drug discovery and development programs are based on hits obtained from CGI’s library.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Genetics
3X Genetics develops medical screening solutions to identify genetic disorders. It provides medical technologies for infants and children.
Business Model: unknown
Revenue: 0 - 100000
Employees:
Industry: Genetics
Zymenex is a Scandinavian biopharmaceutical company focused on the development and commercialization of novel enzyme replacement therapies for the treatment of life-threatening, rare genetic diseases. Zymenex is developing several human recombinant enzymes that can be used for therapy within specific disease areas. The products are expected to be able to help patients, who today have serious handicaps, reduced quality of life and a markedly reduced life expectancy. Enzyme replacement therapy is a well-known treatment method and there are a number of products on the market today that validates the company concept. The company’s Research and Development focuses on Lysosomal Storage Diseases, which is a common name for human diseases, where the ability of the human body to break down specific molecules in the lysosomes in the cells is reduced or impaired. The diseases most often affect children, they are lethal and there is no therapy available today.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Genetics
Kinetic Diagnostics is a provider of genetic testing, biomarker analysis and neuromuscular training programs for physicians and fitness trainers.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
Biobiggen is a non-invasive prenatal chromosomal disease and monogenic disease simultaneous screening technology platform. It is focusing on the pregnancy and childbirth period, focusing on prenatal screening, supplemented by newborn screening and prenatal diagnosis, and deeply creating the most complete high-throughput prevention and control of genetic diseases and birth defects Sequencing technology series of innovative products, leading enterprises and unicorn enterprises in the subdivision field. The company is headquartered in Beijing Economic and Technological Development Zone, has an overseas research center in Houston, the United States, and an R&a;D transformation center, GMP production base, and medical testing laboratory in Beijing.
Business Model: unknown
Revenue: 0 - 100000
Employees:
Industry: Genetics
Synaptitude aims to bring revolutionary advances in brain imaging, genomics and neurocognitive assessments to the general public for the benefit of human brain health. We combine sophisticated research and technical analyses to provide our clients with the most comprehensive brain health assessments. Join us in this venture of science and knowledge.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
We are increasing presence in other GCC countries, the company proudly provides comprehensive diagnostic services which include genetic testing, consultations, DNA analysis, DNA ancestry, food intolerance &a; allergy testing, nutrition help, and cancer testing services among others. Scope of Work Preventive Cancer Genetic Tests (Genetic mutation and Cell free DNA analysis) Infectious Disease Tests by PCR Rapid Pathogen Tests by PCR Pre-marital, Pre-natal and Neo-natal Screening DNA Molecular Diagnostic Tests Food Intolerance/ Allergy Tests DNA Relationship &a; Ancestry Tests Genetic Counseling Routine Pathology Tests Eastern Diagnostic Network (EDN) Online Web Portal
Business Model: unknown
Revenue: 4.7M
Employees: 62
Industry: Genetics
CyberGene develops and sells medical test kits for genetic diagnostics. ChromoQuant® QF PCR kit is a CE marked diagnostic kit for fast detection of chromosome disorders in foetuses. Accompanied with decision support software Visualizer™ enables test time to be reduced from weeks to day/days. CyberGene is also a high quality provider of related products and sevices. The customer base is world wide. The ChromoQuant® product is a family of diagnostic kits for analysing chromosomal disorders. ChromoQuant kits are introduced in several countries worldwide. Find out about ChromoQuant® QF-PCR kit - one of the most widely used CE marked In Vitro Diagnostic kits for prenatal diagnosis on the world market. ChromoQuant AZF - PCR based kit diagnosing microdeletions in the Y chromosome
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
Echo Biotech is a biotech firm mainly engaged in the R&a;D and production of exosome molecular diagnostic products and exosome research.
Business Model: unknown
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Genetics
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
InterScope Technologies, Inc. is a privately held company located in Wexford, PA. It was founded in 1998 by Dr. Michael Becich and other staff pathologists associated with University of Pittsburgh Medical Center. Its product suite includes a range of integrated slide imaging, case flow and clinical data management applications for use in anatomic pathology, toxicology and genomic environments by clinical, research and educational institutions.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
Sierra BioSystems offers services to solve the problems behind the high costs of synthetic DNA. They offer services to broaden world access to the equipment used in genetic research. They can be reached by phone.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Genetics
Disulfican Ltd aims to assemble an international research collaboration focused upon the development of the drug formulation to regulatory standards and testing its anti-cancer safety and efficacy.
Business Model: unknown
Revenue: 0 - 100000
Employees:
Industry: Genetics
Geospiza develops software for data-intensive genetic analysis application.
Business Model: unknown
Revenue: 18.3M
Employees: 73
Industry: Genetics
Kuveda provides oncologists with SaaS-based tools and services for the analysis of cancer patients’ molecular profiles to derive personalized therapeutic cancer treatment options. Its patent pending network analysis engine enables oncologists to identify treatment options based on bio-markers, proteins, genes, pathways, specific molecules, and more. It also utilizes curated repositories daily to obtain relevant pharmacological, biological, toxicological, and genetic information to give oncologists comprehensive reports. Kuveda offers oncologists with patient specific drug regiment options, supporting evidence and insights, individual patient biology, patient history, and toxicology considerations. Kuveda is a part of the StartUp Health Academy, a global long-term coaching program and peer network for healthcare entrepreneurs. It has a global peer network of healthcare innovators in seven countries and 45 cities. Kuveda is based in California, United States.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
Business Model: unknown
Revenue: 14.4M
Employees: 80
Industry: Genetics
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
Vandalia Research provides production of industrial scale polymerase chain reaction amplified DNA.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Genetics
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Genetics
VivoLabs is a biopharmaceutical firm that performs genetic diagnostic testing, predictive genetics, genetic identification, and several clinical analyses. Using these methods, clinicians can detect everything from sexually transmitted diseases (STDs) to a person&s;s propensity for developing several illnesses like cancer, Alzheimer&s;s, and other ailments. Along with providing theoretical and applied courses in molecular biology techniques, they also provide relevant qualifications in genetics.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Genetics
iXpressGenes specializes in providing protein services and instrumentation and genetic engineering research services.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
Athletic Genetix, a DNA test that is steering people away from general dieting and training towards a detailed plan based on your unique genetic makeup. From a simple saliva sample, you will get a full breakdown on what your body is predisposed to metabolize and digest while also understanding how to best train for your body and muscles structure. Once you have taken the test, you&s;re in the capable hands of our consultants and trainers to further assist you to reach your peak physical condition.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Genetics
Business Model: unknown
Revenue: 0 - 100000
Employees: 51 - 200
Industry: Genetics
Anlong Bio focuses on the research and development of nucleic acid drugs, including gene therapy, RNA drugs, and gene editing. The core team has experience in domestic and foreign scientific research, multinational pharmaceutical companies, entrepreneurship, and investment. In the fields with huge market potential, the varieties of independent intellectual property rights are developed, and most of them are at the forefront of the country. In the field of rare diseases, they use the rich resources of rare disease patients in China to actively cooperate with foreign companies. The company aims to provide various genetic medicines to fulfill the unmet medical need in China, they develop AAV gene therapies with in-house technologies from vector discoveries to manufacturing and clinical approval.
Business Model: unknown
Revenue: 0 - 100000
Employees:
Industry: Genetics
Business Model: unknown
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Genetics
CentralStar Cooperative is an integrated service-providing company for herd management in dairy and beef producers. They provide herd management products, dairy production analysis, genetic consultation, diagnostic, and dairy herd information services.
Business Model: unknown
Revenue: 0 - 100000
Employees: 201 - 500
Industry: Genetics
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
Datagenno Interactive Research serves as an interactive link between molecular and clinical genetics. Datagenno Interactive Research is a company specializing in the development and research of rare diseases or difficult diagnosis, with strategies tailored for each project.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
Quanticel Pharmaceuticals is a drug discovery firm that develops medicines for the treatment of cancer and other life-threatening diseases.
Business Model: unknown
Revenue: 10M
Employees: 60
Industry: Genetics
Instant Chemistry is a biotechnology company that uses personal genomics to determine compatibility for singles and couples. The company’s platform employ psychological compatibility tests, as well as a tool to improve the chances that singles will find their perfect match. Instant Chemistry was founded by Ron Gonzalez and Sara Seabrooke in 2013 and is based in Toronto, Ontario.
Business Model: unknown
Revenue: 4.8M
Employees: 57
Industry: Genetics
Applied Genomics develops novel tools useful for the detection and classification of human cancer. They accomplish this by having developed a process whereby complex gene expression data is used to target antibody production and generate datasets of protein expression across thousands of tumor tissues. AGI has used these reagents and datasets to reveal a novel approach towards classification of cancer with great potential to account for the clinical variation among patients that clinicians have observed for decades.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
RIA is to help and understand the patients the diagnosis, treatment, and path forward. Their interventional radiologists perform some of the most leading-edge treatments available today. Their services include MRI, CT, digital mammography, ultrasound, pain management, DXA, x-ray, and image-guided biopsies. They offer evening and weekend hours at several centers.
Business Model: unknown
Revenue: 9.6M
Employees: 38
Industry: Genetics
DNA Genetics offers research services such as distribution of genetic potential, multiplication, trait development, measuring, helix database, genomic selection, feed intake recording data, commercial crossbred program, data accuracy, testing program, nucleus offspring testing, and more services for the entire pork chain.
Business Model: unknown
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Genetics
Center For Human Genetics And Laboratory Diagnostics is a healthcare organization that specializes in nutrigenetics, cytogenetics and microbiology.
Business Model: unknown
Revenue: 17M
Employees: 160
Industry: Genetics
JGene Biotechnology is a research and development biotechnology company dedicated to the research and development of universal CAR-NK/T products from iPS. It is hoped that the large-scale production of CAR-NK/T from iPS will provide cancer patients with spot-type, price-friendly, and affordable new immune cell therapy products. Recently received angel round investment.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Genetics
Sage engages in research and development of vivo transgenic disease models.
Business Model: unknown
Revenue: 42M
Employees: 525
Industry: Genetics
PLANTING THE SEEDS OF HUMAN HEALTH.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
Varsomics develops a human genetic analysis platform called varstation that automates the complex, manual process of analysis of the genetic data generated by next generation sequencing. Varstation developed to supply a market solution in the analysis of genetic fields.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Genetics
Beagle Bioinformatics is a Brazilian startup company located in João Pessoa (Brazil), with a branch in São Paulo (Brazil) and Santiago (Chile). Our work is provide innovative &a; collaborative solutions for Genomics, Transcriptomics, Bioinformatics &a; Computational Biology fields. This represents a new paradigm in Genomics &a; Transcriptomics data analysis and storage. Our goals were constructed based on the transformation from the small to the big data, since the Terabases sequencers are already available, and will be commonly used soon. So, the company provides a facility for consulting, infrastructure implementation, analysis, databases &a; tools implementation, cloud solutions for biological data.
Business Model: unknown
Revenue: 4.2M
Employees: 41
Industry: Genetics
Cellomics Technology LLC is a biotechnology company located Cellomics Technology About Usat the Biotech Corridor at the Nation’s Capital. Our vision is to become a leading provider of products and services for gene targeting in mammalian cells. We provide products and services for academic, biotechnology and pharmaceutical companies research needs. In short term, we aim to capitalize our technology expertise in lentiviral vector production by offering a wide range of pre-made lentiviral vectors. We also offer other products and services that help customers to accelerate their gene targeting related works.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
Toldot Genetics is a biotechnology company that provides clinical data and genome analysis services for the pharmaceutical sector.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
Biosettia is a company that develops and commercializes technology for life science research. The firm sells tools and specialized reagents to help with genome-wide functional analysis and induced pluripotent stem cell production (iPSC). Single-strand RNAi, microRNA expression methods, normalized full-length cDNA libraries, and lentiviral delivery systems are just a few examples. They have expanded their research and development activities to include stem cell research, cancer biomarker identification, and the discovery of next-generation therapeutic targets, in addition to offering reagents and services to several academic institutes, biotech, and pharmaceutical firms.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
Negen is a genetic testing and analysis technology company. The company offers genetic tests that are designed to show genetic risks for certain diseases and health problems such as type 2 diabetes and coronary heart disease.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
GENOMICA is a biotechnology company that develops and markets molecular diagnosis devices to analyse human genetic information.
Business Model: unknown
Revenue: 6.5M
Employees: 60
Industry: Genetics
Business Model: unknown
Revenue: 223.2k
Employees: 43
Industry: Genetics
ICBiotec aims to advance reproduction for mammalian species by providing cloning and associated services for domestic and international clients across academia and industry. ICB has grown with the advancement of molecular and reproductive biology and maintains state-of-the-art facilities and a highly skilled team of scientists and production personnel, with a focus on innovative reproductive technologies in livestock species.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
Eve Biomedical, Inc. develops biotechnology solutions to enable genomic and personalized medicine. Eve Biomedical, Inc. was founded in 2006 and is based in Mountain View, California.
Business Model: unknown
Revenue: 10M
Employees: 10
Industry: Genetics
Business Model: unknown
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Genetics
Genizon Biosciences Inc. discovers genes and biomarkers in common diseases using genome wide association studies (GWAS), leveraging its proven and proprietary technology platform and access to patients from the Quebec Founder Population.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
Home is engaged in the research and development of drug therapies for the detection of circulating tumor cells.
Business Model: unknown
Revenue: 0 - 100000
Employees:
Industry: Genetics
Targene Advanced Agriculture specializes in the utilization of biotechnology to provide solutions in agricultural technology. Dror Shatlin founded it on January 1, 2016, with its headquarters in Moshava in Israel.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
FutureCow helps farmers improve operations in the parlor. Their first product, the teatscrubber prep system, hit the market to improve how dairies wash, sanitize, dry, and stimulate teats prior to milking. They build state-of-the-art products that never sacrifice the comfort of their animals. Their manufacturing process includes strenuous control tests to ensure the durability of everything they sell.
Business Model: unknown
Revenue: 2.5M
Employees: 43
Industry: Genetics
Green FaFa is a genome intelligent breeding system platform providing intelligent breeding equipment like gene chips for the growth of plants.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Genetics
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Genetics
Stokes Bio develops and distributes microfluidic technology to its clients. It was founded in 2005 and is based in Ireland. It was acquired by Life Technologies in 2010.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
Tiselia develops a transformational platform for the needs of genetics and biotechnology. Aviad Maizels founded it on August 1, 2016, with its headquarters in Herzliya in Israel.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
Primate is a Florida-based company that offers services such as behavioral consulting, training and also sells handling and training equipment for animals.
Business Model: unknown
Revenue: 33M
Employees: 117
Industry: Genetics
Sistemas Genomics is a Spain-based biotechnology firm that develops and commercializes genetic sequencing kits for patients.
Business Model: unknown
Revenue: 22.6M
Employees: 100
Industry: Genetics
Tom&a;Sawyer is the market segment founder and leader for fresh, gently cooked pet food across Canada. Our mission in founding Tom&a;Sawyer is to help family pets live healthier, happier and longer lives. We were the first fresh cooked pet food subscription company in Canada, launched in 2015, we are still the only fully national Direct-To-Consumer (DTC) subscription gently cooked pet food company, and we are also in hundreds of specialty pet and grocery retailers across Canada. Tom&a;Sawyer has seen many competitors enter this high growth segment of pet food since our launch, which is great for helping educate pet owners about the significant health benefits of feeding highly nutritious fresh food to the furry members of our family. When we launched, people thought we were crazy for voluntarily adopting human food regulations in making the highest quality pet food in the world using restaurant quality ingredients! But, our continued research clearly shows it positively impacts the health of our family pets, and lowers both the financial and emotional burden of our pets getting sick. We realized a troubling trend however, in that our new competitors are marketing companies who are seeking to jump onto the high growth subscription bandwagon. None of them make their own food, or invest in any science or research around their products, yet aren&s;t very transparent about that key point. They leverage the dirty secret about pet food in Canada - it is completely unregulated. This is a fundamental reason why we launched Tom&a;Sawyer with transparency and accountability being key hallmarks of our leading brand. It&s;s also the reason why we created the Fresh Cooked Pet Food Alliance industry association to push for enhanced consumer protections so people actually know what they are buying for their beloved pets. We continue to invest in a robust research and development program to bring more innovative and therapeutic products to market in Canada and beyond. We are proud of many firsts in the Canadian market – first to make nutritious gently cooked meals for both dogs and cats, to make specialty diets to help pets with specific health issues, first to have a kitchen facility open to the public to see how our products are made, and first to actually have a head chef and culinary-trained members of the team. We take the production of our products incredibly seriously, and by controlling everything ourselves we can introduce new recipes very quickly and respond to new research findings by our team, which is currently focused on how microbiome and genomics will drive our future recipe development.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Genetics
Genscript Technology (Nanjing) Co., Ltd. (金思特科技) is an experimental platform that focuses on biological technology. It is a comprehensive biological technology service corporation and the biggest bio-medical CRO established in 2004. Genscript Technology has about 600 workers, among whom more than 80% have the college and higher education background and about 30% of the employees have master degrees or above. The American technical directors in all departments of the company have PhD degrees or above, and have many years of research and management experience; 40% management staff have management and scientific research experiences in enterprises of biological medicine field for 5-15 years. Since the foundation, Genscript Technology has established 6 experimental platforms: gene synthesis, PCR cloning, construction of siRNA, polypeptide synthesis, protein expression, and purification, as well as antibody preparation. The scope of services includes one-stop service from genes to antibodies, and biotechnology services for bioengineering, and new drug screening of early development.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
HeartGenetics develops genetic tests for cardiac pathologies.
Business Model: unknown
Revenue: 456.4k
Employees: 7
Industry: Genetics
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
We provide a marketplace where laboratories are financially incentivized to share valuable genetic biomarkers with other stakeholders. Clinicians and insurers have access to a comprehensive database of validated biomarkers, laboratories are compensated for novel contributions, and test developers mitigate regulatory risk by using a regulatory-compliant database. To achieve this, YouGene uses a patent-pending, micro-attribution royalty framework that encourages submission with income payments and trade secret protection. The result is a platform that induces laboratories, clinicians, and insurers to participate
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
Integromics (ITG) develops state-of-the-art software solutions for Life Sciences (Genomics and Proteomics) that enable scientists to effectively organize their data, perform advanced validated analyses, and discover new biomedical knowledge. ITG operates in the global Life Sciences market and has established a network of collaborations and partnerships that has enabled it to access the top-league of players in its sector, as proven by the names of its corporate clients, such as Pfizer, Novartis, Unilever, Merck, Sanofi-Aventis, and Amgen or institutional customers like ETH Zürich, Harvard Medical School, Chinese University of Hong Kong to cite only a few. Since its foundation in 2002, ITG has performed a spectacular, though organic, growth and is currently in a position to further embrace, not only the high-potential bioinformatics market and to consolidate its presence as a leading brand in the Life Sciences community, but also to expand in the personalized genomics clinical market.
Business Model: unknown
Revenue: 6.8M
Employees: 44
Industry: Genetics
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Genetics
Five3 Genomics, LLC offers cancer genome data processing services. The company provides genome processing services for researchers including alignment, mutational calling, rearrangement detection, and copy number estimation. It caters to research, biotech, and patient care sectors. Five3 Genomics, LLC is based in Santa Cruz, California.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
nanoTherics gene transfection studies have shown a significant performance enhancement over the best non-viral techniques currently on the market, demonstrating high levels of transfection whilst, importantly, maintaining the viability of the transfected cells. These two key attributes afford a significant competitive advantage over currently available systems. nanoTherics’s mission is to position its novel gene transfection technology as the new “gold standard†for transfection, underpinning the research and development of current and future gene therapy programmes.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Genetics
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Genetics
yuFlu builds digital health solutions that help you know why you&s;re sick and links you to the best treatment options available. yuFlu is one swab kit that screens for 100s of organisms that cause the common cold and flu. You receive same day notifications of your swab status, results, and treatment options. Plus, every time you swab with yuFlu, you contribute to the health of your family, your friends, and your community.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
Business Model: unknown
Revenue: 0 - 100000
Employees:
Industry: Genetics
Midland Genetics offers locally tested genetics from Monsanto, Bayer, Dow, and Syngenta, as well as leading characteristics from Monsanto, Bayer, Dow, and Syngenta. Their locally customized genetics have outperformed every other brand in more field testing and variety comparisons in your region. Midland Genetics is a seed company that supplies farmers with maize and soybean seed. They use a unique approach to seed placing by creating a customized seed plan for each farm&s;s soil and growth circumstances.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Genetics
CellFor is the world&s;s leading independent supplier of high technology seedlings to the global forest industry. Using plant biotechnology, which is the use of biological processes to manufacture products, CellFor identifies and produces genetically superior conifer seedlings without genetic modification.
Business Model: unknown
Revenue: 0 - 100000
Employees:
Industry: Genetics
Marketing, Commercialization and Medical Diligence Services for Genetics, Genomics and Health-tech Companies
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
MyGenome Institute is a biotechnology company under ALPS Global Holding Berhad (ALPS) specialising in Precision Medicine to provide in-house molecular genomic tests, utilising cutting edge techniques of Next Generation Sequencing (NGS), Digital Gene Platform, Microarray, Real-Time &a; Standard PCR. Our services include a range of genetic profiles on liquid biopsy to assess the risk of diseases at molecular level for cancers, cardiac and metabolic genetic, neurogenetic , pharmacogenetic, inherited diseases, wellness and fitness related diseases etc.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Genetics
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
Accuthera provides commercial physical and biological research and development. Accuthera aims to be an international company that contributes to the development of society based on advanced technology development capabilities centered on accelerators, knowledge and experience in radiation therapy and nondestructive testing of cancer, and networks in Japan and overseas. Based on accelerator design and development, we provide high-energy X-ray sources, software, accelerator related parts, X-ray imaging services, and consulting services.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
Recombinetics is a Minnesota-based biotech firm that offers animal gene editing and gene repairing services in sectors including biomedical research and regenerative medicine.
Business Model: unknown
Revenue: 7.2M
Employees: 45
Industry: Genetics
CDI Bioscience has developed an innovative technology for increased yield of bioproducts, manufactured in cellular systems. Genetic engineering technology is used to control the metabolism of cells, thus shifting the cell from replicative to production mode (RP Shift®). In particular, this technology has been designed for use in mammalian cells, unlocking their potential to produce proteins, peptides and enzymes. The current design of the technology can be readily translated to bacterial and yeast cellular systems for the production of commercial grade bioproducts.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
Origen Therapeutics, Inc., a biotechnology company, develops products from avian transgenic animal technology. It provides human sequence polyclonal antibodies. The company also develops a technology platform based on the genetic engineering of chicken embryonic cells, which can be genetically modified in such a way that the introduced genes are stably expressed in adult birds. Origen Therapeutics, Inc. was incorporated in 1997 and is based in Burlingame, California.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Genetics
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
HiTech Health offers strategy and supply chain, EU-qualified person services, regulatory and compliance, technical due diligence, vendor selection, and project management. They provide the development, manufacture, and supply of cell and gene therapies for clinical trials and also the supply of approved medicines to patients.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Genetics
Micar Innovation is a drug discovery factory. The company has found a niche where it is able to create a large societal impact by improving the quality of life through discovery novel blockbuster drug molecules for a large class of diseases (Pipeline).
Business Model: unknown
Revenue: 1.5M
Employees: 28
Industry: Genetics
Vision genomics, LLC is a biotechnology-based company that focuses on research and development of therapeutics for age-related eye diseases. Their company undertakes an interdisciplinary approach using big data analysis to produce working solutions for age-related eye diseases. Their primary disease of interest is Age-related macular degeneration (AMD). AMD is the leading cause of visual impairment and blindness in older adults and one of the most common causes of visual impairment worldwide. Vision Genomics, LLC is focused on operations and development of its AMD Medicine TM drug discovery with a personalized medicine platform. AMD Medicine TM was developed using the advanced genomic and transcriptomic analysis algorithms already successfully used in cancer research and precision medicine in oncology. The AMD Medicine platform contains broad databases of gene expression, genetic and epigenetic data in ocular diseases as databases of drugs with known molecular targets and effects on gene expression in a variety of tissues and cell lines. It includes advanced parametric and machine learning algorithms that screen for drugs that minimize the difference between healthy and disease states while targeting signaling pathways that are pathologically activated or down regulated and accounting for pharmacogenomic effects. For years the founding scientists have engaged in projects related to the understanding of the interplay of inter-cellular signaling pathways in age-related diseases and progeroid syndromes and have looked for interventions to modulate and delay the onset of the pathological processes resulting from and driving aging. Age-related macular degeneration (AMD) was identified as one of the disease models , in which some of the interventions may be effective. To accelerate research scientists decided to form a company and engage with the country’s top ophthalmologists to find working personalized solutions for AMD.
Business Model: unknown
Revenue: 4.2M
Employees: 22
Industry: Genetics
Alpaqua Engineering provides laboratory automation solutions and engineering services that are meant to increase and improve the functionality of liquid handling platforms. They concentrate on creating and producing magnet plates for use in nucleic acid purification using magnetic beads. Heating and cooling blocks, SBS tube racks, deck expansion platforms, labware stations, and Alpillo® microplate holders with integrated spring-cushion technology are among the other commodities.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
LivoGen Pharmed offers pharmaceutical firms and community researchers working in the field of biotechnology services advanced laboratory services based on GLP principles and quality control of biotechnological drugs as well. Creating kits for calculating the quantity of DNA present in common cells used to make recombinant proteins has made a step toward lowering the costs for biopharmaceutical companies. In particular, the following cell lines are included in kits for estimating the quantity of host cell DNA mycoplasma detection kits by the qPCR method, and molecular detection kits for covid-19.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Genetics
GeneCell is a provider of collection, processing and storage of umbilical cord blood from which stem cells can be extracted to treat diseases.
Business Model: unknown
Revenue: 10M
Employees: 10
Industry: Genetics
The Center for Genetics and Society is a nonprofit information and public affairs organization working to encourage responsible uses and effective societal governance of human genetic and reproductive technologies and other emerging technologies. We work with a growing network of scientists, health professionals, civil society leaders, and others.The Center supports benign and beneficent medical applications of these technologies, and opposes those applications that objectify and commodify human life and threaten to divide human society.The Center works in a context of support for the equitable provision of health technologies domestically and internationally; for women&s;s health and reproductive rights; for the protection of our children; for the rights of the disabled; and for precaution in the use of technologies that could alter the fundamental processes of the natural world.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
Sinochips Diagnostics provides pharmacogenetic testing services. They concentrate on genetic testing. Their service is based on the patient&s;s DNA analysis, other prescriptions, and lifestyle. Their customer contacts through phone and email.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Genetics
ID-GENE provides fast, sensitive, and reliable genetic tests for environmental bioassessment and biomonitoring. They aim to empower environmental agencies, consultancies, and the industry through innovative tools for environmental impact assessment. The company works to foster scientific innovation in an entrepreneurial mindset to make environmental genomics accessible and to improve the long-term management of environmental resources.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
Viaken Systems is the premier full service ASP (Application Service Provider) for the life sciences, offering solutions for biotechnology, pharmaceutical, and agricultural companies. Viaken hosts third-party research informatics application solutions and e-commerce services in the areas of genome informatics, chem informatics, and pharmaco informatics at its tier one data center and delivers these services via the Internet. The company’s unique ASP platform enables companies of all sizes to utilize the same state-of-the-art research information technology (IT) as implemented by top-tier organizations. Viaken specializes in architecture design, application and database hosting, distributed access to high performance computing services, secure network management, and 24x7x365 system and application support. The company also designs, implements, and hosts custom solutions to meet any of its customers’ IT requirements.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
DiaGenic seeks to create value for patients, partners and investors by developing innovative and patient friendly in vitro diagnostic (IVD) products for early detection of diseases. The Company’s proprietary concept implies that a disease evokes systemic responses in the blood unique for the disease, which can be measured by using blood samples. DiaGenic is a world leader in identifying gene expression signatures in blood and is focused on the development of IVD biomarker products in the field of Alzheimer’s disease (AD).
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Genetics
Healthy Nevada Project is a community-based population health study. Their project aspires to offer genetic testing to any Nevadan interested in learning more about their health and genetic risks while serving as a model for other communities across the country. They understand how genetics, environment, social factors, and healthcare interact they can help predict who may be at greater risk – allowing for quicker diagnoses and the development of more precise treatment.
Business Model: unknown
Revenue: 0 - 100000
Employees:
Industry: Genetics
Exogen Biotechnology is a health startup aimed at developing cutting-edge technologies for individuals to monitor damage to their DNA and to assess their DNA repair capacities for the purposes of personalized and preventive health care. Damage to your DNA can result from normal metabolic processes as well as exposure to exogeneous agents, such as ultraviolet light, ionizing radiation, and some environmental and industrial chemicals. Your ability to repair your DNA upon damage is vital to the integrity of your genome and normal functioning. DNA damage and poor DNA repair has been linked to many diseased states including cancer, neurodegenerative disorders, immunological diseases, and premature aging. Exogen’s technological platform for assessing DNA damage and repair capacities was developed at the Lawrence Berkeley National Laboratory by a team of scientists and engineers. Exogen was founded in 2012 to translate this new technology to enable rapid processing of human blood specimens and to make testing services affordable and accessible to the public.
Business Model: unknown
Revenue: 4.4M
Employees: 64
Industry: Genetics
Alveole is a medical device company that develops tools to control the cell microenvironment for biologists.
Business Model: unknown
Revenue: 5M
Employees: 17
Industry: Genetics
Opsin Biotherapeutics develops a pipeline of opsin-based gene therapies for pain management.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
GeneAssess, Inc. is a New Jersey-based biotechnology company that is working to validate FRY, a cancer molecular signature gene discovered by GeneAssess scientists that could provide a more accurate diagnostic biomarker for cancer staging. The FRY gene appears to be found in the breast cancer model but also shows potential for other cancers. In research performed to date, mutations in the gene increase rat susceptibility to mammary cancer and FRY reduced the growth of highly aggressive human breast cancer cells in animal models. GeneAssess plans to validate FRY as a predictive biomarker for breast and other cancers, to detect genetic mutations in at-risk populations and to explore target validation for FRY. The company has an exclusive license to the intellectual property developed by Dr. Zarbl.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
Agrotis offers laboratory genetics and services for livestock, vet, and agrifood.
Business Model: unknown
Revenue: 0 - 100000
Employees:
Industry: Genetics
AB DNA Testing Services provides genealogy testing, carrier testing, presymptomatic testing, genetic testing, sibling relationship, biological relationship studies, twin studies, deceased paternity, forensic testing, and child identity testing services.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Genetics
LumiGenics is a contract research organization. They provide preclinical optical imaging and contract research. They offer research services.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
ValueGene is an oligonucleotide synthesis services firm that focuses on custom DNA synthesis services for biological research laboratories.
Business Model: unknown
Revenue: 7M
Employees: 10
Industry: Genetics
Business Model: unknown
Revenue: 0 - 100000
Employees: 1001 - 5000
Industry: Genetics
PsiGenex provides patient resources including reproductive testing, hereditary cancer testing, and billing information. Their promise is to support patients through every stage of life. If you want would contact them please contact them via phone call or email.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Genetics
Shenzhen Huada Ocean is a comprehensive development group that integrates aquatic product production, study, research and application. It mainly engages in the protection and utilization of aquatic organisms germplasm resources, molecular marker breeding of aquatic products, ecological breeding and industrial breeding, the promotion and application of new varieties and technologies, and water Product intensive processing, import and export trade, etc.
Business Model: unknown
Revenue: 0 - 100000
Employees: 501 - 1000
Industry: Genetics
JLG Enterprises provides semen collection and bull housing, semen storage, semen shipments, mobile semen testing, and semen collection services. If you want any information please contact them via phone call or email.
Business Model: unknown
Revenue: 10.3M
Employees: 73
Industry: Genetics
Tritech Research is a biotechnology company. It specializes in the research, development, manufacturing, marketing, and sales of equipment and supplies for molecular biology and genetic research. Tritech offers products to the international biomedical research community and has customers at top universities and research institutions on every continent including Antarctica. Among Tritech&s;s core technologies are gene transfer, temperature control, and fluorescence microscopy.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
Business Model: unknown
Revenue: 310k
Employees: 100
Industry: Genetics
LIDSEN Publishing is a publishing platform. They aim to select ground-breaking research based on novelty, timeliness, scientific significance, and potential audience interests. They maintain rigorous, thorough, and unbiased peer review, and quality control is built into every step of the editorial process as well as each internal and external editor&s;s responsibilities.
Business Model: unknown
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Genetics
EdgeBio provides DNA sequencing and bioinformatics products and services for biopharmaceutical, research, academic and government institutions.
Business Model: unknown
Revenue: 7M
Employees: 81
Industry: Genetics
Floragenex Inc. is a privately owned Oregon-based biotechnology company providing innovative solutions for genomic analysis in human, plant and animal systems. Since 2007, Floragenex has delivered impact results in hundreds of genomics studies focused on answering fundamental questions in genetics, ecology, evolutionary biology and biomedical research. Floragenex technologies permit investigation of genomes at unprecedented levels for academic, governmental and commercial researchers worldwide.
Business Model: unknown
Revenue: 2.9M
Employees: 33
Industry: Genetics
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
Aktogen offers behaviour and genetic services.
Business Model: unknown
Revenue: 0 - 100000
Employees:
Industry: Genetics
PEG has supplied dairy farms of various sizes with dairy-specific fodder. They combine dairy-specific seed genetics procurement with advice and support at the bunker, field, and barn to provide cumulative predictability and consistency, resulting in increased profitability for the dairy. They safeguard genetic variants that benefit and sustain the dairy industry in particular.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
CytoGenix, Inc. is a biopharmaceutical company that develops and markets innovative compounds and services based on its proprietary gene regulating and DNA production technologies. CytoGenix has products in pre-clinical development including an antimicrobial compound, DNA vaccines and anti-herpes and anti-inflammatory topical creams. The Company has developed a cell free process for synthesizing DNA which it uses for its own products as well as marketing specific compounds to other companies. CytoGenix, Inc. currently has 11 granted patents (1 US, 1 China, 9 Europe) covering our basic ssDNA expression technology, with one additional allowance (India) pending. We have an additional 11 applications pending in various countries which are currently progressing through the normal prosecution process. The Company actively collaborates with numerous academic centers of excellence, government agencies and biotechnology industry partners. Cytogenix, Inc. is publicly traded under the symbol CYGX on the NASDAQ Over the Counter Bulletin Board.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
Syntheseas, Inc. is a biotech company researching gene discovery for producing marine aquaculture crops with greater yields, better nutrition, and resistance to disease for future food security. The leadership at Catalina Sea Ranch, LLC, formed Syntheseas, Inc. to conduct research for genetic innovations that improve marine animal welfare and better productivity traits for marine aquaculture. This research promises to result in sustainably produced, responsibly grown, and healthier marine crops to increase our global food supply and provide for the future population, while protecting our oceans.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
Business Model: unknown
Revenue: 0 - 100000
Employees:
Industry: Genetics
Optimal Behavioral Health provides genetic testing, assessment, past developmental, diagnostic clarification, functional impairments, psychoeducation, alternative treatments, non-medication treatments, healthy coping skills, preventative interventions, safe medication management, therapy, cognitive behavioral therapy, dialectical behavioral therapy, motivational interviewing, psychoeducation, focused-family treatment, interpersonal and social rhythm therapy, anger management, collaborative problem solving, and parent training services.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Genetics
DrGene has developed a prototype of genetic panels, genetic analysis software, and genetic findings presentation. They offer genetic testing services to help with disease identification through DNA screening. The company&s;s genetic testing services are provided using DNA test kits that track and save genetic information while also monitoring the abnormal growth of disease-carrying cells in human bodies, allowing users to detect and reduce cancer and hereditary disease risks.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Genetics
genXone co-creates science and medicine, help businesses grow and improve the quality of life. GenXone&s;s mission is to popularise genetics in everyday life. They believe that with this approach, they can truly change the world. They are convinced that molecular genetics is the key to transforming their lives and businesses. They develop and make available innovative solutions that improve, simplify and save lives. They also teach how to use them, and they open up new possibilities for business with their tools and expertise. They believe in a future where they are all conscious of genetics and evolution as intrinsic parts of their development. At genXone, they apply nanopore sequencing technology (fourth-generation of NGS) to many areas of science and business, including genetic diagnostics and the food industry. They are the first in Poland commercial certified partner of Oxford Nanopore Technologies (ONT), the world leader in biotechnology innovation (www.nanoporetech.com). They specialise in developing new products and solutions based on the latest technologies of nucleic acid sequencing. Their team includes specialists in the field of microbiome research, polygenic diseases, RNA, genomics, metagenomics, bacteriophage transcriptomics, nutrigenomics, genetics of metabolic diseases, molecular ecology and genetic engineering.
Business Model: unknown
Revenue: 0 - 100000
Employees:
Industry: Genetics
Business Model: unknown
Revenue: 0 - 100000
Employees:
Industry: Genetics
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
FIT Biotech develops and licenses Gene Transport Unit vector technology solutions for DNA vaccines and gene therapies.
Business Model: unknown
Revenue: 8.5M
Employees: 90
Industry: Genetics
Spectral Genomics, a pioneer in technology for the genome with headquarters in Houston, TX, is a global supplier of innovative products for human genetics and performs Genomic Profiling(SM) services for customers in academic and industrial research laboratories.
Business Model: unknown
Revenue: 0 - 100000
Employees:
Industry: Genetics
ADNid is a biotechnology research company providing genetic information. It offers DNA analyses for manufacturers to strengthen food quality control and confidence in commercial transactions. It provides the detection of unfair practices and traceability of product vulnerability sheets.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
Genetics Society is a membership organization for scientific researchers and educators in the field of genetics.
Business Model: unknown
Revenue: 7.6M
Employees: 82
Industry: Genetics
EquiTech Therapeutics, LLC&s;s mission is serving as a pioneer in the forward development of CRISPR-Cas9 genome editing for equine diseases and is focused on rapidly moving such transformative therapies towards clinical trials. EquiTech Therapeutics is building a team of world-class researchers and drug developers to work to translate CRISPR/Cas9 technology into breakthrough equine therapeutics. Our lead program targets equine herpes and Coggins diseases. Our company’s unique strengths include the expertise of our team in discovering, manipulating and developing genome editing products using a proprietary versatile lipid nanoparticle delivery system. EquiTech&s;s focus is on both in vivo and ex vivo product development which can help control or even eradicate diseases in our livestock. Such discoveries are eminent in research as they can be extrapolated later for human studies to find cures.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Genetics
Gknowmix is knowledge management company underpinned by genetic research translated into clinically useful applications. The service offering is governed by a Board of Directors, general manager of the database tool and a group of Scientific and Medical Advisors. In addition, based on their experience in the field, a multi-disciplinary consultancy team has been appointed to educate healthcare practitioners and the public in the application of genetic testing in clinical practice. The Genetic Care Centre provides support to a network of healthcare practitioners who incorporated Pathology-Supported Genetic Testing in clinical practice.
Business Model: unknown
Revenue: 0 - 100000
Employees:
Industry: Genetics
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
Business Model: unknown
Revenue: 0 - 100000
Employees:
Industry: Genetics
g&a;life provides provide products and services both for b2b and b2c clients. They provide genetics and epigenetics, to deliver cutting-edge solutions for everyday life and well-being. Their customers contact them through address, phone, mail, and online applications.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
OPTIGEN is a diagnostic laboratory that provides DNA-based testing services for genetic diseases in purebred dogs.
Business Model: unknown
Revenue: 8M
Employees: 15
Industry: Genetics
Celtek Bioscience specializes in the development and research of cell-based technologies and products that lead to the creation of novel therapeutic drugs and preventative medicines. The company develops novel agents that facilitate the delivery of target compositions intracellularly.
Business Model: unknown
Revenue: 28.7M
Employees: 98
Industry: Genetics
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
Paradise Seeds is a biotechnology research company. They provide paradise classics, cannabis seeds collection, compound genetics, and CBD cannabis seeds.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Genetics
SeqCentral, LLC, aims to provide and harness the high-performance computational power of the cloud as a usable, collaborative, online service to all members of the computational genomics community. We believe that your data is your data and that the abundance of digital genetic information from next-generation sequencing machines requires next-generation computational infrastructure, interfaces, insight, and innovation. With access to the cloud through SeqCentral, LLC, you as a researcher can easily collaborate and continue your own research without having to be concerned with the computational complexities involved in creating the highly-scalable, highly-reliable, highly-distributed software necessary for large-scale genetic sequence search. We want you to focus on your own science and not computer science.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
Arklatex Fertility provides IVF and surgical infertility care services. They also provide infertility testing, fertility treatment, fertility testing, fertility blood test, genetic testing, ovarian reserve testing, semen analysis, sonohysterogram, ultrasound testing, and hysteroscopy services. Their customers contact through address, phone, mail, and online applications.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
Business Model: unknown
Revenue: 0 - 100000
Employees:
Industry: Genetics
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Genetics
ElementZero Biolabs is the next generation of technology for genetic research. Their team has a blend of biological insight and business drive with years of solutions for life sciences and business management.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
Lab P53 is the first Cancer Genomics Company in India to build a sophisticated model to bridge current trends in genomic sciences with Oncologists. Lab P53’s Personalized Cancer Therapy(PCT) will help Oncologists in selecting the best suitable treatment available for every patient, by analyzing the genomics of tumor.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Genetics
Evinome, LLC catalyzes evidence-based genomic healthcare by offering key information and tools supporting shared decision-making to individuals with genetic risk for significant disease and community healthcare providers.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
DNAeX enable sporting professionals to provide ground breaking technology to their athletes.
Business Model: unknown
Revenue: 4.4M
Employees: 27
Industry: Genetics
Henan Alcon Technology is an active promoter of the practical application of eugenic genetic testing that provides integrated solutions for birth defect intervention. The company is a government&s;s key support enterprise, the authoritative operating organization of newborn screening, prenatal screening, and tandem mass spectrometry projects.
Business Model: unknown
Revenue: 0 - 100000
Employees:
Industry: Genetics
Digital model of a cancer patient to predict therapy effect and clinical trial outcome using AI &a; deep learning
Business Model: unknown
Revenue: 0 - 100000
Employees:
Industry: Genetics
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
HumanCellDesign provides truly translational human cell models for R&a;D, Human Cell Design combines the potential of human iPSC technology or human primary cells with a patented maturation platform. Our NatLine Platform® amplifies and maturates hiPSC-derived and primary progenitor cells to provide unlimited quantities of truly mature and functional human cells. The produced terminally differentiated cells replicate native adult human cells. NatLine® platform is adapted to large-scale and reproducible production of healthy or diseased human cell models.
Business Model: unknown
Revenue: 0 - 100000
Employees:
Industry: Genetics
CancerGuide Diagnostics, Inc. operates as a molecular diagnostics company. The company engages in the development and commercialization of genomic based clinical and pharmaceutical cancer tests and services. The company was formerly known as Oncogenomics, Inc. CancerGuide Diagnostics, Inc. was founded in 2006 and is based in Durham, North Carolina.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
Ancestris Association allows all genealogists, from beginners to experts, to build their genealogy in complete freedom. They can manage an unlimited number of individuals, families, and other documents for as many genealogies. They are free to store, read, manipulate, and publish the genealogy without depending on any software.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
GeneticMe Inc. has evolved into a a diverse bioinformatics organization that mainly operates two decentralized platforms (GeneticMe/GenomicMe) for personalized data. Our GeneticMe™ blockchain is a decentralized platform enabling secure, fast &a; transparent exchange and usage of personalized data based on your genetics, environments, lifestyle &a; therapies. Our GenomicMe™ blockchain is a decentralized platform for distributing data from the genomic biomarkers of chronic diseases in recently diagnosed patients on pathway to precision medicine. Participatory medicine is a vital factor in discovery &a; self-managing of your health potential. Since all of the interactions are based on your genetics, GeneticMe Inc offers some packaged genetic testing services to get you going. We will be launching an private PreICO and public ICO later this year in 2018
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
Cygenex offer management solutions for groups, including third-party administrators, brokers, and insurance payors, with data analytics. They provide non-clinical genetics tests that can help people lose weight, improve athletic performance, and support healthy ageing and optimal nutrition, all based on biology. They also provide clinical settings, such as private and group practices, hospital systems, home health care, nursing homes, and Medicare.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Genetics
GGC DNA is an India-based research laboratory that offers DNA testing for breeding in pet animals including dogs, goats, and donkeys.
Business Model: unknown
Revenue: 5M
Employees: 15
Industry: Genetics
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
Geshem Genomics makes plant genomic data accessible for plant breeders. This provides breeders with the insights necessary to speed up the plant breeding process and create improved plants.They scan worldwide seed collections to easily find plants with desired characteristics and genetic compatibility. They use advanced genomic selection algorithms to identify traits at seedling stage, and save breeders time and money on the development of new crops.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
Seqpipe is a software consulting firm that assists life scientists dealing with large amounts of next-generation sequencing data. Founded in 2017 and is based in Sofia, Sofia.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
InspireBio Consulting provides research-based solutions and expertise to companies from the biotechnology industry. It is based in Idaho, USA.
Business Model: unknown
Revenue: 0 - 100000
Employees:
Industry: Genetics
Hireomics, Inc. is an American company that operates an online marketplace for scientific services, primarily genetics, biochemistry, and omics. Based in Dallas, Texas, the platform allows entrepreneurs to hire researchers for assignments or Omics, online.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
BGI JAPAN is a genetic analysis company that offers a prenatal diagnosis to examine fetal chromosomal abnormalities in pregnant women&s;s blood.
Business Model: unknown
Revenue: 0 - 100000
Employees:
Industry: Genetics
Ion Flux is a clinical informatics company, founded in Los Angeles in September 2010. Demand for person genome is quickly gaining steam with medical practitioners as the insights gained from the Human Genome Project are developed into medical diagnostic tests. While the technology for producing DNA sequence data has become more robust and affordable, a bottleneck has remained for transforming these data into meaningful information for the patient. Ion Flux solves this problem by providing fast, cost-effective, robust analytical services for DNA sequence data. Our core R&a;D team has deep expertise in genomics, mathematics, computer science, and software engineering.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
AION SCIENTIFIC is a Singapore based company, as a service distributor of equipment, glassware, consumables and research chemicals for local and region research laboratories. AION SCIENTIFIC represents industry leading manufacturers in providing equipment and techniques to speed up your research. AION SCIENTIFIC dedicates ourselves exclusively to supporting our customers in the fields of Chemistry, Materials, Life Science, Pharmaceuticals and Food and Agriculture. AION SCIENTIFIC has built the long term cooperation with many famous producers in Mainland China and other countries; AION SCIENTIFIC can provide a lot of customized work in glassware-making industry, ultrasonic cleaner producing and other fields.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
GenomSoft is a Swiss company located at the Campus Biotech EPFL Innovation Park in Geneva, a state-of-the-art hub hosting companies and institutions working on biotechnology and life science projects. Our team is composed of engineers and entrepreneurs with an extensive experience in research, development, and project management of high-end domains and industrial segments, such as digital signal processing, telecommunications, information security and avionics. We are developing a new set of software tools, derived from the digital-media industry, in order to provide every organization working with genomic data with enterprise-grade technologies and devices able to store, transport and process genomic information in compliance with MPEG-G, the new ISO standard for genomic information representation.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
Business Model: unknown
Revenue: 2.6M
Employees: 36
Industry: Genetics
Adamâs Genetics provides DNA-based diet and fitness testing services.
Business Model: unknown
Revenue: 6.4M
Employees: 37
Industry: Genetics
Advanced Genetic Solutions company provides healthcare management services. They offer molecular diagnostics and specialty laboratory services. They provide hereditary cancer screening, pharmacogenomics, respiratory pathogen panel test, and noninvasive prenatal screening services.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Genetics
GenoMed is a Next Generation Disease Managementtm company that uses medical genomics to improve patient outcomes. GenoMed is working to translate knowledge of medical genomics (the study of which genes cause disease) into clinical practice: developing better drugs, using existing drugs for new indications, and identifying diseases before symptoms arise. By studying disease genes, we hope to make medicine less invasive and more proactive.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
NeoCodex is providing a deeper understanding of the genetic roots of disease. Applying NeoCodex&s;s breakthrough whole genome association study (WGAS) technology, genomic services and biomaterials, researchers are gaining a clearer path to creating tomorrow&s;s medicines through uncovering a greater understanding of human genetics and genetic variability.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Genetics
Big Horn Basin Children’s Clinic provides newborn care, pediatric care, telemedicine, genetic testing, allergy testing, sports physicals, and immunizations services. Their customers contact through address, phone, mail, and online applications.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
CellMade is a biotechnology firm that provides inflammation drug and biomarker discovery services.
Business Model: unknown
Revenue: 4.5M
Employees: 15
Industry: Genetics
Bovigen LLC, a genomics company, engages in the development, validation, and commercialization of genetic tools that enable producers to impact the economics of the beef industry. It offers DNA diagnostic test products, such as Feed Efficiency, a test to identify difference in feed cost in animals; Tenderness, a multi-marker single trait test for identifying animals that produce tender cuts of beef; and Quality Grade, a DNA genetic marker panel test that identifies the presence of genes associated with quality grade and marbling. The company also provides SureTRAK, an innovative genetic testing system for traceability of animals and meat; SireTRACE, which is used to identify animals through DNA fingerprinting; BLACK test, a coat color test that is primarily used to identify black coat genes in black animals; and Elite Tender that enables restaurants, retailers, and food service distributors to check for tender beef in buying and serving. It distributes its products through various companies and individuals in the United States, as well as in Canada, Central America, and South America. The company was founded in 2003 and is based in Harahan, Louisiana. As of March 27, 2008, Bovigen LLC operates as a subsidiary of Pfizer Animal Health.
Business Model: unknown
Revenue: 5.8M
Employees: 26
Industry: Genetics
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Genetics
DNage is a life sciences company founded in 2004 as a spin off from the Department of Genetics of the Erasmus Medical Center Rotterdam. The Company was seed-funded through an equity investment of an international syndicate of venture capitalists including LSP (NL) and Inventages (CH).
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
The Genetics Policy Institute (GPI) is a leading promoter and defender of stem cell research and other cutting-edge medical research targeting cures. We are the catalyst and provide leadership to the Pro-Cures Movement, an influential global network of stakeholders&s; from patient-advocacy, science and industry. GPI seeks to catalyze and help lead a global network of influential stakeholder groups representing patient advocates, scientists, physicians and health care professionals, industrialists, bioethicists, lawyers, educators, and policy-makers. GPI pursues this mission through co-sponsorship and management of its flagship annual World Stem Cell Summit, publication of the World Stem Cell Report, special projects, speaking engagements, teaching initiatives, and strategic collaborations. Upon this base of activities and relationships, GPI serves as a communications channel, helping to build the knowledge base needed for ethical and thoughtful policy-making in support of scientifically and medically worthy research and clinical translation in the broad field of stem cells and the even broader field of developmental biology.
Business Model: unknown
Revenue: 2.6M
Employees: 79
Industry: Genetics
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Genetics
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
The only UK source for all the bulls from the main studs in the USA (CRI) and Germany (GGI). We have 30 of the top 100 PLI bulls in the UK which is more than any other semen supplier. Because Bullsemen.com receives the proven product from over 1,400 tested bulls per year, we continue to sell more top PLI profit bulls than any other UK retailer. At a time when stock values are at an all time high, it pays more than ever to buy the highest ranking bulls. Working in partnership with British Dairy Farmers we endeavour to ensure your peace of mind with regards to pricing - any orders placed will benefit from our price promise to you. The price per straw is secured on the day of order and delivery may be reserved up to six months in advance. Should the market price increase before delivery, you still pay the price when ordered. Should the price decrease by the delivery date you only pay the new lower price. We also operate a Loyalty Scheme - allowing us to reward customers throughout the year with the best level of pricing available.
Business Model: unknown
Revenue: 45.1M
Employees: 502
Industry: Genetics
DNA sequencing is driving the new genomic revolution but it’s currently bottlenecked with high compute costs and inaccuracies. Genome Surveillance is revolutionizing DNA sequencing to make it ten times faster and more accurate through reducing the heavy computational load and dropping it to a fraction of the cost of current technologies.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Genetics
Lakeview Integrative Medicine provides thermography testing, parkinson’s disease, personalized nutrition therapies, genomic testing, genetic analysis, intravenous nutrition, zyto scanning, and mold illness services. They treat fatigue, depression, poor digestion, constipation, blood pressure, and poor impulse control.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Genetics
LifeSct is a high-tech biotechnology company. It is an innovative technique and combinative use of molecular biology and cell biology, their research subjects cover many areas, that includes in vitro diagnosis, molecular markers, medical research, food safety, drug development, and environment protection. It is focused on genomic and proteomic technologies. It offers products like cell transfection, reverse transcription, cell apoptosis, nucleic acid detection, plasmid purification kits, and more.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Genetics
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Genetics
Business Model: unknown
Revenue: 10M
Employees: 10
Industry: Genetics
FDA cleared device for early detection of Barrett’s Esophagus and other Upper GI diseases such as cancer and H-pylori. Opportunity to launch the FDA 510k clearedNon-endoscopic swallowable screening device for esophageal bottle-brush cellular retrieval for use with new Genome Sequencing diagnostic tests (Biomarkers) that are expected to become mass "out-patient" screening tests used for the early detection of Barrett’s Esophagus and other diseases.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
Berry Genomics is a provider of medical device manufacturing, clinical testing, genomic database integration and genetic counseling services.
Business Model: unknown
Revenue: 0 - 100000
Employees:
Industry: Genetics
Fit DNA RX offer a platform based on genetic predisposition to help achieve weight loss, healthy cholesterol levels, blood pressure control, and an improvement in blood glucose levels. They offer DNA-based fitness and nutrition testing. Their portal services include a customised genetic health content library, articles, videos, and recipes designed for genetic profiles, and recommendations for weight loss, nutrition, exercise, and longevity.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Genetics
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
Choose Health Wellness Center is a medicine practice center. Their services include health with bio-identical hormone replacement, food sensitivity testing, adrenal stress fatigue, thyroid, detoxification, heavy metal removal, vitamin and mineral replenishment, cardiometabolic panels, anxiety, depression, weight gain, low libido, headaches, hair loss, and chronic disease.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Genetics
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Genetics
Business Model: unknown
Revenue: 11.2M
Employees: 99
Industry: Genetics
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Genetics
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Genetics
Genetic and Environmental Toxicology Association of Northern California offers research services. Their services include genetics, toxicology, environmental health, pharmaceuticals, pharmacology, biology, carcinogens, reproductive, developmental, research and development, risk assessment, hazard identification, epidemiology, science, statistics, new approach methodologies, health, chemistry, genotoxicity, food safety, machine learning, and biomedical science.
Business Model: unknown
Revenue: 0 - 100000
Employees: 51 - 200
Industry: Genetics
G &a; G is a biotech company and that develops enzymes isolated from microbes for laboratory &a; agricultural use. The company is involved in the development of hyper-thermostable enzymes to address environmental and health issues. It can be used in the bioremediation of organophosphorus chemicals for the degradation of insecticides and chemical warfare nerve agents. They also offer an alternative to antibiotics with bacterial anti-virulence agents.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
ChromoCare provides genetic insights and diagnostic tools for physicians that improve patient treatment.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Genetics
Kidney Care Specialists provides genetic testing, dialysis management, and transplant management services. They treat acute kidney failure, chronic kidney disease, end-stage renal disease, electrolyte disorders, uncontrolled hypertension, blood or protein in the urine, glomerular or interstitial disease, formation of kidney stones, pre-op surgery clearance, peritoneal dialysis, polycystic kidney disease, glomerular and vascular disorders, tubular and interstitial disorders.
Business Model: unknown
Revenue: 23.3M
Employees: 176
Industry: Genetics
GeeNomics.ai is a cloud-based genetic analysis platform that helps scientists make use of genetic data. We provide gene annotation services, genetic mapping services, and protein mapping services to the scientific community.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
Business Model: unknown
Revenue: 1.4M
Employees: 72
Industry: Genetics
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Genetics
Business Model: unknown
Revenue: 19.6M
Employees: 51
Industry: Genetics
Genosyn is a biotechnology company that develops techniques to understand the genetic code of an organism.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
Reproductive Genetics Institute provides genetic counseling, pre-implantation genetic screening, products of conception testing, embryology, next generation sequencing, pre-implantation genetic diagnosis, pre-implantation genetic testing, andrology, single gene, and genetic testing. they offer family balancing, human leukocyte antigen matching, reproductive genetic innovations, reproductive genetic institute, testing, genetic testing, biopsy training, embryo biopsy, cryopreservation, trophectoderm biopsy, polar biopsy, and embryo selection.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Genetics
GeneTalk guides to the latest scientific publications related to variants of interest. They assist clients in filtering their data for rare genetic variants by providing a powerful filter that is adaptable for different inheritance models and frequency cutoffs. They added service for computing polygenic risk scores.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
MyGeneTeam connects genetic counselors with healthcare providers, organizations, and patients. Genetic tests are being ordered more frequently by healthcare providers with limited training in medical genetics and current technologies.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Genetics
Business Model: unknown
Revenue: 601.7k
Employees: 6
Industry: Genetics
Business Model: unknown
Revenue: 0 - 100000
Employees:
Industry: Genetics
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
DNA Worx is a Genetic testing company. Use your genetics to optimize your nutrition and performance DNA Worx introduce you to invaluable lifestyle modifications.
Business Model: unknown
Revenue: 0 - 100000
Employees:
Industry: Genetics
AborGen Holdings is a producer of tree seedling products and provider of a technology-enhanced genetics for the forest industry. The company&s;s technology aims to improve the productivity of forestry land by enabling customers to grow trees that yield more wood, demonstrate greater consistency, uniformity, and quality, grow in a shorter period of time; and are resilient and disease resistant. It develops and expands ArborGen’s pipeline of industry-leading advanced genetics, including building a future supply of its high-value premium MCP products in the US and transitioning customers from open-pollinated (OP) genetics to advanced MCP and varietal genetics. It was headquartered in Auckland, Auckland, New Zealand in 2001.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1001 - 5000
Industry: Genetics
Inovio AS, an Oslo, Norway-based gene delivery technology company.
Business Model: unknown
Revenue: 16.4M
Employees: 53
Industry: Genetics
Business Model: unknown
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Genetics
Business Model: unknown
Revenue: 0 - 100000
Employees: 10001 - 1
Industry: Genetics
amYmed provide high precision immunhistochemical classification of the diverse amyloid diseases with respect to specific and causal treatment as a service for patients and physicians. amYmed are in the process of extending this service by producing and offering test kits in order to enable clinics and institutes of pathology to perform this classification by themselves.
Business Model: unknown
Revenue: 0 - 100000
Employees:
Industry: Genetics
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
Business Model: unknown
Revenue: 0 - 100000
Employees:
Industry: Genetics
Lighthouse Genomics is a product genomic analysis company. They provide premium analytics for Cannabis and other botanical species, with a focus on crop performance improvement and natural product authentication.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
LabOmics , skip molecular engineering and speed-up to gene expression and regulation analysis: mirna amongst our 1500 precursors expression clones readied for both lentiviral transduction tricky and conventional transfection. Alternately select your target genes amongst the 54000 validation microRNA target 3’ UTR sequences and focus on measuring expression inhibition in cells.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
Business Model: unknown
Revenue: 0 - 100000
Employees:
Industry: Genetics
Conejo Women’s Medical Center provides acute illness treatment, bioidentical hormone therapy, cancer screening, cholesterol management, da vinci robotic surgery, family planning, genetic testing, obstetrics, pelvic relaxation treatment, thyroid disorder treatment, skincare, urogynecology, vulvovaginal atrophy treatment, birth control, osteoporosis, gynecology, dyspareunia, and vaginal dryness.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Genetics
Business Model: unknown
Revenue: 3.9M
Employees: 39
Industry: Genetics
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Genetics
Lintecum and Nickell, PC provides treatments for menstrual disorders including heavy bleeding, PMS, endometriosis, and polycystic ovarian syndrome. They also provide pelvic floor exercises, endometrial biopsy, and colposcopy. Their customers contact through address, phone, mail, and online applications.
Business Model: unknown
Revenue: 6.3M
Employees: 32
Industry: Genetics
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
Scripps Research is a California-based nonprofit medical research facility that focuses on research and education in the biomedical sciences.
Business Model: unknown
Revenue: 14M
Employees: 3k
Industry: Genetics
Genetics and genomics research has grown at a bewildering pace in the past 15 years. The techniques of these fields are being applied to a wealth of biological questions and experimental systems. PLOS Genetics reflects the full breadth and interdisciplinary nature of this research by publishing outstanding original contributions in all areas of biology. PLOS Genetics publishes human studies, as well as research on model organisms—from mice and flies, to plants and bacteria. Their emphasis is on studies of broad interest that provide significant insight into a biological process or processes. Topics include (but are not limited to) gene discovery and function, population genetics, genome projects, comparative and functional genomics, medical genetics, disease biology, evolution, gene expression, complex traits, chromosome biology, and epigenetics.
Business Model: unknown
Revenue: 0 - 100000
Employees: 51 - 200
Industry: Genetics
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
GenoKey Aps is a Denmark-based biotechnology company that develops data analytics and problem-solving solutions for the healthcare sector.
Business Model: unknown
Revenue: 0 - 100000
Employees:
Industry: Genetics
DNA Consultants provide DNA fingerprint tests.
Business Model: unknown
Revenue: 1.2M
Employees: 112
Industry: Genetics
Business Model: unknown
Revenue: 35.3M
Employees: 205
Industry: Genetics
Core23 BioBank preserving baby&s;s umbilical cord blood and stem cells. They freeze extra stem cells in liquid nitrogen at temperatures around -320 degrees Fahrenheit by storing (cryopreserving) a child’s umbilical cord blood stem cells.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Genetics
Cygene Laboratories Inc., a biotechnology company, develops and commercializes genetic and diagnostic testing, as well as therapies for infectious, genetic, and autoimmune diseases. The company develops proprietary DNA and RNA testing systems for screening, monitoring, and diagnosis of human, veterinary, and plant diseases. The company’s products include Strategic Target Elimination system (STE), an antibody-based technology to clear microbiological, viral, and chemical agents from blood. STE could also act as a pseudo-vaccine, conferring protection to an individual for approximately 60 days.
Business Model: unknown
Revenue: 569.4k
Employees: 4
Industry: Genetics
Epivios GmbH, a Düsseldorf, Germany-based developer of molecular diagnostic cancer tests. Led by Nicole Groth and Dr Simeon Santourlidis, Epivios was founded in 2011 as a spin-off of the Heinrich Heine University of Düsseldorf. Its interdisciplinary team, comprising doctors and biologists, has been working since 2009 on innovative epigenetic procedures for cancer diagnosis. The company’s epigenetic platform technology includes a new kind of standardization tool that allows the comparison of samples with differing genetic constitution for the first time. Epivios´s new procedure also analyzes sequences, which spread across the entire genome.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
GENE IDENTITY provides an up-to-date survey/game for businesses and direct consumers. Our survey/game includes a saliva DNA kit and access to our interactive trait game. We extract and genotype specific genes connected to your game. Services available for businesses, and direct consumers.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
Our goal is to develop a system which allows us to control bacterial gene expression with a remote controller. Our device could be used in bioreactors, making prototyping and multi-phase production chains faster, easier and more profitable. We’re making a proof-of-concept controller prototype for research teams, but it can be further scaled up for industrial purposes, such as medical chemical industry. Currently we are working both inside and outside of the lab. Our research plan is complete and our research has started. You can follow our work via Twitter and our blog.
Business Model: unknown
Revenue: 0 - 100000
Employees:
Industry: Genetics
Genomic Express is a science-driven, consumer-facing personalized genomics company. Genomic Express discovers, develops validates and provides genetic tests and other genomic services both directly to consumers (DTC) and through referring physicians/healthcare providers.
Business Model: unknown
Revenue: 1.3M
Employees: 26
Industry: Genetics
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
Business Model: unknown
Revenue: 0 - 100000
Employees:
Industry: Genetics
AC-Gen Reading Life is a Biotech company incorporating the latest technology for DNA reading enabling Next-generation Sequencing for medical use. AC-Gen Reading Life in a Biotech company focus on the biomedical sector. They offer Health specialists solutions for prevention, diagnosis and treatment of hereditary diseases. Their goal is to improve the health and quality of life of those individuals affected and their families. AC-Gen Reading Life uses Next-generation sequencing technology (NGS) based on semiconductor chips for the detection of mutations associated to recurrent appearance of a disease in members of the same family. AC-Gen Reading Life brings genomic analyses toward clinical utility providing accurate information about the mutations detected. Their report reflects the probability of occurrence of the disease as well as prevention and treatment measures to promote the best clinical decisions based on available scientific knowledge.
Business Model: unknown
Revenue: 1.7M
Employees: 33
Industry: Genetics
Dx assays pte ltd was established in 2008 and is the first commercial developer of molecular diagnostic assays in Singapore. We specialize in Nucleic Acid-based Test (NAT) Development and offer highly customizable services with no restriction to any particular chemistry or instrumentation platform. Our client requirements in areas such as infectious diseases, oncology, genetic testing and companion diagnostics becomes the in-put for our team of scientists to customize our service package to fulfil all your business needs.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Genetics
Business Model: unknown
Revenue: 0 - 100000
Employees:
Industry: Genetics
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
Business Model: unknown
Revenue: 0 - 100000
Employees:
Industry: Genetics
Galileo genomics is a Montreal-based private genetics company that conducts research in Quebecers of French descent using cutting-edge technologies, to identify genes that cause disease, thus providing validated targets for creation of innovative and more effective therapies and diagnostics. The Quebec founder population is the largest such population worldwide, which facilitates rapid patient recruiting. Because of the relatively late founding of the population in the 17th century, the relatively small number of founders, rapid early population growth, minimal intermarriage with other groups, and loss of some family lines while others expanded dramatically, the population is among the most homogeneous and has among the highest genetic sharing of all major founder populations.
Business Model: unknown
Revenue: 0 - 100000
Employees: 51 - 200
Industry: Genetics
Intuitive Genomics helps customers to quickly uncover the vital insights and actionable information they need from their massive genome-scale datasets. Our solutions include the full range of bioinformatics capabilities and expertise to ensure your research is a success.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
Breast Care Specialists is a treatment for breast cancer and non-cancerous breast diseases. They provide breast cancer treatment, including mastectomy, lumpectomy, sentinel lymph node biopsy, and axillary lymph node dissection. They also offer breast cancer genetic testing and counseling.
Business Model: unknown
Revenue: 15.8M
Employees: 25
Industry: Genetics
Delvin Formulations offers API, formulation, medical devices, and wellness products. They dedicated in developing top of the line pharmaceutical products while adhering to highest quality norms by well qualified and renowned research team.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1001 - 5000
Industry: Genetics
The Location Genome Platform is a uniform solution combing Content, Context and Collaboration on top of locations. It offers a set of APIs to access rich content, deep understanding and real time collaborative information sharing about locations. It allows mobile web developers to build a context aware, content rich and personally relevant experience in their location based mobile applications. The APIs are currently in private Beta. Potential users should contact the developer to get more information and get access to the APIs.
Business Model: unknown
Revenue: 0 - 100000
Employees:
Industry: Genetics
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Genetics
Enobia develops therapies to treat serious genetic bone disorders for which there are no approved treatments.
Business Model: unknown
Revenue: 10M
Employees: 10
Industry: Genetics
Computable Genomix was formed by university researchers who pioneered a unique approach (patent pending) to mining MEDLINE abstracts. Their advance in text mining technology enables Computable Genomix to very quickly and efficiently identify existing and novel gene relationships related to complex biological research questions. Today, Computable Genomix is focused on using its technology to develop high value genetic assays for clinical research and biomarker development.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
A medical research laboratory with forensic and drug testing services, DNA Legal provides drug, alcohol, paternity, and paternity testing. The company focuses on ensuring industry sensitivity and accuracy to offer a detailed and wide-ranging selection of testing services. The company offers fast results through accredited testing and is also UK court approved.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Genetics
Precision Medical Technology focuses on the collection and analysis of Chinese genetic big data. Its business is based on the interpretation of genetic data in precision medicine, and provides a one-stop service for personalized diagnosis and treatment based on this; it is a cooperative enterprise of the Cancer Targeted Drug Therapy Professional Committee of the China Anti-Cancer Association, a corporate member of the Genetic Counseling Branch of the China Genetic Association, and Nankai University. Industry-university-research cooperation base and talent training cooperation development base. The growth of the company has been highly recognized by the Tianjin Municipal Government, and has been selected into the municipal entrepreneurship encouragement plan, won the high-level innovation and entrepreneurship team award of the Tianjin Science and Technology Commission Special Talent Support Plan, and the Tianjin Innovation Talent Key Field Innovation Team Promotion Plan. The company&s;s team spans clinical medicine, genetics, bioengineering, bioinformatics, computer science, etc., 30% of which have doctoral degrees, and members are selected as the top ten outstanding scientific and technological talents in Binhai New Area, "131" innovative talent training project, etc.
Business Model: unknown
Revenue: 0 - 100000
Employees:
Industry: Genetics
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Genetics
Diagnotec S.A. provides genetic and aquaculture services in Chile. Its services include identification of genetic ploidÃa sex in salmon; analysis of genetic variability, crossing design, and evaluation; and development of integral genetic handling programs, as well as screening; routine and PVA; and biological evaluation services. The company was founded in 1997 and is based in Santiago, Chile. As of August 29, 2008, Laboratorio Diagnostico GAM operates as a subsidiary of Laboratorios Andromaco S.A.
Business Model: unknown
Revenue: 0 - 100000
Employees:
Industry: Genetics
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
Business Model: unknown
Revenue: 0 - 100000
Employees:
Industry: Genetics
SuperGanadero offers SmartFarmr, software for pig farms to increase its performance and productivity. It enables users to set alerts, view custom reports, perform the traceability of feed, or do a genetic analysis of animals.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
Genes and Us helps families understand how their genetics affect their health. Couples can connect their 23andMe accounts to understand what traits they&s;ll pass on to their children - their good genes and their bad genes, the traits that they&s;ll definitely pass on and the traits that they may or may not pass on.
Business Model: unknown
Revenue: 0 - 100000
Employees:
Industry: Genetics
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
Dor Yeshorim is a non-profit organization. They eliminate the agonizing occurrence of fatal and debilitating genetic diseases through their premarital genetic screening program. They provide a confidential pre-marital screening program, genetic research, genetic guidance, assistance to families with rare genetic diseases, education, advocacy, and central resources for genetic diseases.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Genetics
Business Model: unknown
Revenue: 0 - 100000
Employees: 51 - 200
Industry: Genetics
Ankh Genetics is developing exome sequencing analysis systems to provide patients, doctors, hospitals and more with the genetic data they need to make medical decisions.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Genetics
Business Model: unknown
Revenue: 0 - 100000
Employees:
Industry: Genetics